Primary Site >> Colorectal Cancer
Gene >> CEACAM3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Newer concepts of cancer of the colon and rectum: clinical evaluation of a radioimmunoassay for CEA. PMID: 5026787 Ref: A collaborative study of a test for carcinoembryonic antigen (CEA) in the sera of patients with carcinoma of the colon and rectum. A joint National Cancer Institute of Canada-American Cancer Society investigation. PMID: 5042884 |
Ref: Studies of carcinoembryonic antigen activity of whole and extracted serum in ulcerative colitis. PMID: 4354145 Ref: Proceedings: Comparison between collagenase activity in rectal biopsies and plasma carcinoembryonic antigen (CEA) levels in patients with carcinoma of the colon and rectum. PMID: 4357151 |
Ref: Isolation and partial characterization of macromolecular urinary aggregates containing carcinoembryonic antigen-like activity. PMID: 4136840 Ref: Combination of carcinoembryonic antigen and gamma glutamyl transpeptidase in the study of the evolution of colorectal cancer. PMID: 4155643 Ref: Carcinoembryonic antigen (CEA) in feces and plasma of normal subjects and patients with colorectal carcinoma. PMID: 4204181 Ref: Carcinoembryonic antigen (CEA). Use and limitations of the CEA radioimmunoassay in the diagnosis and follow-up of colo-rectal carcinoma. PMID: 4421371 Ref: CEA levels and prognosis in colon carcinoma. PMID: 4427460 Ref: Carcinoembryonic antigen and alpha 1-fetoprotein in ulcerative colitis and regional enteritis. PMID: 4825147 |
Ref: Carcinoembryonic antigen and alpha fetoprotein in malignant tumors of the female genital tract. PMID: 47262 Ref: Detection in colorectal carcinoma patients of antibody cytotoxic to established cell strains derived from carcinoma of the human colon and rectum. PMID: 51831 Ref: Demonstration of two molecular variants of carcinoembryonic antigen by concanavalin A sepharose affinity chromatography. PMID: 52402 Ref: Carcinoembryonic antigen: evidence for multiple antigenic determinants and isoantigens. PMID: 53843 Ref: The present status of DEA in diagnosis, prognosis, and evaluation of therapy. PMID: 764963 Ref: Variations in carcinoembryonic antigen localization in tumors of the colon. PMID: 1092873 Ref: Carcinoembryonic antigen (CEA) levels and tumor histology in colon cancer. PMID: 1094196 Ref: CEA as a monitor of gastrointestinal malignancy. PMID: 1111949 Ref: Alterations in glycosyltransferase activity in human colon cancer. PMID: 1113312 Ref: Diagnosis and prognosis in colon cancer based on a profile in immune reactivity. PMID: 1113318 Ref: Carcinoembryonic antigen and prognosis in patients with colon cancer. PMID: 1119871 Ref: Migration of peripheral leukocytes in the presence of carcinoembryonic antigen. Studies in patients with chronic inflammatory diseases of the intestine and carcinoma of the colon and pancreas (32568). PMID: 1121500 Ref: Carcinoembryonic antigen in rheumatic diseases. PMID: 1121634 Ref: CEA as an adjunct in the diagnosis and prognosis of colorectal carcinoma. PMID: 1135606 Ref: Radioiodinated antibody to carcinoembryonic antigen: binding to normal and cancerous human colon in vitro. PMID: 1159817 Ref: Carcinoembryonic antigen in patients suffering from ulcerative proctocolitis. PMID: 1168988 Ref: CEA levels at recurrence and metastases; importance for detecting secondary disease. PMID: 1202621 Ref: CEA levels in patients with colorectal polyps. PMID: 1203857 Ref: [Immunologic research on human colonic cancer]. PMID: 1212527 Ref: [Clinical use of carcinoembryonic antigen (CEA) determination]. PMID: 1212528 Ref: Arylsulfatse B in colorectal cancer. PMID: 1212650 Ref: Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer of the Dukes' C classification. Preliminary clinical results. PMID: 1212660 Ref: Prognostic significance of peripheral lymphocyte counts and association with CEA in colorectal cancer. PMID: 1216085 Ref: [Value and limits of the determination of carcinoembryonic antigen (CEA) in postoperative evaluation of patients with colonic and rectal carcinomas]. PMID: 1220002 Ref: The role of carcinoembryonic antigen (CEA) in colorectal cancer. PMID: 1220914 Ref: Detection of carcinoembryonic antigen in tissue sections by immunoperoxidase. PMID: 1237519 |
Ref: [The immunologic tumor diagnosis]. PMID: 65843 Ref: The demonstration of carcinoembryonic antigen in colorectal carcinoma and colonic polyps using an immunoperoxidase technique. PMID: 782689 Ref: Specific lysis of human colon tumor cells by antibodies to CEA and isoantigen A: dependence on rabbit serum or neuraminidase. PMID: 792333 Ref: Morphologic and immunologic studies of a human colon tumor cell line (SW-48). PMID: 793708 Ref: Carcinoembryonic antigen in histopathology: immunoperoxidase staining of conventional tissue sections. PMID: 794493 Ref: Demonstration and immunochemical characterization of carcinoembryonic antigen in human pancreatic juice. PMID: 825652 Ref: Use of a passive hemagglutination inhibition test for monitoring levels of serum carcinoembryonic antigen following surgical therapy. PMID: 943151 Ref: [Radioimmunoassay of CEA (carcinoembryonic antigen of Gold) in plasma of patients with colorectal carcinoma]. PMID: 951263 Ref: Restriction of CEA synthesis to the stationary phase of growth of cultured human colon carcinoma cells. PMID: 964319 Ref: Carcinoembryonic antigen (CEA) monitoring of radiation therapy for colorectal cancer. PMID: 970537 Ref: Carcinoembryonic antigen and glucose phosphate isomerase in a human colonic cancer model (GW-39). PMID: 973998 Ref: Immunochemical studies on carcinoembryonic antigen-reactive glycoproteins from carcinomas of the colon and breast separated by concanavalin A affinity chromatography. PMID: 975108 Ref: Plasma CEA, tumor CEA, and tumor histology. PMID: 994512 Ref: [The use of CEA radioimmunoassay for the detection of recurrence of carcinoma of the large bowel (author's transl)]. PMID: 994637 Ref: [Reaction of inhibition of macrophage electrophoretic mobility in differential diagnosis of carcinomas]. PMID: 1020256 Ref: Significance of CEA determinations in patients with cancer of the colon-rectum and the mammary gland in comparison to physiological states in connection with pregnancy. PMID: 1021185 Ref: Correlation between clinical course and CEA levels during chemotherapy. PMID: 1023892 Ref: Carcinoembryonic antigen (CEA). A prospective clinical trail in patients with gastrointestinal cancer. PMID: 1064149 Ref: An optical and ultrastructural study of the localization of carcinoembryonic antigen (CEA) in normal and cancerous human rectocolonic mucosa. PMID: 1246127 Ref: Carcinoembryonic antigen (CEA) as a prognostic and monitoring test in clinically complete resection of colorectal carcinoma. PMID: 1247300 Ref: Carcinoembryonic antigen: clinical and historical aspects. PMID: 1247968 Ref: Familial colon cancer. PMID: 1253119 Ref: Carcinoembryonic antigen in colorectal practice: report of three cases. PMID: 1253660 Ref: CEA levels in fluids bathing gastrointestinal tumors. PMID: 1254136 Ref: Carcinoembryonic antigen. Its role in the evaluation of intraocular malignant tumors. PMID: 1267924 Ref: A galactosidase immunosorbent test for carcinoembryonic antigen. PMID: 1277194 |
Ref: Affinity in radioimmunoassay of antibody cross-reactive with carcinoembryonic antigen (CEA) and colon carcinoma antigen-III (CCA-III). PMID: 63521 Ref: CEA monitoring of palliative treatment for colorectal carcinoma. PMID: 64132 Ref: Sequential antitumour immunoreactivity and carcinoembryonic antigen levels as a guide to prognosis in colorectal carcinoma. PMID: 273407 Ref: Chemoimmunotherapy of metastatic large bowel cancer: nonspecific stimulation with BCG and levamisole. PMID: 336190 Ref: A putatively new antigen (CSAp) associated with gastrointestinal and ovarian neoplasia. PMID: 407152 Ref: Lack of effectiveness of combined 5- fluorouracil and methyl-CCNU therapy in advanced colorectal cancer. PMID: 589555 Ref: Prognostic factors in colon carcinoma: correlation of serum carcinoembryonic antigen level and tumor histopathology. PMID: 611410 Ref: Prognostic use of preoperative and immediate postoperative carcinoembryonic antigen determinations in colonic cancer. PMID: 832207 Ref: CEA as an early indicator for second-look procedure in colorectal carcinoma. PMID: 847376 Ref: Carcinoembryonic antigen: 3 years' experience in a cancer clinic. PMID: 849560 Ref: Localization of GW-39 human tumors in hamsters by affinity-purified antibody to carcinoembryonic antigen. PMID: 851962 Ref: Antibody-dependent cell-mediated cytolysis of human colon carcinoma cells induced by specific antisera against carcinoembryonic antigen. PMID: 872092 Ref: K cell mediated lysis of cultured colon carcinoma and urinary bladder carcinoma cells induced by monospecific antisera against carcinoembryonic antigen (CEA) and two CEA-related normal glycoproteins. PMID: 873641 Ref: The quantitative relationship of carcinoembryonic antigen to tumor cells of different organs. PMID: 890660 Ref: Carcinoembryonic antigen in colonic lavage. PMID: 892376 Ref: [The CEA test and other immunological tests as disease course controls in gastrointestinal adenocarcinoma]. PMID: 929129 |
Ref: Circulating immune complexes in patients following clinically curative resection of colorectal cancer. PMID: 205963 Ref: Isolation of CEA-like material from urinary bladder carcinoma. PMID: 217136 Ref: Transient carcinoembryonic antigen (CEA) elevations following resection of colorectal cancer: a limitation in the use of serial CEA levels as an indicator for second-look surgery. PMID: 277718 Ref: Lymphocyte subpopulations in colo-rectal cancer. Preoperative evaluation. PMID: 310638 Ref: Tissue localization of zinc glycinate marker and carcinoembryonic antigen by immunofluorescence. II. Immunofluorescence microscopy. PMID: 349170 Ref: Chemotherapy and chemoimmunotherapy of colorectal cancer. Role of the carcinoembryonic antigen. PMID: 354057 Ref: A prospective evaluation of the leukocyte adherence inhibition test in colorectal cancer and its correlation with carcinoembryonic antigen levels. PMID: 359486 Ref: Carcinoembryonic antigen in patients with breast or colon cancer. PMID: 364839 Ref: The use and abuse of CEA test in clinical practice. PMID: 416901 Ref: [Antiserums against carcino-embryonic antigen (CEA) can induce a specific lysis of colon carcinoma cells by normal lymphocytes]. PMID: 566464 Ref: Quantitation and immunochemical characterization of carcinoembryonic antigen and glucose phosphate isomerase in blood and washings of patients with gastric and colonic diseases. PMID: 619627 Ref: Carcinoembryonic antigen test for recurrent colorectal carcinoma. Inadequacy for early detection. PMID: 628054 Ref: CEA: a monitor of therapy for breast and colon cancer. PMID: 645535 Ref: Serial plasma carcinoembryonic antigen measurements in the management of metastatic colorectal carcinoma. PMID: 646245 Ref: Immunology and immunotherapy of colorectal cancer. PMID: 647509 Ref: [Attachment to the ShchL-56 slit lamp for biomicroophthalmoscopy in polarized light]. PMID: 673308 Ref: Presumed spontaneously regressed retinoblastoma. PMID: 677667 Ref: Characteristics of adenocarcinomas of the colorectum with low levels of preoperative plasma carcinoembryonic antigen (CEA). PMID: 679156 Ref: Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer. PMID: 697433 Ref: [Carcinoembryonic antigen as a control parameter in cryosurgical treatments of patients with rectal carcinoma]. PMID: 700593 Ref: Pre- and postoperative uses of CEA. PMID: 709509 Ref: Carcinoembryonic antigen (CEA) as a monitor of chemotherapy in disseminated colorectal cancer. PMID: 709511 Ref: Carcinoembryonic antigen (CEA): its role as a monitor of radiation therapy for colorectal cancer. PMID: 709512 Ref: Reversible elevation of plasma CEA associated with iatrogenic unilateral hydronephrosis in a patient operated for colorectal cancer. PMID: 709513 Ref: Long-term follow-up of colorectal carcinoma patients by repeated CEA radioimmunoassay. PMID: 709514 Ref: [Studies on the culture of human cancer cells--establishment of human rectal cancer cell lines and their production of carcinoembryonic antigen (CEA) (author's transl)]. PMID: 716812 Ref: Serial CEA levels in colorectal carcinoma on adjuvant immuno (chemo) therapy. PMID: 732334 Ref: [Leukocyte migration test and determination of carcinoembryonic antigens in the postoperative follow-up care of colon and rectum carcinoma]. PMID: 752590 |
Ref: [After care following surgery for colon cancer. 2. The value of CEA for diagnosis and after care]. PMID: 32794 Ref: Immunologic and biochemical studies on the carcinoembryonic antigen-like substance in human neuroblastoma. PMID: 86182 Ref: Antibody-dependent cellular cytotoxicity to human colon-tumour cells. II. Analysis of the antigens involved. PMID: 89858 Ref: [Determination of the lymphocytic and oncofetal antigen subpopulations in patients with adenocarcinomas of the stomach and of the colon and rectum (author's transl)]. PMID: 93670 Ref: Colorectal carcinoma antigens detected by hybridoma antibodies. PMID: 94699 Ref: Neuraminidase-augmented anticarcinoembryonic antigen (CEA)-complement lysis of human colon tumor cells: lack of correlation with anti-CEA-mediated K-cell lysis and iodine-125 binding. PMID: 283279 Ref: Carcinoembryonic antigen in endoscopic brush specimens from benign and malignant gastric lesions. PMID: 393292 Ref: A reappraisal of the value of carcinoembryonic antigen in the management of patients with various neoplasms. PMID: 420982 Ref: Clinical value of carcinoembryonic antigen: diagnosis, prognosis, and follow-up of patients with cancer. PMID: 444049 Ref: Immunoreactive carcinoembryonic antigen [CEA] levels in feces from colorectal cancer patients. PMID: 449127 Ref: [Indication for selective surgical excision of hepatic metastases]. PMID: 451506 Ref: Antibody-dependent cellular cytotoxicity to human colon-tumour cells. I. Lack of tumour specificity in a population study. PMID: 475969 Ref: Carcinoembryonic antigen (CEA) as prognostic marker in colonic cancer. PMID: 491680 Ref: Plasma carcinoembryonic antigen and erythrocyte sedimentation rate in patients with colorectal carcinoma. PMID: 492000 Ref: [Carcinoembryonic antigen (CEA) test. Review of possibilities of its use in cancer of the colon and rectum]. PMID: 494404 Ref: The value of serial carcinoembryonic antigen (CEA) in predicting response rate and survival of patients with gastrointestinal cancer treated with chemotherapy. PMID: 498010 Ref: [Immunological differences between gastric and colorectal cancer patients in lymphocyte functions and serum innumosuppressive effects--with particular references to serum CEA (author's transl)]. PMID: 501188 Ref: Predictive value of plasma CEA in patients with colorectal carcinoma. PMID: 522488 Ref: [Practical applications of the radioimmunoassay of carcinoembryonic antigen (CEA) in the follow-up of colo-rectal carcinoma patients]. PMID: 542458 Ref: [Carcinoembryonic antigen: Comparison of radioimmunoassay and enzyme immunoassay in postoperative surveillance of patients with carcinoma of the colon or rectum (author's transl)]. PMID: 547142 Ref: [Interest and limits of estimation of the carcinoembryonic antigen in colonic and rectal (author's transl)]. PMID: 555768 Ref: Carcinoembryonic antigen (CEA) in gastric juice or feces as an aid in the diagnosis of gastrointestinal cancer. PMID: 758861 Ref: Preoperative carcinoembryonic antigen levels in colorectal carcinoma. PMID: 758878 |
Ref: Value of serial CEA determinations in a surgical adjuvant trial of colorectal and gastric carcinoma. PMID: 6156364 Ref: [Local recurrence following anterior resection of rectal cancer. CEA-titer (author's transl)]. PMID: 6161497 Ref: Evaluation of CEA in patients with known residual disease after resection of colonic cancer. PMID: 6164789 Ref: [Clinical applications of the carcinoembryonic antigen (CEA) determination in colorectal cancer (observations of 119 cases)]. PMID: 6166402 Ref: Factors affecting the expression of carcinoembryonic antigen at the surface of cultured human colon carcinoma cells. PMID: 6254650 Ref: Observations on the synthesis of carcinoembryonic antigen by an established human colonic carcinoma cell line. PMID: 6255389 Ref: Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): an effective treatment for metastatic colorectal carcinoma in the liver. PMID: 6446376 Ref: A human tumour-associated membrane antigen from squamous-cell carcinoma of the lung. PMID: 6775653 Ref: A method to measure carcinoembryonic antigen neosynthesis by cultured colon carcinoma cells. PMID: 6931257 Ref: Carcinoembryonic antigen production by human colorectal adenocarcinoma cells in matrix-perfusion culture. PMID: 6988326 Ref: Carcinoembryonic antigen in fetal tissues and in material serum. PMID: 6990684 Ref: MItomycin C, methyl-CCNU and 5-fluorouracil in the treatment of metastatic colorectal carcinoma. PMID: 7006846 Ref: A direct competitive binding radioimmunoassay for carcinoembryonic antigen. PMID: 7204983 Ref: [Clinical significance of routine serum CEA determination in postoperative control in colorectal cancer]. PMID: 7207116 Ref: [Carcinoembryonic antigen (CEA) and non-oncological liver diseases (case report)]. PMID: 7247673 Ref: Immunological reactivity of glycoprotein antigens from human lung cancers. PMID: 7254422 Ref: Use of limitations of radiolabeled anti-CEA antibodies and their fragments for photoscanning detection of human colorectal carcinomas. PMID: 7279698 Ref: The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer. PMID: 7357243 Ref: Maturation-induction of tumor cells using a human colon carcinoma model. PMID: 7357510 Ref: Radioimmunodetection of colorectal cancer. PMID: 7357516 Ref: Serial CEA levels in colorectal carcinoma on adjuvant immuno(chemo)therapy--further follow-up. Modulation of adjuvant treatment. PMID: 7359922 Ref: Observations on the synthesis of carcinoembryonic antigen by an established human colonic carcinoma cell line. PMID: 7360484 Ref: Immunohistological patterns of carcinoembryonic antigen in colorectal carcinoma. Correlation with staging and blood levels. PMID: 7375147 Ref: Carcinoembryonic antigen (CEA) in diagnosis and prognosis of colorectal carcinoma. PMID: 7379666 Ref: The occurrence of carcino-embryonic antigen-like immunoreactivity in human semen. PMID: 7386896 Ref: [Carcino-embryonic antigen as screening protein in the follow-up of patients with surgically-treated gastrointestinal cancer (author's transl)]. PMID: 7395229 Ref: Preoperative CEA level: a prognostic test in patients with colorectal carcinoma. PMID: 7406353 Ref: [Serum CEA levels in various gastrointestinal diseases with special reference to colorectal cancer (author's transl)]. PMID: 7411991 Ref: Serum CEA levels in gastrointestinal diseases. PMID: 7414628 Ref: Arteriovenous carcinoembryonic antigen gradient: determination by selective angiography for localization of metastatic colorectal cancer. PMID: 7416960 Ref: Preoiperative carcinoembryonic antigen level and prognosis in colorectal cancer. PMID: 7421682 Ref: Comparison of "direct" and "indirect" zirconyl-phosphate technics for carcinoembryonic antigen determination in plasma from patients having benign or malignant disease. PMID: 7424829 Ref: [The CEA-concentration in plasma of patients with colorectal carcinoma and polyps has been determined by radioimmunoassay (RIA, Z-gel-method)]. PMID: 7436700 Ref: Serum CEA monitoring in the follow-up of colorectal cancer patients with negative preoperative serum CEA. PMID: 7439224 Ref: The use of preoperative plasma CEA levels for the Stratification of patients after curative resection of colorectal cancers. PMID: 7447529 Ref: Effectiveness of intermediate-dose methotrexate and high-dose 5-fluorouracil as sequential combination chemotherapy in refractory breast cancer and as primary therapy in metastatic adenocarcinoma of the colon. PMID: 7448820 |
Ref: Correlation of Plasma CEA and CEA tissue staining in poorly differentiated colorectal cancer. PMID: 6167166 Ref: [Value of carcinoembryonic antigen (CEA) in the diagnosis and postoperative monitoring of patients with colorectal cancer]. PMID: 6789243 Ref: Localization and concentration of carcinoembryonic antigen (CEA) in gastrointestinal tumors: correlation with CEA levels in plasma. PMID: 6944526 Ref: Immunocytochemical localization of carcinoembryonic antigen in benign and malignant colorectal tissues. Assessment of diagnostic value. PMID: 7010989 Ref: Plasma carcinoembryonic antigen levels in ovarian cancer patients: a chart review and survey of published data. PMID: 7012337 Ref: Distribution of carcinoembryonic antigens and blood group substances in adenocarcinoma of the colon. PMID: 7015005 Ref: Immunohistochemical demonstration of carcinoembryonic antigen in normal, transitional and inflamed colonic mucosa. PMID: 7036104 Ref: [Is the clinical significance of CEA determination in patients with colorectal carcinoma exaggerated?]. PMID: 7219141 Ref: [Early judgement on the results in radiation therapy of colorectal cancer: determination of carcinoembryonic antigen (CEA) in blood serum at daily intervals from the beginning of irradiation (author's transl)]. PMID: 7222135 Ref: A statistical evaluation of baseline and follow-up carcinoembryonic antigen in patients with resectable colorectal carcinoma. PMID: 7226032 Ref: Second-look laparotomy based on CEA elevations in colorectal cancer. PMID: 7226104 Ref: Serum glycoproteins in diagnosis and monitoring of patients with large-bowel cancer. PMID: 7227130 Ref: Value of serial carcinoembryonic antigen determinations for early detection of recurrent cancer. PMID: 7231281 Ref: Evaluating serial cancer marker studies in patients at risk of recurrent disease. PMID: 7248444 Ref: Experimental studies of tumor radioimmunodetection using antibody mixtures against carcinoembryonic antigen (CEA) and colon-specific antigen-p (CSAp). PMID: 7251228 Ref: Correlations between serial CEA levels and surgery in patients with colorectal carcinoma. PMID: 7265973 Ref: CEA testing in colorectal cancer. PMID: 7300722 Ref: Prognostic significance of CEA in colorectal cancer: a statistical study. PMID: 7310333 Ref: Further investigations of immunoreactive carcinoembryonic antigen (CEA) in colorectal cancer patients--with particular emphasis on the correlation between immunoreactive CEA levels in tissue, feces and blood. PMID: 7311185 Ref: The usefulness and limitations of CEA assay in the management of colorectal cancer. PMID: 7311186 Ref: Prognostic value of preoperative serum CEA level compared to clinical staging. I. Colorectal carcinoma. PMID: 7317270 Ref: Postoperative screening of patients with carcinoma of the colon. PMID: 7318620 Ref: A retrospective study of serial CEA determinations in the early detection of recurrent colorectal cancer. PMID: 7318628 Ref: [Evaluation of carcinoembryonic antigen (CEA) in patients with neoplasms and hematologic diseases]. PMID: 7340729 Ref: Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer? PMID: 7466616 |
Ref: The radioimmunoassay of a carcinoembryonic antigen fraction. PMID: 6175914 Ref: Colon-specific antigen-p (CSAp). I. Initial clinical evaluation as a marker for colorectal cancer. PMID: 6178498 Ref: The presence of oncofoetal antigens in large bowel carcinoma. PMID: 6280663 Ref: [The value of computer tomography in the diagnosis of local recurrences of carcinoma of the rectum (author's transl)]. PMID: 6284616 Ref: CEA positivity in sera and breast tumor tissues obtained from the same patients. PMID: 6289290 Ref: Plasma carcinoembryonic antigen concentrations and immunohistochemical patterns of epithelial marker antigens in patients with large bowel carcinoma. PMID: 6749906 Ref: Sandwich enzyme immunoassay using three monoclonal antibodies against different epitopes of carcinoembryonic antigen (CEA). PMID: 6759373 Ref: Demonstration of carcinoembryonic antigen (CEA) by means of the immunoperoxidase technique in paraffin-embedded specimens of tumour tissues. PMID: 6807709 Ref: Coproduction of carcinoembryonic antigen and nonspecific cross-reacting antigen by a continuous cell line from a human pancreatic tumor. PMID: 6810002 Ref: Lactosylsphingosine-reactive antibody and CEA in patients with colorectal cancer. PMID: 6889963 Ref: The role of Tennessee antigen in the diagnosis of gastrointestinal malignancy. PMID: 6951548 Ref: Value of plasma alpha-1-acid glycoprotein assay in the detection of human colorectal cancer: comparison with carcinoembryonic antigen. PMID: 7033631 Ref: CEA monitoring among patients in multi-institutional adjuvant G.I. therapy protocols. PMID: 7046656 Ref: Serial CEA assays and liver scintigraphy for the detection of hepatic metastases from colorectal carcinoma. PMID: 7067557 Ref: Carcinoembryonic antigen: physician attitudes, patterns of use, and impact upon patient care. PMID: 7067580 Ref: Monoclonal antibody detection of a circulating tumor-associated antigen. II. A longitudinal evaluation of patients with colorectal cancer. PMID: 7068816 Ref: Tissue carcinoembryonic antigen, dysplasia, and disease duration in colonic inflammatory bowel disease. PMID: 7072691 Ref: Extracorporeal immunoadsorption of plasma from a metastatic colon carcinoma patient by protein A-containing nonviable Staphylococcus aureus: clinical, biochemical, serologic, and histologic evaluation of the patient's response. PMID: 7074582 Ref: Sensitization of human lymphocytes to carcinoembryonic antigen (CEA): neutralization experiments with anti-CEA sera. PMID: 7075717 Ref: Correlation of single and serial CEA determinations with the clinical evolution of cancer patients. PMID: 7103688 Ref: A direct assay for carcinoembryonic antigen in serum and its diagnostic value in metastatic breast cancer. PMID: 7116619 Ref: Plasma CEA in the post-surgical monitoring of colorectal carcinoma. PMID: 7126423 Ref: The identification of patients at high risk following curative resection for colorectal carcinoma. PMID: 7127037 Ref: The role of tumor markers in the management of colorectal cancer. PMID: 7139557 Ref: Colon cancer: special surgical considerations. PMID: 7139558 Ref: Vindesine: phase II evaluation in colon cancer and description of its platelet stimulating activity. PMID: 7139851 Ref: Tumor volume correlated serum CEA levels in nude mice after primary xenotransplantation of human colorectal carcinoma. PMID: 7151065 Ref: [Plasma exchange therapy in colonic cancer with hepatic metastasis]. PMID: 7184463 |
Ref: [Immunologic profile of patients with carcinoma of the colorectum in the aged]. PMID: 6084562 Ref: Is CEA analysis of value in screening for recurrences after surgery for colorectal carcinoma? PMID: 6133709 Ref: Limitations of immune complex measurements in colorectal disease. PMID: 6135482 Ref: Acute-phase reactant proteins and carcinoembryonic antigen in cancer of the colon and rectum. PMID: 6189579 Ref: Purification and characterization of a 50,000 mol. wt glycoprotein antigen, and localization of determinants involved in cross-reactivity with carcinoembryonic antigen. PMID: 6191208 Ref: Plasma carcinoembryonic antigen (CEA) as an indicator for radical or palliative radiotherapy in patients with rectal cancer. PMID: 6192917 Ref: Overview of oncofetal antigens in cancer. PMID: 6194734 Ref: Comparison of colon-, lung-, and breast-derived carcinoembryonic antigen and cross-reacting antigens by monoclonal antibodies and fingerprint analysis. PMID: 6200051 Ref: Detection of carcinoembryonic antigen and related antigens in sera of patients with gastrointestinal tumors using monoclonal antibodies in double-determinant radioimmunoassays. PMID: 6205981 Ref: Granular cell myoblastoma: an immunoperoxidase study using a variety of antisera to human carcinoembryonic antigen. PMID: 6301969 Ref: Carcinoembryonic antigen: assay following heat compared with perchloric acid extraction in patients with colon cancer, non-neoplastic gastrointestinal diseases, or chronic renal failure. PMID: 6311999 Ref: [Studies on carcinoembryonic antigen (CEA), lactate dehydrogenase (LDH), and LDH isozymes in the tissue of colorectal carcinoma]. PMID: 6325865 Ref: Leucocyte adherence inhibition and carcinoembryonic antigen in combination for diagnosis of colorectal cancer. PMID: 6339824 Ref: Carcinoembryonic antigen detection by immunocytochemical methods in carcinomas of the colon and stomach. PMID: 6341008 Ref: Cancer trends: the role of CEA in managing colorectal cancer. PMID: 6342292 Ref: Monoclonal antibodies to carcinoembryonic antigen: ionic strength as a factor in the selection of antibodies for immunoscintigraphy. PMID: 6344991 Ref: Differential binding to human mammary and nonmammary tumors of monoclonal antibodies reactive with carcinoembryonic antigen. PMID: 6365268 Ref: [Immunohistologic determination of a tumor marker (CEA) in diseases of the gastrointestinal tract]. PMID: 6373575 Ref: Cross-reactivity with normal antigens in commercial anti-CEA sera, used for immunohistology. The need for tissue controls and absorptions. PMID: 6401380 Ref: [Cancer of the rectum: preoperative radiotherapy (344 cases)]. PMID: 6418238 Ref: Postsurgical follow-up of colorectal cancer patients monitored by the leukocyte migration test. PMID: 6572745 Ref: Differential expression of tumor-associated antigens in human colon carcinomas xenografted into nude mice. PMID: 6575198 Ref: Limitations of CEA monitoring as a guide to second-look surgery in colorectal cancer follow-up. PMID: 6623661 Ref: [Does an obturation in colorectal cancer also modify the behavior of the serum CEA level?]. PMID: 6637204 Ref: Intraoperative high-resolution hepatosonography in the detection of occult metastases in colorectal carcinoma. PMID: 6643011 Ref: Carcinoembryonic antigen in patients with colorectal cancer: correlation between stage of disease and antigen level. PMID: 6643017 Ref: Studies on effect of carcinoembryonic antigen on leucocyte migration inhibition test in patients with colorectal cancer. PMID: 6653990 Ref: Establishment and characterization of a human colon carcinoma cell line (KMS-4) from a patient with hereditary adenomatosis of the colon and rectum. PMID: 6654524 Ref: [Histopathological study on hepatic metastases and blood CEA levels in patients with intestinal carcinoma]. PMID: 6676645 Ref: Human lymphocyte response to CEA: titration of different CEA samples and neutralization experiments with monoclonal anti-CEA antibodies. PMID: 6685630 Ref: Multivariate analyses as aids to diagnosis and assessment of prognosis in gastrointestinal cancer. PMID: 6688531 Ref: Characterization of human colon carcinoma cell lines isolated from a single primary tumour. PMID: 6830688 Ref: Monoclonal antibody radioimmunodetection of human-derived colon cancer. PMID: 6832932 Ref: Usefulness of preoperative CEA levels in the assessment of colorectal cancer patient stage. PMID: 6834846 Ref: Carcinoembryonic antigen (CEA) in human colorectal cancers growing subcutaneously in nude mice. PMID: 6853586 Ref: Antigenicity of a fetal extract in the leucocyte migration-inhibition test. PMID: 6856483 Ref: Monitoring of patients with carcinoma of the large intestine by use of acute phase proteins and carcinoembryonic antigen. PMID: 6857457 Ref: CEA radioimmunoassay. Clinical applications in colorectal cancer. PMID: 6858539 Ref: [Prognostic significance of preoperative CEA titers in colorectal cancer]. PMID: 6862990 Ref: Subcellular distribution, synthesis, and release of carcinoembryonic antigen in cultured human colon adenocarcinoma cell lines. PMID: 6871845 Ref: [Recent progress in tumor markers of the digestive system]. PMID: 6876437 Ref: Prognostic significance of preoperative carcinoembryonic antigen in stomach and colorectal cancer. PMID: 6883376 Ref: The biological and clinical significance of tumor markers in tissue extracts. PMID: 6883394 |
Ref: Sialomucins and carcinoembryonic antigen in the evolution of colorectal cancer. PMID: 6083971 Ref: Immunohistochemical study of mammary and extra-mammary Paget's disease. PMID: 6098546 Ref: Pre-operative carcino-embryonic antigen and survival in patients with colorectal cancer. PMID: 6199071 Ref: Initial clinical evaluation of an immunoradiometric assay for CA 19-9 using the NCI serum bank. PMID: 6199316 Ref: Comparative study of CEA staining in gastric and colorectal cancer tissues. PMID: 6202582 Ref: [Clinical significance of the circulating tumor-associated antigen CA 19-9 in cancers of the digestive tract]. PMID: 6204834 Ref: [A case of alpha-fetoprotein producing rectal cancer]. PMID: 6208473 Ref: The distribution of blood group substance H and CEA in colorectal carcinoma. PMID: 6318951 Ref: Tumor markers in colorectal carcinoma. An evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase and pseudouridine. PMID: 6328884 Ref: Tissue CEA in colorectal carcinoma. PMID: 6360593 Ref: Immunoscintigraphy of colon carcinoma. PMID: 6366160 Ref: The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP (National Surgical Adjuvant Breast and Bowel Project) clinical trials. PMID: 6370155 Ref: [Demonstration of circulating CEA or CEA-like antigens and immunoglobulin G containing immune complexes in colorectal carcinoma]. PMID: 6374276 Ref: A study of the reliability of carcinoembryonic antigen blood levels in following the course of colorectal cancer. PMID: 6375928 Ref: Prospective randomised trial of early cytotoxic therapy for recurrent colorectal carcinoma detected by serum CEA. PMID: 6376291 Ref: Immunocytochemical demonstration of carcinoembryonic antigen in cerebrospinal fluid with carcinomatous meningitis from rectal cancer. PMID: 6380184 Ref: Ultrastructural localization of carcino-embryonic antigen in a continuous human tumour cell line (LS 174 T) in relation to morphometric investigations. PMID: 6385822 Ref: Clinical perspective of human colorectal cancer metastasis. PMID: 6394125 Ref: Morphologic changes, mucin secretion, carcinoembryonic antigen (CEA) and peanut lectin reactivity in colonic mucosa of patients at high risk for colorectal cancer. PMID: 6397881 Ref: Cost effectiveness of postoperative carcinoembryonic antigen monitoring in colorectal cancer. PMID: 6418372 Ref: Hepatic artery ligation and portal vein infusion for liver metastases from colon cancer. PMID: 6439837 Ref: Characterization of a common antigen of colorectal and mucinous ovarian tumors, COTA. PMID: 6442455 Ref: A prospective evaluation of serum carcinoembryonic antigen (CEA) levels in the management of colorectal carcinoma. PMID: 6464483 Ref: [Clinical evaluation of tissue polypeptide antigen in patients with esophageal, stomach and colon cancer]. PMID: 6481966 Ref: The use of computerized tomography scan in the staging and follow-up study of carcinoma of the rectum. PMID: 6484790 Ref: Serum carcinoembryonic antigen and acute phase reactant proteins in the pre-operative detection of fixation of colorectal tumours. PMID: 6498459 Ref: Carcinoembryonic antigen production, secretion, and kinetics in BALB/c mice and a nude mouse-human tumor model. PMID: 6498810 Ref: Evaluation of a sequential 5-FU and hydroxyurea combination in advanced bowel cancer. PMID: 6498854 Ref: Combined measurement and significance of lipid-bound sialic acid and carcinoembryonic antigen in detection of human cancer. PMID: 6499373 Ref: Prospective studies of laboratory and radiologic tests in the management of colon and rectal cancer patients: I. Selection of useful preoperative tests through an analysis of surgically occult metastases. PMID: 6499621 Ref: [Prognostic value of CEA in postoperative monitoring of colorectal cancers]. PMID: 6504398 Ref: Circulating immune complexes (CIC), carcinoembryonic antigen (CEA) and CIC containing CEA as markers for colorectal cancer. PMID: 6509799 Ref: [Carcinoembryonic antigen in serum and the tissue of patients with colon cancer]. PMID: 6513021 Ref: [Value of radioimmunological serum levels of carcinoembryonic antigen in the postoperative monitoring of rectocolonic cancer]. PMID: 6529177 Ref: Targeting of liposomes: monoclonal antibodies coupled to phospholipid vesicles provide selective transfer of trapped reagents into cultured cells. PMID: 6541804 Ref: Chordoma. Antibodies to epithelial membrane antigen and carcinoembryonic antigen in differential diagnosis. PMID: 6548365 Ref: Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases. PMID: 6582896 Ref: Sensitivity of human carcinoma cell lines to lysis by blood natural killer cells correlating with surface expression of carcinoembryonic antigen. PMID: 6583436 Ref: Correlation between plasma carcinoembryonic antigen (CEA) and sialyltransferase as tumor marker. PMID: 6599115 Ref: Serum CEA in the follow-up of colorectal carcinoma: experience in a district general hospital. PMID: 6691692 Ref: [Using CEA for diagnostic, therapeutic and prognostic evaluation in colorectal cancers]. PMID: 6696454 Ref: Lack of radioimmunodetection and complications associated with monoclonal anticarcinoembryonic antigen antibody cross-reactivity with an antigen on circulating cells. PMID: 6713409 Ref: Monoclonal antibodies identify a CEA crossreacting antigen of 95 kD (NCA-95) distinct in antigenicity and tissue distribution from the previously described NCA of 55 kD. PMID: 6724739 Ref: A comparison of fast homoarginine-sensitive alkaline phosphatase and carcinoembryonic antigen as markers in colon carcinoma. PMID: 6726299 Ref: Hepatic resection for metastatic colorectal carcinoma. William Beaumont Hospital experience. PMID: 6742623 |
Ref: Ca2 and Ca3. New monoclonal antibodies evaluated as tumor markers in serous effusions. PMID: 2408723 Ref: Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen. PMID: 2408729 Ref: Immunohistochemical localization and molecular characteristics of three monoclonal antibody-defined epitopes detectable on carcinoembryonic antigen (CEA). PMID: 2410375 Ref: Biodegradable mitomycin C microspheres given intra-arterially for inoperable hepatic cancer. With particular reference to a comparison with continuous infusion of mitomycin C and 5-fluorouracil. PMID: 2412682 Ref: Multiple markers of malignancy in sera of patients with colorectal carcinoma: preliminary clinical studies. PMID: 2414037 Ref: Tumor markers: value and limitations in the management of cancer patients. PMID: 2416441 Ref: Immunological characteristics of monoclonal antibodies against human carcinoembryonic antigen (CEA). PMID: 2419936 Ref: Monoclonal antibody recognizing human melanoma-carcinoma cross-reacting oncofetal antigen epitopically associated with carcinoembryonic antigen. PMID: 2582173 Ref: [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract]. PMID: 2582313 Ref: Circulating tumor markers and assessment of response to intrahepatic chemotherapy of colon carcinoma. PMID: 2939709 Ref: [Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen in gastrointestinal neoplasms. Comparison of markers]. PMID: 2940782 Ref: [Immune response in rabbits to tumoral tissue extracts of human colon]. PMID: 2940803 Ref: CEA tissue staining in colorectal cancer patients. A way to improve the usefulness of serial serum CEA evaluation. PMID: 2986820 Ref: Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump. PMID: 3155793 Ref: A prospective study of continuous hepatic perfusion with implantable pump. PMID: 3156027 Ref: Preoperative carcinoembryonic antigen and prognosis in patients with colorectal cancer. PMID: 3830268 Ref: Tissue CEA determination and cytophotometric DNA analysis of colorectal mucosa in patients with colorectal cancer. PMID: 3831499 Ref: The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies. PMID: 3856076 Ref: Full expression of blood group-related, transplantation-related, and carcinoembryonic antigens in human colorectal cancer cells with different degrees of phenotypic differentiation. PMID: 3856476 Ref: A clinical evaluation of carbohydrate antigen 19-9 and carcinoembryonic antigen in patients with pancreatic carcinoma. PMID: 3857396 Ref: Clinical value of CA 19-9 (carbohydrate antigen) in gastrointestinal adenocarcinoma. PMID: 3858272 Ref: Determination and significance of a new carbohydrate antigen CA19-9 in digestive system cancers. PMID: 3860677 Ref: Long-term-cultured colon epithelial cell lines from individuals with and without colon cancer genotypes. PMID: 3860681 Ref: [Clinical utility of tumor markers in gastric and colon cancer]. PMID: 3861884 Ref: The significance of CA19-9 tumor antigen in the serum of patients with carcinomas. PMID: 3863154 Ref: Value of serum levels of carcinoembryonic antigen, CEA, and gastrointestinal cancer antigen, GICA or CA 19-9, for preoperative staging and postoperative monitoring of patients with colorectal carcinoma. PMID: 3864628 Ref: Immunohistochemical study of carcinoembryonic antigen in patients with colorectal cancer. Correlation with plasma carcinoembryonic antigen levels. PMID: 3880653 Ref: [Carcinoembryonic antigen in intestinal lavage fluids and the tissue of colorectal tumors]. PMID: 3883295 Ref: Differences in CEA values determined by EIA and RIA in patients with benign and malignant biliary obstructions. PMID: 3887894 Ref: [Significance of CEA in gastric and colorectal cancer]. PMID: 3889583 Ref: [Clinical evaluation of CEA in colorectal carcinoma]. PMID: 3897618 Ref: [Comparison between stool CEA and serum CEA in colorectal cancer measured by monoclonal anti-CEA antibody]. PMID: 3903470 Ref: Comparison of a CEA-EIA assay based on monoclonal antibody with a CEA-RIA assay with polyclonal antiserum. PMID: 3903552 Ref: Role of carcinoembryonic antigen assay in the management of cancer. PMID: 3916663 Ref: Detection of recurrent cancer of the colon and rectum. PMID: 3918217 Ref: Long-term survivors of colorectal cancer with unresectable hepatic metastases. PMID: 3926443 Ref: Use and limitations of serum total and lipid-bound sialic acid concentrations as markers for colorectal cancer. PMID: 3965096 Ref: A more specific, simpler radioimmunoassay for carcinoembryonic antigen, with use of monoclonal antibodies. PMID: 3967348 Ref: Major hepatic resection for metachronous metastases from colon cancer. PMID: 3970601 Ref: Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study. PMID: 3971297 Ref: Colon carcinoma in children and adolescents. A review of 30 cases. PMID: 3971300 Ref: Cell kinetics and in vitro clonogenicity of primary colorectal cancer: clinicopathological relationships and the implications for chemotherapy. PMID: 3972273 Ref: [Three cases of colonic-type adenocarcinoma in the head and neck region with positive CEA]. PMID: 3981805 Ref: Prognostic value of preoperative serum CEA level compared to clinical staging: III. An approach to scoring of prognostic factors in colorectal cancer. PMID: 3982036 Ref: [Computer tomography in the diagnosis of recurrence of rectal and colonic cancer]. PMID: 3984558 Ref: Unresectable hepatic metastases from carcinoma of the colon and rectum. PMID: 3992446 Ref: Serum IgE levels in patients with cancer. PMID: 3994074 Ref: The use of flow cytometry and cell sorting in a human colon carcinoma model. PMID: 3996140 Ref: Carcinoembryonic antigen fraction in digestive cancer. PMID: 4000309 Ref: Hepatic resection for metastatic colon and rectal cancer. An evaluation of preoperative and postoperative factors. PMID: 4015224 Ref: [A case of multiple carcinomas of the colon and rectum associated with ulcerative colitis]. PMID: 4021107 Ref: Combination of tissue polypeptide antigen (TPA) and carcino embryonic antigen (CEA) in different types of cancer. PMID: 4034127 Ref: CEA-directed second-look surgery in the asymptomatic patient after primary resection of colorectal carcinoma. PMID: 4037904 Ref: Monoclonal antibodies for carcinoembryonic antigen (CEA) as a model system: identification of two novel CEA-related antigens in meconium and colorectal carcinoma tissue by Western blots and differential immunoaffinity chromatography. PMID: 4045198 Ref: High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: biodistribution and imaging in nude mice bearing human colon cancer xenografts. PMID: 4053043 Ref: Macrocreatine kinase type 2 in the serum of patients with tumors and with nonmalignant colonic diseases. PMID: 4053110 Ref: Pre-operative staging of rectal neoplasm and its impact on clinical management. PMID: 4063751 Ref: Tissue polypeptide antigen and carcinoembryonic antigen in colon tumors: serum levels and immunohistochemical localization. PMID: 4064041 Ref: Carcinoembryonic antigen, ferritin, anionic glycoproteins, and their sialic acid content in advanced colorectal cancer. PMID: 4064042 Ref: The use of carcinoembryonic antigen in the clinical management of patients with colorectal cancer. PMID: 4064062 Ref: Magnetic resonance imaging using gadolinium labeled monoclonal antibody. PMID: 4066240 Ref: In vivo kinetics of radiolabeled monoclonal anti-CEA antibodies in animal models. PMID: 4067644 Ref: Postoperative monitoring of CEA in the prediction of surgical outcome in colorectal cancer. PMID: 4078776 |
Ref: Characterization of monoclonal antibodies to carcinoembryonic antigen with increased tumor specificity. PMID: 2417036 Ref: Significance of measurement of a carbohydrate antigenic determinant 19-9 (CA 19-9) for monitoring colorectal cancer patients. PMID: 2421035 Ref: Serial levels of CA 19-9 and CEA in colonic cancer. PMID: 2423655 Ref: [Antitumor effect of adriamycin entrapped in liposomes conjugated with anti-human alpha-fetoprotein or anti-carcinoembryonic antigen monoclonal antibodies]. PMID: 2423862 Ref: Clinical usefulness of three monoclonal antibody-defined tumor markers: CA 19-9, CA 50, and CA 125. PMID: 2437641 Ref: A comparison of the predictive value and diagnostic efficiency of FHAP and CEA as cancer markers. PMID: 2437642 Ref: Heterogeneous expression of two oncodevelopmental antigens, CEA and SSEA-1, in colorectal cancer. PMID: 2874119 Ref: Adenosine deaminase complexing protein in cancer studies. PMID: 2879510 Ref: Hepatic arterial infusion with floxuridine and cisplatin: overriding importance of antitumor effect versus degree of tumor burden as determinants of survival among patients with colorectal cancer. PMID: 2943876 Ref: Follow-up on a prospective study of continuous hepatic perfusion with implantable pump. PMID: 2945707 Ref: Cellular growth modulation. I. Effects of extracellular matrix and tumor cell conditioned medium. PMID: 3023158 Ref: [Experiences with determining carcinoembryonic antigen in tumors of the digestive tract]. PMID: 3024422 Ref: [A case of multiple liver metastases from sigmoid carcinoma treated successfully with arterial infusion chemotherapy]. PMID: 3089178 Ref: Measurement of a pancreatic cancer-associated antigen (DU-PAN-2) detected by a monoclonal antibody in sera of patients with digestive cancers. PMID: 3457770 Ref: [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis]. PMID: 3459133 Ref: [Diagnosis and treatment of colorectal cancer using monoclonal antibodies]. PMID: 3460528 Ref: Multiparameter evaluation of the expression in situ of normal and tumor-associated antigens in human colorectal carcinoma. PMID: 3461200 Ref: [Determination of carcinoembryonic and carbohydrate antigens in the diagnosis of recurrences and metastases of rectal cancer]. PMID: 3462448 Ref: [Utility of CA19-9 and CEA as tumor marker in colorectal cancer--comparison between serum level and distribution]. PMID: 3463631 Ref: [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms]. PMID: 3463886 Ref: [Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9]. PMID: 3466003 Ref: The clinical value of the tumor markers CA 19/9 and carcinoembryonic antigen (CEA) in colorectal carcinomas: a critical comparison. PMID: 3480321 Ref: Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies. PMID: 3484753 Ref: Polyclonal and monoclonal anti-CEA antibodies in immunolocalization of colorectal cancer. PMID: 3495029 Ref: Carcinoembryonic antigen. PMID: 3510056 Ref: Immunoperoxidase staining of carcinoembryonic antigen as a prognostic indicator in colorectal carcinoma. PMID: 3510834 Ref: Biochemical and immunohistochemical studies on carcinoembryonic antigen of ovarian mucinous and serous tumors. PMID: 3514390 Ref: COTA (colon-ovarian tumor antigen). An immunohistochemical study. PMID: 3524190 Ref: A monoclonal antibody against human colon cancers. PMID: 3526636 Ref: An unusual presentation of colon cancer. PMID: 3531728 Ref: Immunostaining of colorectal cancer with monoclonal anti-CEA antibodies compared to serum and tumor CEA content. PMID: 3541780 Ref: Cancer precursors and their control by BCG. PMID: 3596046 Ref: Carcinoembryonic antigen (CEA) and alkaline phosphatase in progressive colorectal cancer with special reference to patient survival. PMID: 3699082 Ref: Dynamics of monoclonal antibody distribution and prolonged tumour localisation in nude mice bearing a human CEA-producing colon carcinoma xenograft. PMID: 3704478 Ref: Abdominal exploration for suspected recurrent carcinoma of the colon and rectum based upon elevated carcinoembryonic antigen alone or in combination with other diagnostic methods. PMID: 3704903 Ref: [Localization of radiolabeled antibody to carcinoembryonic antigen in patients with gastrointestinal carcinoma]. PMID: 3713682 Ref: [Prognostic value of postoperative determination of CEA in carcinoma of the large intestine]. PMID: 3714087 Ref: Correlation between the results of carcinoembryonal antigen (CEA) test and the clinical stage of colorectal carcinoma. PMID: 3716715 Ref: Carcinoembryonic antigen slope analysis as an early indicator for recurrence of colorectal carcinoma. PMID: 3723883 Ref: [Monoclonal antibody 9A3 raised against a human poorly differentiated gastric adenocarcinoma cell line]. PMID: 3729460 Ref: The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer. PMID: 3731019 Ref: Faecal carcinoembryonic antigen in colorectal cancer patients. PMID: 3732896 Ref: Effect of tunicamycin on synthesis and secretion of carcinoembryonic antigen by human colonic adenocarcinoma cells. PMID: 3733260 Ref: Prognostic value of preoperative serum CEA level compared to clinical staging. IV. Histological grading and tumor type in colorectal and gastric cancer. PMID: 3736053 Ref: Diagnosis and management of colorectal cancer. PMID: 3742993 Ref: Comparing predictive decision rules in postoperative CEA monitoring. PMID: 3756825 Ref: [Immunologic findings in patients with colorectal carcinoma. V. CEA in colorectal carcinoma. Comparison with the activity of biological markers of malignancy]. PMID: 3764590 Ref: Association of the Y hapten with glycoproteins, glycolipids and carcinoembryonic antigen in colorectal carcinoma. PMID: 3768863 Ref: Preoperative imaging of colorectal carcinoma with 111In-labeled anticarcinoembryonic antigen monoclonal antibody. PMID: 3779657 Ref: Testis imaging with 111In-labeled anticarcinoembryonic antigen monoclonal antibody: identification of carcinoembryonic antigen in normal germ cells. PMID: 3779658 Ref: Uptake of a monoclonal antibody against CEA (Tumak 431/31) in a human colon tumor (Co-112) xenografted in the nude mouse. Dependence on tumor size and injected dose. PMID: 3779711 Ref: [Cancer of the colon: prognostic factors]. PMID: 3780447 Ref: [Significance of 2d look operations in colorectal cancers]. PMID: 3788330 Ref: [Significance of carcinoembryonic antigen in the treatment of colorectal cancers]. PMID: 3788331 Ref: In vitro binding and in vivo localization in colorectal cancer of a high affinity monoclonal antibody to carcinoembryonic antigen. PMID: 3790959 Ref: Urinary polyamines in colorectal cancer. PMID: 3792170 Ref: [Carcinoembryonic antigen (CEA) levels of peripheral and portal blood and tumor histopathology in colorectal cancer]. PMID: 3807878 Ref: [Carcinoembryonic antigen (CEA) in the serum of patients with cancer of the colon and rectum]. PMID: 3822848 Ref: [Biosynthesis and secretion of CEA by colon carcinoma cells-- ultrastructural and immunocytochemical studies with the protein-A-gold method]. PMID: 3825251 Ref: Prospective evaluation of the diagnostic efficacy of CA 19-9 assay as a marker for gastrointestinal cancers. PMID: 3940235 Ref: Radioimmunolocalization and selection for surgery in recurrent colorectal cancer. PMID: 3947880 Ref: Localisation of gastrointestinal cancer with a 131 I labelled monoclonal antibody to CEA. PMID: 3954942 |
Ref: Carcinoembryonic antigen as a prognostic indicator in the radiotherapeutic management of rectal cancer. PMID: 2434361 Ref: [Possibilities of prognosis in cancer of the transverse colon and rectum using CEA, AFP and immunoglobulins A, M and G]. PMID: 2438847 Ref: Mapping of monoclonal antibody-defined epitopes associated with carcinoembryonic antigen, CEA. PMID: 2439201 Ref: An initial appraisal of the value of serum carbohydrate antigenic determinant (CA 19-9) levels in patients with pancreatic cancer. PMID: 2439345 Ref: Modulation of carcinoembryonic antigen release by HT-29 colon carcinoma line in the presence of different agents. PMID: 2444456 Ref: [Clinical evaluation of tumor markers in patients with colorectal cancer]. PMID: 2444727 Ref: Ulcerative colitis and familial polyposis oncologic transformation to colon carcinoma: changes in carcinoembryonic antigen release. PMID: 2822426 Ref: Biological features and chemosensitivity of human colorectal cancer xenografted in nude mice. PMID: 2824273 Ref: [Value of carcinoembryonic antigen (CEA) in assessing therapeutic success in small cell bronchial cancer]. PMID: 2827397 Ref: [Value of CT following surgery for rectal cancer (a prospective study)]. PMID: 2830075 Ref: Isolation and characterization of cDNA clones encoding the human carcinoembryonic antigen reveal a highly conserved repeating structure. PMID: 3033671 Ref: [Clinical application of carcinoembryonic antigen (CEA) monoclonal antibodies (McAbs)]. PMID: 3297586 Ref: A comparison of monoclonal antibodies against distinct colon tumor-associated antigens in immunohistochemistry and in tumor localization. PMID: 3298170 Ref: Comparison of two lymphokines (macrophage migration inhibition, leukocyte adherence inhibition factors) and carcinoembryonic antigen, in colorectal cancer and colonic premalignant lesions. PMID: 3318403 Ref: Current trends in the treatment of colorectal cancer. PMID: 3318646 Ref: Tissue CEA as prognostic indicator in a series of 44 cases of colorectal cancer. PMID: 3329161 Ref: Immunohistochemical studies of colorectal carcinoma with a monoclonal antibody against carcinoembryonic antigen. PMID: 3329344 Ref: [Immunoscintigraphy, an aid to the oncologist--the Rennes experience in using anti-CEA, anti-CA 19.9 monoclonal antibodies and radiolabelled OC-125]. PMID: 3330945 Ref: Early detection of liver metastasis in patients with colorectal carcinoma by increased levels of circulating IgA- and IgM-associated secretory component. PMID: 3426927 Ref: Significance of a fall in serum CEA concentration in patients treated with cytotoxic chemotherapy for disseminated colorectal cancer. PMID: 3428690 Ref: Serum CEA in the management of recurrent colorectal cancer. PMID: 3435012 Ref: Isolation and characterization of an undifferentiated human colon carcinoma cell line (MIP-101). PMID: 3442732 Ref: CEA levels in gastric juice in precancerous conditions and cancer. PMID: 3451930 Ref: Comparison of the tumor markers CEA, TPA, and CA 19-9 in colorectal carcinoma. PMID: 3467817 Ref: Follow-up of colorectal cancer resected for cure. An experience with CEA, TPA, Ca 19-9 analysis and second-look surgery. PMID: 3470172 Ref: Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9. PMID: 3474158 Ref: [Significance of CA19-9 values in the feces of patients with colorectal carcinoma]. PMID: 3474513 Ref: [Tumor markers in gastrointestinal cancer and its clinical significance]. PMID: 3479051 Ref: Neopterin. A tumor marker in colorectal carcinoma? PMID: 3479311 Ref: [Prognostic value of tumor markers in cases of colorectal cancer: CEA and CA 19-9]. PMID: 3480671 Ref: The value of CA 19-9 in gastric and colorectal carcinoma. PMID: 3480768 Ref: Carcinoembryonic antigen, CA 19-9, and CA 125 in normal and carcinomatous human colorectal tissue. PMID: 3481558 Ref: Use of second antibody in radioimmunotherapy. PMID: 3493442 Ref: [Immunoscintigraphy using radio-labeled monoclonal antibodies. Development of a method of cancer diagnosis and hopes for a new form of therapy]. PMID: 3499666 Ref: Expression of carcinoembryonic antigen, T-antigen, and oncogene products as markers of neoplastic and preneoplastic colonic mucosa. PMID: 3500109 Ref: [Immunoscintigraphy using 111In-DTPA-labeled monoclonal antibodies: comparison with ECT and planar scintigraphy]. PMID: 3501859 Ref: Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids. PMID: 3545451 Ref: Efficacy and specificity of vindesine monoclonal anti-carcinoembryonic antigen conjugate with nine human cancer cell lines. PMID: 3547144 Ref: Relationship of radioantibody localization and cell viability in a xenografted human cancer model as measured by whole-body autoradiography. PMID: 3548950 Ref: Discrepancies in carcinoembryonic antigen measurements: survey and control values vs values for patients. PMID: 3549059 Ref: [Brain metastases of colorectal cancer--a case report]. PMID: 3560451 Ref: Antibody protein dose and radioimmunodetection of GW-39 human colon tumor xenografts. PMID: 3570553 Ref: Production of carcinoembryonic antigen from a human colon adenocarcinoma cell line. I. Large-scale cultivation of carcinoembryonic antigen-producing cells on cylindric cellulose-based microcarriers. PMID: 3582767 Ref: A simplified plan for follow-up of patients with colon and rectal cancer supported by prospective studies of laboratory and radiologic test results. PMID: 3589978 Ref: The determination of urinary oxypurines as markers of gastrointestinal tumors. PMID: 3603725 Ref: [Colon carcinoma. Preoperative CEA, tumor differentiation and prognosis]. PMID: 3608853 Ref: [Early clinical diagnosis of stomach and large intestine cancer]. PMID: 3617781 Ref: Monoclonal antibodies to detect markers specific for tumors. PMID: 3619397 Ref: Usefulness of carcinoembryonic antigen measurement in feces of patients with colorectal cancer. PMID: 3622164 Ref: Tumor scintigraphy with 131I anti CEA monoclonal antibodies and F(ab')2 in colorectal cancer. PMID: 3622555 Ref: Serum concentration of laminin, and course of the disease in patients with various malignancies. PMID: 3625257 Ref: Immunoscintigraphy of gastric or colon carcinoma with F(ab')2 fragments of anti-CEA monoclonal antibody. PMID: 3628863 Ref: Imaging of colon carcinoma with 111-indium-labeled anti-CEA monoclonal antibodies (Indacea) prior to surgery. PMID: 3657182 Ref: Faecal carcinoembryonic antigen (CEA) in patients with large bowel cancer. PMID: 3666160 Ref: [CEA determination in the follow-up of colorectal cancers]. PMID: 3673304 Ref: Therapy of peritoneal carcinomatosis of human colon cancer xenografts with yttrium 90-labeled anti-carcinoembryonic antigen antibody ZCE025. PMID: 3675197 Ref: [Correlation of carcinoembryonic antigen (CEA) content in the resected tissue with the serum CEA levels in patients with colorectal carcinoma]. PMID: 3681244 Ref: Colorectal cancer. Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern. PMID: 3689111 Ref: Comparison of carcinoembryonic antigen levels between portal and peripheral blood in patients with colorectal cancer. Correlation with histopathologic variables. PMID: 3815304 |
Ref: [Preoperative elevation of CEA, CA 19-9 and CA 50 in the inoperable stages of colorectal cancer]. PMID: 2453075 Ref: The adenoma-carcinoma sequence in rectal adenomas. Support by the expression of blood group substances and carcinoma antigens. PMID: 2456006 Ref: [Clinical evaluation on an enzyme immunoassay kit for basic fetoprotein (BFP). (2) Comparison and combination of BFP with other tumor markers]. PMID: 2456040 Ref: [Portal blood level of carcinoembryonic antigen (CEA) in colorectal cancer: correlation between tumor CEA content and immunohistochemical staining]. PMID: 2457355 Ref: Characterization of a cDNA clone for the nonspecific cross-reacting antigen (NCA) and a comparison of NCA and carcinoembryonic antigen. PMID: 2830274 Ref: Hepatic resections: an eight year experience at a community hospital. PMID: 2837115 Ref: [Value of preoperative serum CEA determination in colorectal carcinoma]. PMID: 2855507 Ref: Biochemical tissue markers of human colorectal carcinoma. PMID: 2894933 Ref: The clinical relevance of tumor marker CEA, CA 19-9 in regional chemotherapy of hepatic metastases of colorectal carcinoma. PMID: 2977396 Ref: Release of carcinoembryonic antigen from human colon cancer cells by phosphatidylinositol-specific phospholipase C. PMID: 3042807 Ref: Improved tumor localization with increasing dose of indium-111-labeled anti-carcinoembryonic antigen monoclonal antibody ZCE-025 in metastatic colorectal cancer. PMID: 3045263 Ref: Phenotypic and genetic alterations in pre-cancerous cells in the colon. PMID: 3052255 Ref: Ornithine decarboxylase as a marker for colorectal polyps and cancer. PMID: 3054922 Ref: A cell surface glycoprotein expressed by colorectal carcinomas including poorly differentiated, noncarcinoembryonic antigen-producing colorectal tumors. PMID: 3056611 Ref: Protein G-gold immunoelectron microscopy of colon carcinoma: the effect of tumor differentiation on carcinoembryonic antigen immunostaining. PMID: 3058504 Ref: Serological relationship between rat and human carcinoembryonic antigen. PMID: 3068153 Ref: [A case of remarkable regression of a colonic cancer involving metastasis to the liver as a result of FT-207 treatment]. PMID: 3128669 Ref: Immunohistochemistry of human gastrointestinal cancer-associated antigen detected by monoclonal antibody PA 8-15. PMID: 3130361 Ref: Differential expression of carcinoembryonic antigen and nonspecific crossreacting antigen genes in human colon adenocarcinomas and normal colon mucosa. PMID: 3133333 Ref: Tissue concentrations of CEA and CA 19-9 in the carcinogenesis of colorectal carcinoma exemplified by the adenoma-carcinoma sequence. PMID: 3163815 Ref: Alteration in the behavior of a colon carcinoma cell line by extracellular matrix components. PMID: 3164644 Ref: Preoperative serum markers in carcinoma of the rectum and rectosigmoid. I. Prediction of tumour stage. PMID: 3165869 Ref: [Histopathological and immunohistochemical studies on the elevation mechanism of cancer associated antigens, CEA and CA19-9, in patients with colorectal cancer]. PMID: 3166103 Ref: Carcinoembryonic antigen and carbohydrate antigen 19-9 levels of peripheral and draining venous blood in colorectal cancer patients. Correlation with histopathologic and immunohistochemical variables. PMID: 3167774 Ref: Correlation of DNA hypomethylation with expression of carcinoembryonic antigen in human colon carcinoma cells. PMID: 3167826 Ref: [Clinical evaluation of a combination assay of CEA, CA-19-9 and TPA in patients with colorectal cancer]. PMID: 3172515 Ref: Artifactual CEA elevation due to human anti-mouse antibodies. PMID: 3178471 Ref: An evaluation of serum CA 50 levels in cancer using a time-resolved fluoroimmunoassay. PMID: 3179405 Ref: [Correlation of microangiographic findings of colorectal carcinoma with the level of various tumor markers in portal blood]. PMID: 3200237 Ref: [Immunohistochemical studies on colorectal adenoma and carcinoma--correlation of cellular dysplasia and intracellular CEA distribution, lectin-binding sites and quantities of nuclear Feulgen DNA content]. PMID: 3200238 Ref: Tumour markers in colorectal cancer. PMID: 3201159 Ref: [Liver resection in patients with metastases of colorectal cancers. Results and prognostic factors]. PMID: 3203563 Ref: CA15-3 serum levels in breast cancer and other malignancies--correlation with clinical course. PMID: 3204010 Ref: [Carcinoembryonic antigen in multiple primary cancer of the colon]. PMID: 3205122 Ref: Pancreatic oncofetal antigen and carcinoembryonic antigen in breast and colon carcinoma. PMID: 3206109 Ref: A comparison of carcinoembryonic antigen (CEA) and epithelial membrane antigen (EMA) in human colorectal cancer. PMID: 3209300 Ref: Biodistribution of 131I-labelled monoclonal antibodies in human colon tumours by an ex vivo perfusion model. PMID: 3209304 Ref: [Natural history of synchronous hepatic metastases from a non-treated colorectal cancer]. PMID: 3209636 Ref: [Effect of serial CEA determination on diagnosis, therapy and prognosis of recurrent colorectal cancer]. PMID: 3210846 Ref: [Radioimmunotherapy of solitary liver metastases using intratumor instillation of 131I-labeled monoclonal antibodies--initial results of a clinical study]. PMID: 3217256 Ref: Localization of human colorectal carcinoma xenografts in mice using radiolabeled monoclonal antibody to carcinoembryonic antigen. PMID: 3219783 Ref: Monoclonal anti-CEA antibody: factors affecting localization in a preclinical study. PMID: 3235853 Ref: [Efficacy of follow-up in colorectal cancer: second look guided by carcinoembryonic antigen (CEA) and secondary neoplasms]. PMID: 3238157 Ref: Suppression of the growth of human colorectal carcinoma cells (LS174T) by radiolabeled monoclonal antibody (131I-MAbC27) in tissue culture and nude mice. PMID: 3262492 Ref: High-dose folinic acid and 5-fluorouracil in the treatment of advanced colon cancer. PMID: 3263037 Ref: [Tumor markers in colorectal neoplasm pathology: our experience of the diagnostic and prognostic importance of CEA antigen]. PMID: 3267476 Ref: Colorectal tumors: scintigraphy with In-111 anti-CEA monoclonal antibody and correlation with surgical, histopathologic, and immunohistochemical findings. PMID: 3277244 Ref: Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases. PMID: 3278167 Ref: CEA-containing immune complexes in sera of patients with colorectal and breast cancer--analysis of complexed immunoglobulin classes. PMID: 3282655 Ref: Production of monoclonal antibodies to serum antigens in colorectal carcinoma. PMID: 3286775 Ref: The expression of carcinoma-associated antigens and blood-group-related antigens in rectal carcinoids. PMID: 3288450 Ref: Induction of carcinoembryonic antigen secretion and modulation of protein secretion/expression and fibronectin/laminin expression in human colon carcinoma cells by transforming growth factor-beta. PMID: 3289738 Ref: [Colorectal carcinoma: significance of the tumor marker]. PMID: 3293181 Ref: Radioimmunotherapy of human colon carcinoma by 131I-labelled monoclonal anti-CEA antibodies in a nude mouse model. PMID: 3335416 Ref: [Immuno-scanning of human colon cancer xenografts using a labeled monoclonal antibody to the carcinoembryonic antigen]. PMID: 3343904 Ref: Growth potential of human colorectal carcinomas in nude mice: association with the preoperative serum concentration of carcinoembryonic antigen in patients. PMID: 3345536 Ref: Expression of carcinoembryonic antigen by adenoma and carcinoma derived epithelial cell lines: possible marker of tumour progression and modulation of expression by sodium butyrate. PMID: 3345582 Ref: Large bowel adenomas containing carcinoma--a diagnostic and therapeutic approach. PMID: 3361224 Ref: [Clinical significance of serum immunosuppressive substance as a marker of colorectal cancer]. PMID: 3362126 Ref: The effect of sodium butyrate and retinoic acid on growth and CEA production in a series of human colorectal tumor cell lines representing different states of differentiation. PMID: 3365571 Ref: Regression analysis of prognostic factors in colorectal cancer after curative resections. PMID: 3366023 Ref: Polyamine levels and gastrin receptors in colon cancers. PMID: 3389934 Ref: Recurrent rectal cancer: diagnosis with MR imaging versus CT. PMID: 3393651 Ref: A multivariate analysis of pathologic prognostic indicators in large bowel cancer. PMID: 3422035 |
Ref: Effect of tumor mass and antigenic nature on the biodistribution of labeled monoclonal antibodies in mice. PMID: 2470499 Ref: Measuring of immunoreactivity of carcinoembryonic antigen (CEA) in colorectal cancer by microdensitometry. PMID: 2471180 Ref: Serologic mapping and biochemical characterization of the carcinoembryonic antigen epitopes using fourteen distinct monoclonal antibodies. PMID: 2474516 Ref: Monoclonal antibody recognizing a carcinoembryonic antigen epitope differentially expressed in human colonic carcinoma versus normal adult colon tissues. PMID: 2477148 Ref: [A comparative evaluation of methods for diagnosing recurrence of rectal cancer after radical surgery]. PMID: 2479175 Ref: Serum levels of CA 125 in patients with gastrointestinal cancers. PMID: 2480631 Ref: Enhanced recognition of human colorectal tumour cells using combinations of monoclonal antibodies. PMID: 2481485 Ref: [Plasma levels of alpha-fetoprotein and carcinoembryonic antigen in patients with malignant gastrointestinal tumors]. PMID: 2483025 Ref: Immunoscintigraphy of primary and metastatic colorectal cancers with radiolabelled monoclonal antibodies anti-CEA. PMID: 2486018 Ref: [Colorectal cancer: follow-up after curative resection]. PMID: 2488519 Ref: The use of cancer registry data to study preoperative carcinoembryonic antigen level as an indicator of survival in colorectal cancer. PMID: 2492877 Ref: [Blood serum galactosyltransferase in oncologic diseases]. PMID: 2494414 Ref: Modulation of carcinoembryonic antigen messenger RNA levels in human colon carcinoma cells by recombinant human gamma-interferon. PMID: 2496918 Ref: [Study of long-survival cases with liver metastasis of colorectal cancer by hepatic arterial infusion chemotherapy]. PMID: 2506832 Ref: Detection of increased fecal carcinoembryonic antigen and its characterization as a membrane-bound form in colorectal carcinoma and other gastrointestinal disorders. PMID: 2516843 Ref: [Immunology in gastric cancer]. PMID: 2518031 Ref: [Validity and limitations of the CEA test in the treatment of colorectal carcinoma]. PMID: 2518432 Ref: Isolation of anti-carcinoembryonic antigen (CEA), specific immunoglobulins and their use in immunocytochemical and enzyme-immunoassays (ELISA). PMID: 2519633 Ref: Prevention of extrahepatic disease during intraarterial floxuridine of colorectal liver metastases by simultaneous systemic 5-fluorouracil treatment? A prospective multicenter study. PMID: 2531992 Ref: Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-beta. PMID: 2539253 Ref: Do aggressive subclones within primary colorectal cancer give rise to liver metastases? PMID: 2545806 Ref: [Clinical significance of serum NCC-ST 439 as a tumor marker for colorectal cancer]. PMID: 2549882 Ref: [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibodies]. PMID: 2594001 Ref: Selective killing of carcinoembryonic-antigen (CEA)-producing cells in vitro by the immunoconjugate cytorhodin-S and CEA-reactive cytorhodin-S antibody CA208. PMID: 2598192 Ref: Tumor markers in colorectal cancer. PMID: 2600057 Ref: 99mTc-labeled monoclonal anti-carcinoembryonic antigen antibody (BW 431/26). Clinical results in the detection of colorectal carcinomas and recurrences. PMID: 2602902 Ref: Influence of animal host and tumor implantation site on radio-antibody uptake in the GW-39 human colonic cancer xenograft. PMID: 2606573 Ref: Radioimmunoscintigraphy with 111In labelled monoclonal antibody fragments (F(ab')2 BW 431/31) against CEA: radiolabelling, antibody kinetics and distribution, findings in tumour and non-tumour patients. PMID: 2616103 Ref: [Clinical significance of serum CEA determination in the diagnosis of colo-rectal cancer]. PMID: 2620629 Ref: Homogeneous penetration but heterogeneous binding of antibodies to carcinoembryonic antigen in human colon carcinoma HT-29 spheroids. PMID: 2624920 Ref: [Imaging and biodistribution of 111In-labeled anti-carcinoembryonic antigen monoclonal antibodies in nude mice bearing human colon cancer xenografts]. PMID: 2625105 Ref: Prognostic factors in colorectal carcinoma: significance of peripheral T lymphocytes. PMID: 2625398 Ref: [Study of the tissue localization of carcinoembryonic antigen in tumors of the colonic mucosa]. PMID: 2627895 Ref: [Synchronous hepatic metastases of colorectal adenocarcinoma: what is the course? Apropos of 36 cases]. PMID: 2632469 Ref: The clinical significance of a new monoclonal antibody defined antigen CA195 as a tumor marker in colorectal cancer. PMID: 2634457 Ref: The application of leukocyte adherence inhibition assay to patients with colorectal cancer. Comparison with serum level of carcinoembryonic antigen and sialic acid. PMID: 2646084 Ref: [Clinical evaluation of CA-50 in cases with colorectal cancer]. PMID: 2654447 Ref: Current status of tumor markers in large bowel cancer. PMID: 2658354 Ref: Marker profile of mesothelial cells versus ovarian carcinoma cells. PMID: 2659540 Ref: Serum levels of CA 72.4, CEA and CA 19.9 in patients with colorectal carcinoma. Preliminary results. PMID: 2664021 Ref: CEA directed second-look surgery for colon and rectal cancer. PMID: 2667446 Ref: Histological correlation of 17 prospective immunoscintigraphies of recurrences of colorectal carcinomas using indium-111-labeled anti-cea and(or) 19-9 monoclonal antibodies. PMID: 2670570 Ref: [Clinical relevance of tumor markers]. PMID: 2672606 Ref: Imaging of colorectal carcinoma with radiolabeled antibodies. PMID: 2678479 Ref: Tumour markers: from carcinoembryonic antigen to products of hybridoma technology. PMID: 2680066 Ref: Prospective monitoring trial for carcinoma of colon and rectum after surgical resection. PMID: 2683153 Ref: The role of CEA, TPA and CA 19-9 in the early detection of recurrent colorectal cancer. PMID: 2693562 Ref: Carcinoembryonic antigen: function in metastasis by human colorectal carcinoma. PMID: 2697474 Ref: Immunochemical characterization of the antigen recognized by the murine monoclonal antibody A7 against human colorectal cancer. PMID: 2711385 Ref: Multivariate analysis of a tissue CEA, TPA, and CA 19.9 quantitative study in colorectal cancer patients. A preliminary finding. PMID: 2714130 Ref: The safe and effective use of postoperative radiation therapy in modified Astler Coller Stage C3 rectal cancer. PMID: 2720584 Ref: Heterogeneity in the induction and expression of carcinoembryonic antigen-related antigens in human colon cancer cell lines. PMID: 2720685 Ref: Immunoscintigraphy with indium-111 labeled monoclonal antibodies: the importance of a good display method. PMID: 2736845 Ref: [Clinical evaluation of radioimmunoscintigraphy using a I-131 anti CEA and CA 19-9 monoclonal antibodies cocktail (IMACIS-1)]. PMID: 2739074 Ref: A prospective study of the use of 111In-labelled monoclonal antibody against carcino-embryonic antigen in colorectal cancer and of some biological factors affecting its uptake. PMID: 2746136 Ref: Immunophenotypic analysis of colorectal carcinomas with monoclonal antibodies 47D10 and anti-carcinoembryonic antigen. PMID: 2762739 Ref: Preoperative prediction of late cancer-specific deaths in patients with rectal and rectosigmoid carcinoma. PMID: 2769002 Ref: [CEA (carcinoembryonic antigen): its value as an early indicator of recurrence of neoplastic disease in carcinoma of the colon and rectum]. PMID: 2771111 Ref: Colon carcinoma-associated glycoproteins recognized by monoclonal antibodies CO-029 and GA22-2. PMID: 2777278 Ref: [Surgical treatment of metastatic lung cancer arising from the colon and rectum]. PMID: 2779050 Ref: [Clinical evaluation of serum level of NCC-ST-439 as a new tumor marker for colorectal diseases--fluctuation of serum NCC-ST-439 in patients with colorectal cancers before and after surgery]. PMID: 2782914 Ref: A novel derivative of the chelon desferrioxamine for site-specific conjugation to antibodies. PMID: 2786509 Ref: Human chorionic gonadotropin in colorectal cancer and its relationship to prognosis. PMID: 2789946 Ref: Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer. PMID: 2789951 Ref: The impact of radioimmunoguided surgery (RIGS) on surgical decision-making in colorectal cancer. PMID: 2806020 Ref: Comparative study of carcinoembryonic antigen and epithelial membrane antigen expression in normal colon, adenomas and adenocarcinomas of the colon and rectum. PMID: 2806995 Ref: Comparison of serum CA 19-9 and CEA levels in a population at high risk for colorectal cancer. PMID: 2807313 Ref: [Tissue carcinoembryonic antigen: a screening test for increased cell proliferation?]. PMID: 2811584 Ref: [Carcinoembryonal antigen and the follow up of patients after resection of colon carcinoma with curative intent: a Markov process in decision analysis]. PMID: 2812076 Ref: Significance of alkaline phosphatase isozymes in the monitoring of patients with colorectal carcinoma. PMID: 2814231 Ref: Comparison of CA 72-4 with CA 19-9 and carcinoembryonic antigen in the serodiagnostics of gastrointestinal malignancies. PMID: 2814339 Ref: Studies on the control of gene expression of the carcinoembryonic antigen family in human tissue. PMID: 2912558 Ref: Implantation of colon cancer cells onto renal pelvic mucosa. A case report. PMID: 2920105 Ref: [The value of tumor markers in colorectal cancer]. PMID: 2927234 Ref: Second antibody for improvement of antibody imaging: liposome-entrapped and free preparations in animal and human studies. PMID: 12412766 |
Ref: [Two cases of ulcerative colitis with colon cancer: immunoperoxidase staining using monoclonal antibodies against gastrointestinal tumor and mucin staining]. PMID: 1691318 Ref: Value of serum acute-phase reactant proteins and carcinoembryonic antigen in the preoperative staging of colorectal cancer. A multivariate analysis. PMID: 1695546 Ref: Modulation of differentiation and proliferation in human colon carcinoma cells by transforming growth factor beta 1 and beta 2. PMID: 1697568 Ref: Murine monoclonal anti-idiotype antibody as a potential network antigen for human carcinoembryonic antigen. PMID: 1698862 Ref: Monoclonal antibodies to carcino-embryonic antigen. PMID: 1701159 Ref: The effect of interferon treatment on 14 human colorectal cancer cell lines: growth and carcinoembryonic antigen secretion in vitro. PMID: 1707938 Ref: [DNA content in hepatic metastasis of colorectal carcinoma--a comparative study with tumor growth rate (CEA doubling time): preliminary report]. PMID: 2079939 Ref: Importance of determining lysozyme in colorectal cancer. PMID: 2087630 Ref: [Immunoscintigraphy in colorectal cancers from the viewpoint of the gastroenterologist]. PMID: 2087823 Ref: The role of CEA and liver function tests in the detection of hepatic metastases from colo-rectal cancer. PMID: 2090187 Ref: Clinical usefulness of CEA as tumor marker in patients with colorectal cancer. PMID: 2092102 Ref: A protocol of the use of CEA in colorectal cancer. PMID: 2092104 Ref: Tissue CEA concentration in colorectal carcinoma and in the proximal mucosa. PMID: 2092141 Ref: Relationship between tissue and serum concentrations of carcinoembryonic antigen (CEA) in gastric and colonic carcinomas. PMID: 2092570 Ref: [Histochemical demonstration of CEA in pathology of the colorectum]. PMID: 2096882 Ref: Comparative analysis of certain metals and tumor markers in bronchopulmonary cancer and colorectal cancers. Metals and tumor markers in the neoplastic process. PMID: 2103900 Ref: The use of monoclonal anti-CEA antibody immunohistochemistry in detecting the origin of oral cavity metastasis. PMID: 2114461 Ref: [Continuous hepatic arterial infusion chemotherapy using implantable reservoir in liver metastases from colorectal cancer]. PMID: 2117907 Ref: Regulation of carcinoembryonic antigen expression in different human colorectal tumor cells by interferon-gamma. PMID: 2119252 Ref: Detection of mRNAs of carcinoembryonic antigen and nonspecific cross-reacting antigen genes in colorectal adenomas and carcinomas by in situ hybridization. PMID: 2125040 Ref: Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma. PMID: 2140070 Ref: [A case of multiple tumors]. PMID: 2161471 Ref: The adenoma to carcinoma sequence. PMID: 2163117 Ref: Immunoscintigraphy using a technetium-99m labelled monoclonal anti-CEA antibody in the follow-up of colorectal cancer and other tumours producing CEA. PMID: 2166552 Ref: Value of tissue carcinoembryonic antigen in patients with colorectal carcinoma. PMID: 2168182 Ref: Imaging with indium111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE-025 of recurrent colorectal or carcinoembryonic antigen-producing cancer in patients with rising serum carcinoembryonic antigen levels and occult metastases. PMID: 2193120 Ref: Current status of immunoscintigraphy in colorectal cancer--results of 5 years' clinical experiences. PMID: 2199223 Ref: Flow cytometry and prognostic implications in patients with solid tumors. PMID: 2201096 Ref: Surveillance strategies after resection of carcinoma of the colon and rectum. PMID: 2201097 Ref: [Study on the clinical usefulness of NCC-ST-439 in cases of digestive tract cancer]. PMID: 2212836 Ref: Monoclonal anti-CEA antibodies in the discrimination between primary pulmonary adenocarcinoma and colon carcinoma metastatic to the lung. PMID: 2235987 Ref: [Diagnostic and prognostic value of CEA and GICA in colo-rectal tumors. A caseload contribution]. PMID: 2255411 Ref: Induction of carcinoembryonic-antigen-gene expression in human colorectal carcinoma by sodium butyrate. PMID: 2268282 Ref: Is ultrasound superior to carcinoembryonic antigen (CEA) measurement in recurrent tumor screening of patients with colorectal carcinoma? PMID: 2271809 Ref: [Radioimmunoscintigraphy with monoclonal antibodies in recurrences and metastases of colorectal tumors]. PMID: 2273952 Ref: Feasibility study of radioimmunoguided surgery of colorectal carcinomas using indium-111 CEA-specific monoclonal antibody. PMID: 2286202 Ref: Postoperative surveillance of patients with carcinoma of the colon and rectum. PMID: 2294807 Ref: Polyamines in colorectal cancer. Evaluation of polyamine concentrations in the colon tissue, serum, and urine of 50 patients with colorectal cancer. PMID: 2297664 Ref: Detection of occult nodal metastases in patients with colorectal carcinoma. PMID: 2297665 Ref: Radioimmunotherapy of human colon carcinomatosis xenograft with 90Y-ZCE025 monoclonal antibody: toxicity and tumor phenotype studies. PMID: 2297752 Ref: Carcinoembryonic antigen as a selective enhancer of colorectal cancer metastasis. PMID: 2304087 Ref: A proposal of indices to describe the carcinoembryonic antigen time course in in order to assess the effects of treating recurrent colo-rectal carcinoma. PMID: 2304284 Ref: D-14 monoclonal antibody to carcinoembryonic antigen: immunohistochemical analysis of formalin-fixed, paraffin-embedded human colorectal carcinoma, tumors of non-colorectal origin and normal tissues. PMID: 2312605 Ref: Advanced colon cancer: staging and prognosis by CEA test. PMID: 2314825 Ref: Tissue carcinoembryonic antigen and DNA aneuploidy in precancerous and cancerous colorectal lesions. PMID: 2317759 Ref: [The relation between serum carcinoembryonic antigen (CEA) and response to chemotherapy in patients with advanced colorectal cancer]. PMID: 2321973 Ref: [Clinical application of radioimmunolocalization in colorectal cancer]. PMID: 2329866 Ref: [The significance of the preoperative CEA value for the prognosis of rectal cancer]. PMID: 2329893 Ref: Induction of carcinoembryonic antigen and its crossreactive gene products in human colonic adenomas and carcinomas by transforming growth factor-beta. PMID: 2334536 Ref: Utility and cost of carcinoembryonic antigen monitoring in colon cancer follow-up evaluation. A Markov analysis. PMID: 2337875 Ref: Brachytherapy in the treatment of solitary colorectal metastases to the liver. PMID: 2342376 Ref: Contents of tissue CEA and CA19-9 in colonic polyp and colorectal cancer, and their clinical significance. PMID: 2347472 Ref: Iodine-131-labeled MAb F(ab')2 fragments are more efficient and less toxic than intact anti-CEA antibodies in radioimmunotherapy of large human colon carcinoma grafted in nude mice. PMID: 2348233 Ref: The efficacy of preoperative computed tomography in patients with colorectal carcinoma. PMID: 2350106 Ref: Localization of intraperitoneal xenografts of human colon cancer by radiolabeled anti-CEA antibodies. PMID: 2355744 Ref: Serum CA 12-5 concentrations and CA 12-5/CEA ratios in patients with epithelial ovarian cancer. PMID: 2355747 Ref: Serial determinations of serum CEA in monitoring management of patients with colorectal carcinoma. PMID: 2367057 Ref: Detection of tumor associated antigen, PA8-15, in sera from pancreatic and gastrointestinal carcinoma patients. PMID: 2370693 Ref: The effects of adverse growth conditions on the shedding of carcinoembryonic antigen from cultured LS180 colon cancer cells. PMID: 2372472 Ref: Comparison of anti-fetal colonic microvillus and anti-CEA antibodies in peroperative radioimmunolocalisation of colorectal cancer. PMID: 2372492 Ref: Lectins and immunohistochemistry of colorectal cancer, its recurrences and metastases. PMID: 2379590 Ref: [CEA levels of draining venous blood and draining-peripheral CEA gradient in colorectal cancer patients: correlation with postoperative survival]. PMID: 2385221 Ref: [A study of growth and malignancy grading of stomach and colorectal cancers by serial serum carcinoembryonic antigen levels analysis]. PMID: 2398857 Ref: Independent prognostic value of ploidy in colorectal cancer. A prospective study using image cytometry. PMID: 2400968 Ref: Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy. PMID: 2407810 Ref: Tumor specificity of monoclonal antibodies to carcinoembryonic antigen. Immunohistochemical analysis. PMID: 2408131 |
Ref: Carcinoembryonic antigen regulation in human colorectal tumor cells by a site-selective cyclic AMP analogue: a comparison with interferon-gamma. PMID: 1645700 Ref: [Sialic acid and carcinoembryonic antigen (CEA) as markers of colon cancer: Preliminary report]. PMID: 1669462 Ref: [Expression and clinical significance of type-1 blood group antigens (Lea, Leb, CA19-9) in colorectal cancer--comparison with CEA]. PMID: 1675759 Ref: [Immunohistochemical study of Y hapten and carcinoembryonic antigen in rectal carcinoma]. PMID: 1686223 Ref: [Simultaneous assay of SLX and CEA does not increase the clinical usefulness of the latter in patients with colorectal carcinoma]. PMID: 1686330 Ref: Reoperation for colorectal carcinoma. PMID: 1703330 Ref: [The combined radionuclide diagnosis of rectal cancer recurrences]. PMID: 1708073 Ref: [Tumor markers--personal experience. The use of tumor markers for cancer of digestive organs]. PMID: 1709347 Ref: Reactivity of an anti-(human gastric carcinoma) monoclonal antibody with core-related peptides of gastrointestinal mucin. PMID: 1709822 Ref: Transduction and expression of the human carcinoembryonic antigen gene in a murine colon carcinoma cell line. PMID: 1712245 Ref: PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. PMID: 1714497 Ref: [Determination of carcinoembryonic antigen content as a diagnostic and prognostic test in colorectal cancer]. PMID: 1714984 Ref: Tumour marker CA 125 in patients with digestive tract malignancies. PMID: 1715601 Ref: Serological and immunohistochemical studies on sialylated carbohydrate antigens in colorectal carcinoma. PMID: 1716232 Ref: Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. PMID: 1717210 Ref: [The clinical information value of an immunoenzyme study of the tumor markers CA-19-9, CEA and AFP in cancer of the stomach, pancreas, colon and rectum]. PMID: 1726842 Ref: [Critical evaluation of preoperative instrumental staging of rectal tumors. Research on the adequate use of US, CT and MR]. PMID: 1742395 Ref: SPECT anti-CEA monoclonal antibody detection of occult colorectal carcinoma metastases. PMID: 1752096 Ref: Heterogeneity in antigenic expression and radiosensitivity in human colon carcinoma cell lines. PMID: 1757394 Ref: [Circulating "tumor markers" in gastrointestinal tumors]. PMID: 1758235 Ref: Radioimmunolocalization of colorectal carcinoma. A correlation among RIL results, surgical findings, serum tumor marker levels and the presence of CEA and CA 19.9 in tumor tissue: the experience of the Hospital de la Santa Creu i Sant Pau. PMID: 1768627 Ref: [Diagnosis using monoclonal antibody imaging in the clinical follow-up of colorectal cancer]. PMID: 1768746 Ref: [Immunoscintigraphy of colorectal cancer with 111In labeled anti-CEA monoclonal antibody (ZCE-025)]. PMID: 1770658 Ref: Serum carcinoembryonic antigen and DNA ploidy in colorectal carcinoma. A prospective study. PMID: 1771385 Ref: Evaluation of TATI and other markers in solid tumors. PMID: 1780686 Ref: Tumor-associated trypsin inhibitor (TATI) in patients with colorectal carcinoma. A critical comparison with CEA. PMID: 1780689 Ref: Tumor-associated trypsin inhibitor, TATI, in gastrointestinal cancer and related benign diseases. PMID: 1780697 Ref: [Control of colorectal cancer recurrence treated with curative surgery: results of a prospective study]. PMID: 1784761 Ref: Detection of hepatic metastases from colorectal carcinoma using indium-111 (111In) labeled monoclonal antibody (mAb): MSKCC experience with mAb 111In-C110. PMID: 1787079 Ref: Biosynthesis of carcinoembryonic antigen (CEA) gene family members expressed in human tumor cell lines: evidence for cleavage of the glycosyl phosphatidyl inositol (GPI) anchor by GPI-PLC and GPI-PLD. PMID: 1815506 Ref: Significance of CA72.4 in patients with colorectal cancer. Comparison with CEA and CA19.9. PMID: 1816871 Ref: Production and characterization of monoclonal antibodies against carcinoembryonic antigen (CEA). PMID: 1824544 Ref: An evaluation of the clinical usefulness of CEA in colorectal cancer. PMID: 1832005 Ref: [A case of pulmonary metastasis from colon cancer responding completely to high-dose 5'-DFUR plus MMC combination chemotherapy]. PMID: 1834025 Ref: [Tumor markers--a diagnostic and prognostic test]. PMID: 1851587 Ref: A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA). PMID: 1860736 Ref: The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. PMID: 1867517 Ref: Gastrointestinal cancer follow-up: the effectiveness of sequential CEA, TPA and Ca 19-9 evaluation in the early diagnosis of recurrences. PMID: 1877936 Ref: [Patients with high risk of hematogenous metastasis and recurrence in colorectal cancer: correlation with histopathologic variables and tumor markers, CEA and CA19-9, in peripheral and draining venous blood]. PMID: 1886571 Ref: Comparative analysis of cancer-associated antigen CA-195, CA 19-9 and carcinoembryonic antigen in diagnosis, follow-up and monitoring of response to chemotherapy in patients with gastrointestinal cancer. PMID: 1890143 Ref: Evaluation of serum sialic acid and carcinoembryonic antigen for the detection of early-stage colorectal cancer. PMID: 1890538 Ref: Clinical evaluation of serum tumor-associated glycoprotein-72 as a novel tumor marker for colorectal cancer patients. PMID: 1892526 Ref: Immunohistochemical analysis of plasminogen activator expression in human colorectal carcinomas: correlation with CEA distribution and tumor cell kinetics. PMID: 1901119 Ref: [Chemoembolization with degradable starch microspheres for liver metastases of colorectal cancer]. PMID: 1901474 Ref: Control of carcinoembryonic antigen gene family expression in a differentiating colon carcinoma cell line, Caco-2. PMID: 1905198 Ref: [Continuous infusion chemotherapy using an infusional port in colorectal cancer with liver metastases]. PMID: 1908658 Ref: [Effects and complications of continuous hepatic arterial infusion chemotherapy using implantable reservoir for liver metastases from colorectal cancer]. PMID: 1908660 Ref: [The efficacy of intra-arterial infusion chemotherapy in patients with metastatic liver tumors]. PMID: 1908663 Ref: Histological classification of schistosomal egg induced polyps of colon and their clinical significance. An analysis of 272 cases. PMID: 1908760 Ref: Major disagreements between immunoassays of carcinoembryonic antigen may be caused by nonspecific cross-reacting antigen 2 (NCA-2). PMID: 1914175 Ref: Role of carcinoembryonic antigen and liver function tests in the detection of recurrent colorectal carcinoma. PMID: 1914746 Ref: Kinetics of biochemical, electrophysiological and morphological events (including lysosomal disorder) during the course of suramin-induced differentiation of the human colon-cancer cell clone HT29-D4. PMID: 1917163 Ref: [Colorectal cancers: adjuvant therapy and after care (including tumor markers)]. PMID: 1926004 Ref: [Colorectal cancers: therapy of recurrences and metastases]. PMID: 1926005 Ref: [Colorectal carcinoma. Multifactorial analysis of prognostic factors following curative resection]. PMID: 1931241 Ref: Aberrant expression of intestinal mucin antigens associated with colorectal carcinoma defined by a panel of monoclonal antibodies. PMID: 1931599 Ref: Histamine, leukotriene C4 and interleukin-2 increase antibody uptake into a human carcinoma xenograft model. PMID: 1931608 Ref: Value of follow-up in the management of recurrent colorectal cancer. PMID: 1936302 Ref: [The tumor markers CEA and CA-19.9 in patients with colorectal carcinoma]. PMID: 1942906 Ref: [Tissue carcinoembryonic antigen in normal conditions and neoplastic pathology of the colorectum]. PMID: 1947401 Ref: Predominant expression of mRNA coding for nonspecific cross-reacting antigen in colorectal carcinomas. PMID: 1962152 Ref: Occult cancer in patients with deep venous thrombosis. A systematic approach. PMID: 1985747 Ref: Ultrasound-guided hepatic cryosurgery in the treatment of metastatic colon carcinoma. Preliminary results. PMID: 1991262 Ref: Standardization, specificity, and diagnostic sensitivity of four immunoassays for carcinoembryonic antigen. PMID: 1993329 Ref: Effect of hepatic cryotherapy on serum CEA concentration in patients with multiple inoperable hepatic metastases from colorectal cancer. PMID: 1994885 Ref: Leukocyte alkaline phosphatase and carcinoembryonic antigen in colorectal cancer patients (usefulness in the assessment of the stage). PMID: 1997936 Ref: In-111 labeled monoclonal anti-carcinoembryonic antigen antibody (ZCE025) in the immunoscintigraphic imaging of metastatic antigen-producing adenocarcinomas. PMID: 2004491 Ref: Liver-metastatic human colon carcinoma in immunosuppressed mice. PMID: 2011209 Ref: Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases. PMID: 2021550 Ref: Changes in leucocyte populations following murine bifunctional antibody infusion in colon cancer patients. PMID: 2025955 Ref: Tumor markers in cancer of the colon and rectum. PMID: 2036931 Ref: [Value of CEA determination in follow-up of patients with liver metastasis of colorectal cancers with loco-regional chemotherapy]. PMID: 2038900 Ref: Anastomotic recurrence of carcinoma of the colon and rectum. The value of endoscopy and serum CEA levels. PMID: 2039134 Ref: A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584. PMID: 2045852 Ref: [A case report of liver metastasis from rectal cancer effectively treated with intravenous infusion of cisplatin alone]. PMID: 2053776 Ref: [Value of endorectal sonography in the follow-up of patients treated surgically for rectum carcinoma]. PMID: 2058325 Ref: Colorectal cancer patients with high risk of hematogenous metastasis: correlation with CEA levels in peripheral and draining venous blood during the period of operation. PMID: 2062088 Ref: Initial clinical study of indium-111-labeled clone 110 anticarcinoembryonic antigen antibody in patients with colorectal cancer. PMID: 2066759 Ref: Anti-carcinoembryonic antigen immunoscintigraphy (technetium-99m-monoclonal antibody BW 431/26) and serum CEA levels in patients with suspected primary and recurrent colorectal carcinoma. PMID: 2066784 Ref: Correlated expression of mRNAs of carcinoembryonic antigen and nonspecific cross-reacting antigen genes in malignant and nonmalignant tissues of the colon. PMID: 2067130 Ref: Follow-up of patients after primary colorectal cancer resection. PMID: 2068444 Ref: Evaluation of a patient prior to second-look surgery. PMID: 2068445 Ref: Technical surgical considerations for CEA directed second-look operations and hepatic tumor excision. PMID: 2068447 Ref: CEA in tumors of other than colorectal origin. PMID: 2068450 Ref: The effect of long acting somatostatin analogue SMS 201.995 therapy on tumour kinetic measurements and serum tumour marker concentrations in primary rectal cancer. PMID: 2069853 Ref: Carcinoembryonic antigen immunoreactivity patterns in colorectal cancer: Correlation with morphologic parameters. PMID: 17590787 |
Ref: Tumor markers. PMID: 1281552 Ref: Induction of an immune response through the idiotypic network with monoclonal anti-idiotype antibodies in the carcinoembryonic antigen system. PMID: 1281819 Ref: Differences in messenger RNA expression of carcinoembryonic antigen in surgical specimens of colorectal carcinoma. PMID: 1290028 Ref: Usefulness of the determination of carcinoembryonic antigen (CEA) in the serum of patients with colorectal cancer in Albania. PMID: 1293545 Ref: Demonstration of monoclonal anti-carcinoembryonic antigen (CEA) antibody internalization by electron microscopy, western blotting and radioimmunoassay. PMID: 1295459 Ref: [Value of plasma testosterone, carcinoembryonic antigen and CA 19-9 in the differential diagnosis of pancreatic carcinoma and chronic pancreatitis]. PMID: 1300550 Ref: [Colorectal cancer. Experience in 120 patients]. PMID: 1305114 Ref: Carcinoembryonic antigen and carbohydrate 19-9 antigen as markers for colorectal carcinoma in children and adolescents. PMID: 1311626 Ref: [Significance of CEA and CA 19-9 for after care of curatively resected colorectal cancers]. PMID: 1315472 Ref: Investigation, follow-up and recurrence after resection of colorectal cancer. PMID: 1333762 Ref: [Evaluation of combined CA-19-9 and CEA assay in monitoring recurrences and metastases of colorectal cancer]. PMID: 1339738 Ref: [How to improve the results in colorectal cancer?]. PMID: 1339876 Ref: [Factors in recurrence after curative resection of rectal cancer]. PMID: 1358359 Ref: Modulation of differentiation-related responses in human colon carcinoma cells by protein kinase inhibitor H-7. PMID: 1373593 Ref: Comparison of four serum tumour markers in the diagnosis of colorectal carcinoma. PMID: 1379057 Ref: Role of protein kinase C in transforming growth factor-beta 1 induction of carcinoembryonic antigen in human colon carcinoma cells. PMID: 1380512 Ref: In vivo antitumor activity of a panel of four monoclonal antibody-vinca alkaloid immunoconjugates which bind to three distinct epitopes of carcinoembryonic antigen. PMID: 1382618 Ref: Nonspecific immunostimulation with low doses of cyclophosphamide (LDCY), thymostimulin, and Echinacea purpurea extracts (echinacin) in patients with far advanced colorectal cancers: preliminary results. PMID: 1393685 Ref: Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies. PMID: 1394228 Ref: [Metastatic carcinoma of the sigmoid colon to the thyroid gland]. PMID: 1397385 Ref: Radioimmuno-guided endoscopy (RIGE) in the detection of primary and recurrent rectal tumor. PMID: 1402314 Ref: Colon carcinoma immunoscintigraphy by monoclonal anti-CEA antibody labeled with gallium-67-aminooxyacetyldeferroxamine. PMID: 1403142 Ref: [Radioimmunoscintigraphy of colorectal tumors with 99m-Tc marked CEA antibodies. Indications and clinical value]. PMID: 1406470 Ref: [Tumor markers in colorectal cancer]. PMID: 1407623 Ref: DNA analysis of malignant effusions. Comparison with cytologic diagnosis and carcinoembryonic antigen content. PMID: 1418272 Ref: Comparison of plasma prolactin and CEA in monitoring patients with adenocarcinoma of colon and rectum. PMID: 1419646 Ref: CT findings after hepatic chemoembolization. PMID: 1430441 Ref: The role of serum carcinoembryonic antigen (CEA) in the management of patients with colorectal carcinoma: the experience of the Istituto Tumori of Milan. PMID: 1431340 Ref: CEA determination in the follow-up of extracolorectal neoplasms. PMID: 1431341 Ref: Diagnostic applications and therapeutic approaches with different preparations of anti-CEA antibodies. PMID: 1431345 Ref: Application of genetically-engineered anti-CEA antibodies for potential immunotherapy of colorectal cancer. PMID: 1431347 Ref: Effects of hyperthermia and iodine-131-labeled anticarcinoembryonic antigen monoclonal antibody on human tumor xenografts in nude mice. PMID: 1451056 Ref: [Radiolabeled monoclonal antibodies as anti-tumor missiles, their diagnostic success and therapeutic potential]. PMID: 1464034 Ref: [How are tumor markers used in diagnosis and in after-care of gastrointestinal cancers? Results of a nation-wide German survey]. PMID: 1470053 Ref: Serum carcinoembryonic antigen in relation to survival, DNA ploidy pattern, and recurrent disease in 406 colorectal carcinoma patients. PMID: 1475624 Ref: Serum values of CA72.4 in patients with gastrointestinal system tumors comparison with CEA and CA 19.9. PMID: 1486919 Ref: Pattern of growth factor, proto-oncogene and carcinoembryonic antigen gene expression in human colorectal carcinoma cell lines. PMID: 1495747 Ref: Human carcinoembryonic antigen cDNA expressed in rat carcinoma cells can function as target antigen for tumor localization of antibodies in nude rats and as rejection antigen in syngeneic rats. PMID: 1500216 Ref: Postoperative chemotherapy and follow-up program in colon cancer with high serum CEA level. PMID: 1505900 Ref: Autoradiographic analysis of radiolabeled anti-carcinoembryonic antigen monoclonal antibody CEA102 in colorectal cancer using computed radiography. PMID: 1506272 Ref: [Clinical evaluation of four tumor markers (CEA, TPA, CA50 and CA72-4) in colorectal cancer]. PMID: 1507478 Ref: Measurement of tissue carcinoembryonic antigen levels from fine-needle biopsy specimens: technique and clinical usefulness. PMID: 1509055 Ref: Circulating secretory component in relation to early diagnosis and treatment of liver metastasis from colorectal carcinomas. PMID: 1517455 Ref: [Measurement of serum protein-bound hexose--an aid in the diagnosis and after-care of colorectal cancers?]. PMID: 1519392 Ref: Thermo-stability and antitumor activity on colon cancer cell lines of monoclonal anti-CEA antibody-saporin immunotoxin. PMID: 1524725 Ref: The use of the major anoxic stress response protein P34, the K isozyme of lactate dehydrogenase, and carcinoembryonic antigen in the follow-up of patients with colorectal adenocarcinoma. PMID: 1525757 Ref: [Intermittent intra-arterial infusion chemotherapy using implantable reservoir for the treatment of hepatic metastasis]. PMID: 1530296 Ref: An idiotypic replica of carcinoembryonic antigen inducing cellular and humoral responses directed against human colorectal tumours. PMID: 1544714 Ref: Carcinoembryonic antigen levels of peripheral and draining venous blood in patients with colorectal cancer. Correlation with survival. PMID: 1568164 Ref: Role of CEA, TPA, and Ca 19-9 in the early detection of localized and diffuse recurrent rectal cancer. PMID: 1568399 Ref: Effects of recombinant human gamma-interferon on carcinoembryonic antigen expression of human colon cancer cells. PMID: 1571334 Ref: Superimposition of computed tomography and single photon emission tomography immunoscintigraphic images in the pelvis: validation in patients with colorectal or ovarian carcinoma recurrence. PMID: 1572383 Ref: Multicenter clinical trials of monoclonal antibody B72.3-GYK-DTPA 111In (111In-CYT-103; OncoScint CR103) in patients with colorectal carcinoma. PMID: 1576351 Ref: [A case report of complete remission of liver metastasis from rectal carcinoma treated with intra-arterial infusion chemotherapy]. PMID: 1580647 Ref: Radioimmunoscintigraphy of colorectal carcinoma with a 99Tcm-labelled anti-CEA monoclonal antibody (BW 431/26). PMID: 1589179 Ref: Use of serum tumor markers in the differential diagnosis between ovarian and colorectal adenocarcinomas. PMID: 1589694 Ref: [Experimental liver metastases of human colonic cancer: correlation with degree of differentiation and CEA production]. PMID: 1592651 Ref: [Diagnostic value of CA 19-9 and CEA in gastrointestinal pathology]. PMID: 1603581 Ref: Detection of recurrent colon cancer with In-111 labeled MoAb B72.3 in a patient with normal CEA and TAG-72 levels. PMID: 1611787 Ref: Factors influencing variability of localisation of antibodies to carcinoembryonic antigen (CEA) in patients with colorectal carcinoma--implications for radioimmunotherapy. PMID: 1616854 Ref: [Characteristics and reactivities of a panel of monoclonal antibodies (McAbs) recognizing human colon cancer associated antigens]. PMID: 1618088 Ref: Breast cancer mucin: an automated assay to detect mucus glycoproteins. PMID: 1626180 Ref: [The clinical relevance of anti-CEA immunoscintigraphy with the 99mTc-labelled monoclonal antibody BW 431/26. A critical assessment after 119 studies]. PMID: 1638001 Ref: Diagnostic accuracy of 99mTc-anti-CEA immunoscintigraphy in patients with liver metastases from colorectal carcinoma. PMID: 1641359 Ref: [Reoperation in colorectal carcinoma with curative intention]. PMID: 1641613 Ref: N-methylformamide effects on cell proliferation and antigenic pattern in HT-29 colon carcinoma cell line. PMID: 1643188 Ref: Clinical significance of arginase in colorectal cancer. PMID: 1643605 Ref: Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis. PMID: 1733432 Ref: [The value of radioimmunoscintigraphy compared to computed tomography in the diagnosis and relapse diagnosis of colorectal tumors]. PMID: 1733472 Ref: Metastatic potential of human colon cancer cell lines: relationship to cellular differentiation and carcinoembryonic antigen production. PMID: 1733644 Ref: Combination of serum carcino-embryonic antigen and C-reactive protein--a useful test in preoperative staging of colorectal cancer. PMID: 1737592 Ref: Elevated CA19-9 as the most significant prognostic factor in advanced colorectal carcinoma. PMID: 1738240 Ref: Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9. PMID: 1739620 |
Ref: Altered immunoglobulin A (IgA-1) levels in patients with advanced colorectal adenocarcinoma presenting with normal preoperative levels of carcinoembryonic antigen (CEA). PMID: 7504559 Ref: Antiserum to carcinoembryonic antigen recognizes a phosphotyrosine-containing protein in human colon cancer cell lines. PMID: 7680008 Ref: Sensitivity and specificity of Gold types 1 to 5 anti-carcinoembryonic antigen monoclonal antibodies: immunohistologic characterization in colorectal cancer and normal tissues. PMID: 7681033 Ref: Characterization of second-generation monoclonal antibodies against carcinoembryonic antigen. PMID: 7683969 Ref: Clinical evaluation of M43: a novel cancer-associated mucin epitope. PMID: 7684947 Ref: Marked increase in the secretion of a fully antigenic recombinant carcinoembryonic antigen obtained by deletion of its hydrophobic tail. PMID: 7688074 Ref: Serum mucin antigens CASA and MSA in tumors of the breast, ovary, lung, pancreas, bladder, colon, and prostate. A blind trial with 420 patients. PMID: 7689923 Ref: Carcinoembryonic antigen (CEA), alpha-fetoprotein, CA 19.9 and CA 125 in advanced colorectal cancer (ACC). PMID: 7690061 Ref: Adhesion to carcinoembryonic antigen by human colorectal carcinoma cells involves at least two epitopes. PMID: 7690347 Ref: Growth inhibition and differentiation of HT-29 cells in vitro by inositol hexaphosphate (phytic acid). PMID: 7691427 Ref: [Influence of carcinoembryonic protein (CEA) on the proliferation of 13 human cancer cell lines]. PMID: 8087621 Ref: Transfer of the IL-6 gene into a human colorectal carcinoma cell line and consequent enhancement of tumor antigen expression. PMID: 8102353 Ref: An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. PMID: 8141873 Ref: Release of carcinoembryonic antigen from human tumor cells by phosphatidylinositol-specific phospholipase C: highly effective extraction and upregulation from LS-174T colonic adenocarcinoma cells. PMID: 8215392 Ref: Usefulness of carcinoembryonic antigen monitoring despite normal preoperative values in node-positive colon cancer patients. PMID: 8223061 Ref: Radioimmunoscintigraphy of recurrent colorectal carcinoma using 111In-labelled murine monoclonal antibody B72.3: a comparison with contrast-enhanced computed tomography. PMID: 8233244 Ref: Malignant duodenocolic fistula: a case report. PMID: 8252465 Ref: CEA tissue staining in colorectal cancer patients--correlation with plasma CEA, histology and staging. PMID: 8265235 Ref: Modelling of serial carcinoembryonic antigen changes in colorectal cancer. PMID: 8272763 Ref: Therapeutic efficacy of a high-affinity anticarcinoembryonic antigen monoclonal antibody (COL-1). PMID: 8292968 Ref: Immunoscintigraphy with 99mTc-labelled anti-CEA monoclonal antibody in colorectal carcinoma. PMID: 8314389 Ref: Expression of carcinoembryonic antigen (CEA) and nonspecific crossreacting antigen (NCA) in gastrointestinal cancer; the correlation with degree of differentiation. PMID: 8318403 Ref: [Are there prognostic parameters for predicting the success of regional chemotherapy in nonresectable liver metastases of colorectal cancer?]. PMID: 8322537 Ref: Adrenal metastasis from carcinoma of the colon and rectum: a report of three cases. PMID: 8324338 Ref: Correlation between tumor proliferation and tumor tissue level of urokinase-type plasminogen activator. PMID: 8330641 Ref: [Prognostic value of nuclear DNA of 106 colorectal tumors, determined with microspectrocytophotometry]. PMID: 8338705 Ref: CEA-immunoscintigraphy with 99m-technetium correlates with tumour cell differentiation in colorectal cancer. PMID: 8343279 Ref: Carcinoembryonic antigen mediates in vitro cell aggregation induced by interferon-gamma in a human colon cancer cell line: requirement for active metabolism and intact cytoskeleton. PMID: 8364886 Ref: Carcinoembryonic antigen assay of intra-abdominal fine-needle aspirates. PMID: 8368446 Ref: [Continuous intra-hepatic-arterial infusion of low dose 5-fluorouracil for colorectal cancer patients with unresectable liver metastases]. PMID: 8373207 Ref: [Measurement of bile CEA levels in patients with colorectal cancer: is it of value for diagnosis of occult liver metastases aiming at prophylactic regional hepatic chemotherapy?]. PMID: 8373216 Ref: [Two cases of intrahepatic biloma during hepatic arterial infusion chemotherapy proved by CT-Scan]. PMID: 8373256 Ref: TAG-72 (CA 72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer. PMID: 8374868 Ref: [A case of postoperative pulmonary metastasis of colon cancer which responded to treatment with leucovorin and 5-FU]. PMID: 8379680 Ref: Differences between A7 antibody and anti-CEA antibody. PMID: 8383559 Ref: Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen. Experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials. PMID: 8389662 Ref: [Transcatheter arterial chemoembolization to hepatic metastases from colorectal cancer]. PMID: 8396907 Ref: Poor prognosis associated with elevated serum CA 19-9 level in advanced colorectal carcinoma, independent of DNA ploidy or SPF. PMID: 8398296 Ref: Direct comparison of a radioiodinated intact chimeric anti-CEA MAb with its F(ab')2 fragment in nude mice bearing different human colon cancer xenografts. PMID: 8398694 Ref: A comparative analysis of the serum levels of NCC-ST-439, CEA and CA19-9 in patients with colorectal carcinoma. PMID: 8405479 Ref: Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response. PMID: 8410279 Ref: Expression of colorectal carcinoma-associated antigens in colonic polyps. PMID: 8412106 Ref: Colorectal cancer imaging with iodine-123-labeled CEA monoclonal antibody fragments. PMID: 8418273 Ref: [A case of bilateral pulmonary metastasis from rectal cancer successfully treated with resection after high-dose 5'-DFUR plus MMC combination chemotherapy]. PMID: 8422179 Ref: Liver metastases with 10 human colon carcinoma cell lines in nude mice and association with carcinoembryonic antigen production. PMID: 8422623 Ref: Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon. PMID: 8425194 Ref: Histamine but neither angiotensin nor vasopressin increases antibody uptake into xenograft colorectal liver metastases. PMID: 8428300 Ref: Comparison of radioimmunotherapy and external beam radiotherapy in colon cancer xenografts. PMID: 8436526 Ref: Carcinoembryonic antigen: enhancement of liver colonisation through retention of human colorectal carcinoma cells. PMID: 8439497 Ref: AgSK1, a novel carcinoma associated antigen. PMID: 8439957 Ref: Immunoscintigraphy in the surgical management of colorectal cancer. PMID: 8441054 Ref: High-molecular-mass alkaline phosphatase as a tumor marker for colorectal cancer: comparison of two test methods. PMID: 8448874 Ref: Tumor-necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by increasing vascular permeability. PMID: 8449608 Ref: Differential regulation of carcinoembryonic antigen and biliary glycoprotein by gamma-interferon. PMID: 8453631 Ref: [Metachronous liver metastases treated with repeated liver resections and chemotherapy]. PMID: 8456517 Ref: Clinical value of determination of urokinase-type plasminogen activator antigen in plasma for detection of colorectal cancer: comparison with circulating tumor-associated antigens CA 19-9 and carcinoembryonic antigen. PMID: 8467497 Ref: [Extended resection of liver metastases in colorectal cancer]. PMID: 8474293 Ref: Effect of bowel cleansing and colonoscopy on serum CEA levels. PMID: 8478841 Ref: Quantitative analysis of anti-CEA antibody accumulation in human colorectal carcinomas. PMID: 8479932 Ref: Comparative evaluation of serum CA 195 and carcinoembryonic antigen in metastatic carcinoma. PMID: 8490911 Ref: Uptake of radiolabeled anti-CEA antibodies in human colorectal primary tumors as a function of tumor mass. PMID: 8491228 Ref: Somatostatin inhibits both in-vitro and in-vivo carcinoembryonic antigen secretion by human colon cancer. PMID: 8491320 Ref: [A correlation between serum levels of preoperative CEA and CEA immunohistochemical staining in colorectal carcinoma]. PMID: 8494653 Ref: A new approach to tumour marker assessment by perioperative determination in breast and colorectal cancer. PMID: 8496629 Ref: Biodistribution of anti-CEA F(ab')2 fragments conjugated with chelating polymers: influence of conjugate electron charge on tumor uptake and blood clearance. PMID: 8504286 Ref: Evaluation of colorectal cancer-associated mucin CA M43 assay in serum. PMID: 8504532 Ref: Comparison of doubling times of serum carcinoembryonic antigen produced by various metastatic lesions in recurrent gastric and colorectal carcinomas. PMID: 8508370 Ref: In-111 CYT-103 monoclonal antibody imaging in patients with suspected recurrent colorectal cancer. PMID: 8508386 Ref: Surgical treatment of liver metastases in patients with colorectal cancer. PMID: 8508388 Ref: Monoclonal antibody 4D3 detects small intestinal mucin antigen (SIMA)--glycoprotein in the serum of patients with colorectal cancer. PMID: 8509213 Ref: Imaging of colorectal carcinoma with technetium-99m radiolabeled Fab' fragments. PMID: 8511605 Ref: Potentiation of butyrate-induced differentiation in human colon tumor cells by deoxycholate. PMID: 8513444 Ref: Potential contribution of 131I-labelled monoclonal anti-CEA antibodies in the treatment of liver metastases from colorectal carcinomas: pretherapeutic study with dose recovery in resected tissues. PMID: 8518021 Ref: The importance of monitoring colorectal adenomas by tumor markers (ROC analysis). PMID: 8569613 |
Ref: Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. PMID: 7512130 Ref: Normal colonic epithelium adheres to carcinoembryonic antigen and type IV collagen. PMID: 7513665 Ref: Carcinoembryonic antigen staining patterns at the invasive tumor margin predict the malignant potential of colorectal carcinoma. PMID: 7515172 Ref: Pelvic resection of recurrent rectal cancer. PMID: 7524455 Ref: Evaluation of tumor-associated antigen (2H6 antigen) in detecting early stages of gastric cancer. PMID: 7527311 Ref: Adenocarcinoma in the rectum of a capped langur (Presbytis pileata). PMID: 7537336 Ref: Human recombinant TNF-alpha on localization of 90Y-radioantibody in human tumour xenografts. PMID: 7584485 Ref: Pancreas cancer-associated antigen (PCAA) in medullary thyroid carcinoma. PMID: 7609706 Ref: CGM2, a member of the carcinoembryonic antigen gene family is down-regulated in colorectal carcinomas. PMID: 7806520 Ref: [Effectiveness of quarterly assessment of CEA, TPA and GICA serum levels in gastric and colorectal carcinomas: Prospective study of 174 patients undergoing radical surgery]. PMID: 7808670 Ref: Clinical profile of a new monoclonal antibody-based immunoassay for tissue polypeptide antigen. PMID: 7836801 Ref: Differential effects of recombinant interferon-alpha and 5-fluorouracil against colon cancer cells or against peripheral blood mononuclear cells. PMID: 7847809 Ref: Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma. PMID: 7872725 Ref: [Establishment and characterization of a new cell line (KT-COLO-8) derived from a colonic mucinous adenocarcinoma]. PMID: 7873498 Ref: [Establishment of a human colon cancer-derived cell line (KC-1) which produces CEA, CA 19-9 and sialyl SSEA-1(SLX)]. PMID: 7873502 Ref: [Diagnosis and staging of colorectal cancers]. PMID: 7878360 Ref: Attitudes towards detection and management of hepatic metastases of colorectal origin: a second look. PMID: 7880770 Ref: Enhanced immune responses and anti-tumor activity by baculovirus recombinant carcinoembryonic antigen (CEA) in mice primed with the recombinant vaccinia CEA. PMID: 7881636 Ref: [DNA ploidy and cell kinetics in cancer of the rectum]. PMID: 7887585 Ref: The clinicopathologic features of serum CA 19-9-positive colorectal cancers. PMID: 7919734 Ref: p53 nuclear overexpression: an independent predictor of survival in lymph node--positive colorectal cancer patients. PMID: 7931472 Ref: [A long-survival case of unresectable liver metastasis of colon cancer by hepatic arterial intermittent multidrug infusion chemotherapy]. PMID: 7944436 Ref: Relationship of P-glycoprotein and carcinoembryonic antigen expression in human colon carcinoma to local invasion, DNA ploidy, and disease relapse. PMID: 7954255 Ref: Reappraisal of preoperative carcinoembryonic antigen levels as a prognostic factor in resectable colorectal cancer. PMID: 7988985 Ref: Dimeric recombinant IgA directed against carcino-embryonic antigen, a novel tool for carcinoma localization. PMID: 7997243 Ref: Drug monitoring of 5-fluorouracil: in vivo 19F NMR study during 5-FU chemotherapy in patients with metastases of colorectal adenocarcinoma. PMID: 8007780 Ref: [99mTc anti-carcinoembryonic antigen in colorectal cancer]. PMID: 8009660 Ref: Can preoperative and postoperative CEA predict survival after colon cancer resection? PMID: 8010568 Ref: CEA as a prognostic factor in colorectal cancer. PMID: 8010730 Ref: [11 years of experience in the surgical therapy of the liver metastases from colorectal tumors]. PMID: 8025968 Ref: The occurrence of colon cancer in patients with known premalignant colonic mucosal diseases. PMID: 8028339 Ref: Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer. PMID: 8040668 Ref: Disappearance curves of tumor markers after radical surgery. PMID: 8051433 Ref: Complete remission of liver metastases from colorectal cancer by treatment with a hepatic artery infusion (HAI) of interleukin-2-based immunochemotherapy: reports of three cases. PMID: 8054783 Ref: Transcriptional control of the human biliary glycoprotein gene, a CEA gene family member down-regulated in colorectal carcinomas. PMID: 8055923 Ref: Carcinoembryonic antigen (CEA) in serum and bile of colorectal cancer patients with or without detectable liver metastases. PMID: 8067714 Ref: Clinical evaluation of serum tumour markers CEA, CA 50 and CA 242 in colorectal cancer. PMID: 8067718 Ref: Tumor concentration and distribution of carcinoembryonic antigen measured by in vitro quantitative autoradiography. PMID: 8071700 Ref: The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. PMID: 8076486 Ref: Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab')2 antibodies. PMID: 8080740 Ref: The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer. PMID: 8080745 Ref: Immune response to a carcinoembryonic antigen polynucleotide vaccine. PMID: 8118800 Ref: Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer. PMID: 8118811 Ref: Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels. PMID: 8120546 Ref: Clearance of circulating radio-antibodies using streptavidin or second antibodies in a xenograft model. PMID: 8123481 Ref: Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Predictive value and implications for adjuvant treatment based on multivariate analysis. PMID: 8129484 Ref: Follow-up of patients with colorectal cancer. A meta-analysis. PMID: 8129488 Ref: Value of carcinoembryonic antigen in the management of colorectal cancer. PMID: 8137675 Ref: Use of CA 19-9 in the early detection of recurrences in colorectal cancer: comparison with CEA. PMID: 8146525 Ref: [Follow-up of colorectal cancers]. PMID: 8146630 Ref: [The value of CEA immunoscintigraphy for diagnosis of colorectal cancer and its metastases: results of a prospective study]. PMID: 8147155 Ref: CEA expression of colorectal adenocarcinomas is correlated with their resistance against LAK-cell lysis. PMID: 8168994 Ref: Radioimmunodetection of colorectal carcinoma with 111In-labelled monoclonal antibody IVP ZCE 025 (a tissue culture-produced anti-CEA MAb). PMID: 8170642 Ref: Late mortality and levamisole adjuvant therapy in colorectal cancer. PMID: 8198976 Ref: Current follow-up strategies after resection of colon cancer. Results of a survey of members of the American Society of Colon and Rectal Surgeons. PMID: 8200237 Ref: Radioimmunoscintigraphy of CEA/CA 19-9 producing tumors with I-131 labeled monoclonal antibodies. PMID: 8204403 Ref: CEA for monitoring colon cancer. PMID: 8283579 Ref: CEA for monitoring colon cancer. PMID: 8283580 Ref: CEA for monitoring colon cancer. PMID: 8283581 Ref: Plasma prolactin in patients with colorectal cancer. Value in follow-up and as a prognosticator. PMID: 8299078 Ref: Radioimmunodetection of colorectal carcinoma using technetium-99m-labeled Fab' fragments of the IMMU-4 anti-carcinoembryonic antigen monoclonal antibody. PMID: 8306268 Ref: Tumour markers and screening for gastrointestinal cancer: a follow up study in Finland. PMID: 8790487 Ref: Simulated microgravity does not alter epithelial cell adhesion to matrix and other molecules. PMID: 11537961 Ref: Cea and ca-19.9 as markers of colorectal neoplasms during chemotherapeutic treatment. PMID: 21607440 |
Ref: Tissue polypeptide-specific antigen (TPS) in monitoring palliative treatment response of patients with gastrointestinal tumours. PMID: 7529527 Ref: A clinical study on pseudomyxoma peritonei. PMID: 7542493 Ref: Immunohistochemical localization of carcinoembryonic antigen as a predictor of lymph node status in submucosa-invasive colorectal carcinoma. PMID: 7543404 Ref: Tumor targeting and pharmacokinetics of unmodified and modified F(ab)2 fragments of an anti-CEA murine monoclonal antibody (Immu-14). PMID: 7550018 Ref: Augmentation of carcinoembryonic antigen release from intact, viable tumor cells by a factor in human serum. PMID: 7552624 Ref: Growth suppression of human colorectal carcinoma in nude mice by monoclonal antibody C27-abrin A chain conjugate. PMID: 7555421 Ref: [Surgical treatment of metastatic lung tumor from colorectal cancer]. PMID: 7564033 Ref: Follow-up of colorectal cancer. PMID: 7571043 Ref: Effect of hepatic artery chemotherapy on survival of patients with hepatic metastases from colorectal carcinoma treated with cryotherapy. PMID: 7571679 Ref: A randomized trial of cimetidine with 5-fluorouracil and folinic acid in metastatic colorectal cancer. PMID: 7589598 Ref: Interferon alpha enhances expression of TAG-72 and carcinoembryonic antigen in patients with primary colorectal cancer. PMID: 7600563 Ref: Radioimmunoscintigraphy in the differential diagnosis of hepatic mass lesion. PMID: 7607271 Ref: Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine. PMID: 7615803 Ref: A carcinoembryonic antigen polynucleotide vaccine for human clinical use. PMID: 7621253 Ref: CEA: is it of value in colorectal cancer? PMID: 7626815 Ref: Krukenberg tumor and lung metastases from colon carcinoma diagnosed with F-18 FDG PET. PMID: 7628145 Ref: Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine. PMID: 7629885 Ref: CEA monitoring after primary therapy for colon cancer. PMID: 7635866 Ref: In vitro and in vivo footprint analysis of the promoter of carcinoembryonic antigen in colon carcinoma cells: effects of interferon gamma treatment. PMID: 7641207 Ref: Plasma tetranectin and colorectal cancer. PMID: 7646916 Ref: Recurrent pattern of digestive tract carcinoma in the Japanese: comparison of gastric cancer to colon cancer. PMID: 7657490 Ref: Significance of CA 72-4 in colorectal carcinoma. Comparison with CEA and CA 19-9. PMID: 7664904 Ref: Tumour-associated trypsin inhibitor (TATI) in patients with colorectal cancer: a comparison with CEA, CA 50 and CA 242. PMID: 7667604 Ref: Semiquantitative SPECT tumor uptake of technetium-99m-labeled anti-CEA monoclonal antibody in colorectal tumor. PMID: 7699464 Ref: [Immunocytologic detection of micro-metastatic cells in patients with gastrointestinal tumors]. PMID: 7709662 Ref: Preoperative serum levels of CEA and CA 242 in colorectal cancer. PMID: 7710956 Ref: A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity. PMID: 7712333 Ref: Adjuvant radiation therapy for rectal carcinoma: predictors of outcome. PMID: 7721638 Ref: [Tc-99m-labeled anti-CEA antibodies in intraoperative diagnosis of colorectal cancer]. PMID: 7724366 Ref: The association of preoperative serum tumour markers with Dukes' stage and survival in colorectal cancer. PMID: 7734306 Ref: Resection of colorectal liver metastases. PMID: 7740812 Ref: [The prognostic value of common predictive variables in rectal cancer]. PMID: 7742049 Ref: Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse. PMID: 7750106 Ref: Immunoscintigraphy using 99mTc-labeled anti-CEA monoclonal antibody for patients with colorectal cancer. PMID: 7763024 Ref: The effect of extracellular calcium on colonocytes: evidence for differential responsiveness based upon degree of cell differentiation. PMID: 7772641 Ref: Carbohydrate structures of a normal counterpart of the carcinoembryonic antigen produced by colon epithelial cells of normal adults. PMID: 7772858 Ref: Synergistic effects of IL-6 and IFN-gamma on carcinoembryonic antigen (CEA) and HLA expression by human colorectal carcinoma cells: role for endogenous IFN-beta. PMID: 7780031 Ref: Potential value of biliary CEA assay in early detection of colorectal adenocarcinoma liver metastases. PMID: 7781796 Ref: Role of protein kinase C alpha in the induction of carcinoembryonic antigen by transforming growth factor beta 1. PMID: 7790386 Ref: [A case of remarkable response of colon cancer with multiple liver and bone metastasis treated with tegafur and cisplatin]. PMID: 7826067 Ref: CEA-mediated homotypic aggregation of human colorectal carcinoma cells in a malignant effusion. PMID: 7850776 Ref: Carcinoembryonic antigen in staging and follow-up of patients with solid tumors. PMID: 7863220 Ref: Radiolabeled chimeric anti-CEA monoclonal antibody compared with the original mouse monoclonal antibody for surgically treated colorectal carcinoma. PMID: 7884504 Ref: Comparison of complete versus fragmented technetium-99m-labeled anti-CEA monoclonal antibodies for immunoscintigraphy in colorectal cancer. PMID: 7884505 Ref: [10-year follow-up after surgery for colon cancer: no further mortality from cancer after 7 years]. PMID: 7885501 Ref: Elevated carcinoembryonic antigen levels correlating with disease recurrence in a patient with adenoid cystic carcinoma. PMID: 8522446 Ref: DNA fragmentation and CEA production in collagen gel culture of human colon carcinoma cells. PMID: 8528511 Ref: Cancer marker assessment: case report on salivary and urinary CEA. PMID: 8555430 Ref: [A new concept in imaging pelvic recurrence of curatively operated rectal carcinoma--image fusion of nuclear magnetic resonance tomography and anti-CEA immunoscintigraphy (SPECT): technique and clinical example]. PMID: 8560891 Ref: Small intestinal mucin antigen (SIMA); a novel tumour marker in colorectal cancer? PMID: 8572651 Ref: Preclinical evaluation in nonhuman primates of an anti-idiotypic antibody that mimicks the carcinoembryonic antigen. PMID: 8574471 Ref: [Stimulation of differentiation of LIM 1215 large intestinal tumor cells during expression of the p53 exogenous antioncogene or the activated ras oncogene]. PMID: 8579493 Ref: Repeated hepatic resections for recurrent metastasis of colorectal cancer. PMID: 8586373 Ref: Anti-CEA labelling kit BW 431/26. Results of the European multicenter trial. PMID: 8596740 Ref: Detection efficiency of colorectal carcinoma recurrence using technetium pertechnetate-anti-carcinoembryonic antigen monoclonal antibody BW 431/26. PMID: 8625094 Ref: The influence of the local environment on tissue architecture of colorectal carcinoma (CRC) cell aggregates and its consequence for tumour attack by lymphocytes in vitro and in vivo. PMID: 8652264 Ref: [Significance of CEA and CA242 in the diagnosis of colorectal carcinoma]. PMID: 8697997 Ref: Five-year survival versus initial concentrations and longitudinal serum CEA patterns in patients with colorectal carcinoma. PMID: 8748235 Ref: Prognostic factors affecting the survival of operated patients with colorectal cancer: significance of delayed hypersensitivity skin reactions and nutritional status. PMID: 8775467 Ref: The role of tumor markers in the diagnosis of hepatocellular carcinoma, with special reference to the des-gamma-carboxy prothrombin. PMID: 9346575 Ref: Correlation between tps and cea in patients with colorectal-cancer. PMID: 21552835 Ref: Influence of retrovirally transduced human tumor-necrosis-factor-alpha on the expression of C-myc, k-ras, C-jun, p53, tgf-alpha, and cea in human colon-carcinoma cell-lines. PMID: 21556635 Ref: Breast-tumor xenograft targeting and therapy studies using radiolabeled chimeric anti-cea monoclonal-antibody t84.66. PMID: 21597719 Ref: Tissue polypeptide antigen-specific (tps) and carcinoembryonic antigen (cea) levels in cancerous and precancerous lesions in human colon. PMID: 21597777 |
Ref: Field effect of human colon carcinoma on normal mucosa: relevance of carcinoembryonic antigen expression. PMID: 7501974 Ref: Second-look operation for recurrent colorectal cancer based on carcinoembryonic antigen and imaging techniques. PMID: 8601361 Ref: Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibody. PMID: 8605088 Ref: Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. PMID: 8608500 Ref: Prognostic variable in patients with advanced colorectal cancer treated with fluorouracil and leucovorin-based chemotherapy. PMID: 8614363 Ref: Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors. PMID: 8620497 Ref: Identification of a superficial bladder tumor-associated glycoform of the carcinoembryonic antigen by monoclonal antibody 19A211. PMID: 8631032 Ref: Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer. PMID: 8656247 Ref: Value of radioimmunoscintigraphy with technetium-99m labelled anti-CEA monoclonal antibody (BW431/26) in the detection of colorectal cancer. PMID: 8662095 Ref: [Early cerebral metastasis of colonic adenocarcinoma]. PMID: 8664071 Ref: Differences in serum tumor markers between colon and rectal cancer. Comparison of CA 242 and carcinoembryonic antigen. PMID: 8674374 Ref: Prognostic factors of colorectal cancer. Results of multivariate analysis of curative resection cases with or without adjuvant chemotherapy. PMID: 8677916 Ref: Surgery for lung metastases from colorectal cancer: analysis of prognostic factors. PMID: 8683235 Ref: Limited clinical significance of the serum tumour marker Ca 72-4 in colorectal cancer. PMID: 8687147 Ref: Serum CA 242 and CEA detect different patients with recurrent colorectal cancer. PMID: 8687164 Ref: A colorimetric immunoassay for the detection of E-cadherin and carcinoembryonic antigen (CEA) expression on human colon carcinoma cell lines in vitro. PMID: 8689623 Ref: Serum tumor markers in colorectal cancer staging, grading, and follow-up. PMID: 8691835 Ref: [Comparative study on biological difference between gastric cancer and colorectal cancer]. PMID: 8692141 Ref: Novel approaches to tumor detection and therapy using a combination of monoclonal antibody and cytokine. PMID: 8694532 Ref: TAG-72 expression and its role in the biological evaluation of human colorectal cancer. PMID: 8694534 Ref: Comparative evaluation of four tumor markers, CA 242, CA 19/9, TPA and CEA in carcinomas of the colon. PMID: 8694564 Ref: Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group. PMID: 8708720 Ref: [Follow up in carcinoma of the large intestine]. PMID: 8712616 Ref: Management of recurrent colorectal cancer: another look at carcinoembryonic antigen-detected recurrence. PMID: 8719729 Ref: Preoperative therapy for advanced pelvic malignancy by isolated pelvic perfusion with the balloon-occlusion technique. PMID: 8726186 Ref: Surgical resection of pulmonary metastases from colorectal carcinoma. Five-year survival and main prognostic factors. PMID: 8737691 Ref: Resection of liver metastases from colorectal cancer: are there any truly significant clinical prognosticators? PMID: 8756838 Ref: Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancer. PMID: 8758246 Ref: Ultrasensitive heterogeneous immunoassay using photothermal deflection spectroscopy. 2. Quantitation of ultratrace carcinoembryonic antigen in human sera. PMID: 8794934 Ref: Xanthogranulomatous cystitis as a cause of elevated carcinoembryonic antigen mimicking recurrent colorectal cancer. Report of a case. PMID: 8797658 Ref: Detection of occult liver metastases by measurement of biliary carcinoembryonic antigen concentrations. PMID: 8817226 Ref: Enhancement of radiolabeled antibody binding and tumor localization through adenoviral transduction of the human carcinoembryonic antigen gene. PMID: 8818643 Ref: Biodistribution of anti-CEA F(ab')2 fragments after intra-arterial and intravenous injection in patients with liver metastases due to colorectal carcinoma. PMID: 8822748 Ref: Comparative targeting of human colon-carcinoma multicell spheroids using one- and two-step (bispecific antibody) techniques. PMID: 8824563 Ref: Strategies for the development of recombinant vaccines for the immunotherapy of breast cancer. PMID: 8825120 Ref: Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer. PMID: 8826859 Ref: Immunohistochemical characteristics of colorectal carcinoma with DNA replication errors. PMID: 8835761 Ref: Local and regional recurrence of carcinoma of the colon and rectum: II. Factors relating to operative technique. PMID: 8837299 Ref: Accumulation of NCC-CO-411 monoclonal antibody in human colorectal adenocarcinoma through binding of the released carcinoembryonic antigen in nude mice. PMID: 8839961 Ref: Mucin-like carcinoma-associated antigen serum levels in patients with adenocarcinomas originating from ovary, breast and colon. PMID: 8840180 Ref: Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor alpha. PMID: 8840995 Ref: Carcinoembryonic antigen induces cytokine expression in Kuppfer cells: implications for hepatic metastasis from colorectal cancer. PMID: 8841002 Ref: 99Tcm-IMMU4 imaging in recurrent colorectal cancer: efficacy and impact on surgical management. PMID: 8843115 Ref: [Continuous hepatic arterial infusion chemotherapy with low-dose CDDP plus 5-FU for liver metastases from colorectal carcinoma]. PMID: 8854771 Ref: [Prognosis of hepatic metastasis from colorectal cancer following arterial infusion chemotherapy--assessment from the percentage of tumor involved area and tumor markers]. PMID: 8854773 Ref: Regulation of carcinoembryonic antigen expression in human colon carcinoma cells by the organ microenvironment. PMID: 8863665 Ref: [Prognostic factors in local recurrence rate after surgical therapy of rectal carcinomas]. PMID: 8867343 Ref: Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology. PMID: 8874347 Ref: Results of a phase I trial of a recombinant vaccinia virus that expresses carcinoembryonic antigen in patients with advanced colorectal cancer. PMID: 8876893 Ref: [Clinical usefulness of serum CYFRA21-1 in colorectal cancer]. PMID: 8886047 Ref: Bispecific antibody mediated targeting of nido-carboranes to human colon carcinoma cells. PMID: 8889012 Ref: The role of acute-phase reactant proteins, carcinoembryonic antigen and CA 19-9 as a marker in the preoperative staging of colorectal cancer: a prospective clinical study. PMID: 8912078 Ref: MR imaging, CT and CEA scintigraphy in the diagnosis of local recurrence of rectal carcinoma. PMID: 8915293 Ref: Carcino-embryonic antigen--no help with the differential diagnosis. PMID: 8935750 Ref: The carcinoembryonic antigen (CEA) modulates effector-target cell interaction by binding to activated lymphocytes. PMID: 8945616 Ref: NCCN Colorectal Cancer Practice Guidelines. The National Comprehensive Cancer Network. PMID: 8953601 Ref: [Surgical resection of colorectal liver metastases: Gold standard for solitary and radically resectable lesions]. PMID: 8963836 Ref: CA-125 in fine-needle aspirates of solid tumors: comparison with cytologic diagnosis and carcinoembryonic antigen (CEA) assay. PMID: 8964167 Ref: [Hepatic metastases of colorectal cancers: intra-arterial chemotherapy. Value and indications]. PMID: 8977580 Ref: Detection of K-ras point mutations in mesenteric venous blood from colorectal cancer patients by enriched polymerase chain reaction and single-strand conformation polymorphism analysis. PMID: 9001346 Ref: [A case of CEA and CA19-9 producing recurrent transitional cell carcinoma in an Indiana pouch after total cystectomy]. PMID: 9013232 Ref: Identification of carcinoembryonic antigen-producing cells circulating in the blood of patients with colorectal carcinoma by reverse transcriptase polymerase chain reaction. PMID: 9014772 Ref: Australian experience of cryoablation of liver tumors: metastases. PMID: 9019359 Ref: Case report of primary squamous carcinoma of the rectum. PMID: 9028152 Ref: Effect of pre-irradiation on radiopharmaceutical localization in human colon tumor xenografts using mono- and bispecific monoclonal antibodies. PMID: 9042206 Ref: [Lewis antigens in human colon carcinoma]. PMID: 9072776 Ref: [Liver metastasis. Clinico-pathological prognostic factors in metastasis from colorectal cancer]. PMID: 9214268 Ref: [Long-term follow-up results of eleven cases after resection of hepatic metastases from colorectal cancer]. PMID: 9387259 Ref: Phase II study of dual 131I-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancer. PMID: 9816134 Ref: Antigen heterogeneity in advanced colorectal and breast cancer. PMID: 21541535 Ref: Serum carcinoembryonic antigen (CEA) correlates with the survival time during 5-FU hepatic arterial infusion chemotherapy for unresectable colorectal hepatic metastases. PMID: 21541578 Ref: Cell mediated cytotoxicity of human colon carcinoma cells by a monoclonal antibody (R4) recognizing the carcinoembryonic antigen (CEA) and CEA-related molecules. PMID: 21544473 |
Ref: Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site. PMID: 8980361 Ref: A colonic tissue architecture assay applied to human colon carcinoma cells. PMID: 9028835 Ref: Decreased expression of biliary glycoprotein in hepatocellular carcinomas. PMID: 9036863 Ref: Serum carcinoembryonic antigen concentration doubling time correlates with tumor biology and life expectancy in patients with recurrent gastrointestinal carcinoma. PMID: 9041925 Ref: Induction of antitumor immunity by an anti-idiotype antibody mimicking carcinoembryonic antigen. PMID: 9044852 Ref: The 3' untranslated region of the carcinoembryonic antigen gene plays a minimal role in the regulation of gene expression. PMID: 9056678 Ref: Liver resection for colorectal metastases. PMID: 9060531 Ref: Influence of the host microenvironment on the clonal selection of human colon carcinoma cells during primary tumor growth and metastasis. PMID: 9062390 Ref: Docetaxel enhances the expression of E-cadherin and carcinoembryonic antigen (CEA) on human colon cancer cell lines in vitro. PMID: 9066624 Ref: Pharmacokinetics and experimental PET imaging of a bromine-76-labeled monoclonal anti-CEA antibody. PMID: 9074527 Ref: Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies. PMID: 9074529 Ref: Value of carcinoembryonic antigen monitoring in curative surgery for recurrent colorectal carcinoma. PMID: 9075747 Ref: N-terminal peptide of type III procollagen: a possible predictor of colorectal carcinoma recurrence. PMID: 9083150 Ref: Induction of nonspecific cross-reacting antigen mRNA by interferon-gamma and anti-fibronectin receptor antibody in colon cancer cells. PMID: 9085168 Ref: Significance of postoperative serum level of carcinoembryonic antigen (CEA) and actual half life of CEA in colorectal cancer patients. PMID: 9100477 Ref: [Diagnosis of local recurrence of colorectal cancer, using PET and immunoscintigraphy by means of 131I or 111In anti-CEA monoclonal antibody]. PMID: 9101544 Ref: Combination of monoclonal antibodies for radioimmunoguided surgery. PMID: 9112146 Ref: Down-regulation of carcinoembryonic antigen family member 2 expression is an early event in colorectal tumorigenesis. PMID: 9135022 Ref: Slope analysis of CA19-9 and CEA for predicting recurrence in colorectal cancer patients. PMID: 9137502 Ref: Several carcinoembryonic antigens (CD66) serve as receptors for gonococcal opacity proteins. PMID: 9151893 Ref: Cell-surface levels of human carcinoembryonic antigen are inversely correlated with colonocyte differentiation in colon carcinogenesis. PMID: 9166289 Ref: Tumor markers in the diagnosis of malignant serous effusions. PMID: 9167746 Ref: Evaluation of serum carcinoembryonic antigen monitoring in the follow-up of colorectal cancer patients with metastatic lymph nodes and a normal preoperative serum level. PMID: 9176713 Ref: [Carcinoembryonic antigen, CEA, in colorectal cancer. An insensitive marker which may be excluded from follow-ups]. PMID: 9182180 Ref: Immunophenotyping of human HT29 colon cancer cell primary tumours and their metastases in severe combined immunodeficient mice. PMID: 9184853 Ref: Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG. PMID: 9189130 Ref: Expression of CD66a (human C-CAM) and other members of the carcinoembryonic antigen gene family of adhesion molecules in human colorectal adenomas. PMID: 9192807 Ref: Induction of carcinoembryonic antigen expression in a three-dimensional culture system. PMID: 9196893 Ref: Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients. PMID: 9208961 Ref: The miniscule benefit of serial carcinoembryonic antigen monitoring after effective curative treatment for primary colorectal cancer. PMID: 9208962 Ref: Expression of transgenic carcinoembryonic antigen (CEA) in tumor-prone mice: an animal model for CEA-directed tumor immunotherapy. PMID: 9212243 Ref: An evaluation of postoperative follow-up tests in colon cancer patients treated for cure. PMID: 9216852 Ref: Early detection of locally recurrent rectal cancer by endosonography. PMID: 9227247 Ref: Analysis of specific accumulation of radiolabeled anti-carcinoembryonic antigen monoclonal antibody CEA 102 in colorectal cancer using computed radiography. PMID: 9232326 Ref: Dysregulation of carcinoembryonic antigen group members CGM2, CD66a (biliary glycoprotein), and nonspecific cross-reacting antigen in colorectal carcinomas. Comparative analysis by northern blot and in situ hybridization. PMID: 9250164 Ref: Detection of occult liver metastases in colorectal cancer by measurement of biliary carcinoembryonic antigen. PMID: 9252708 Ref: Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model. PMID: 9258460 Ref: Radioimmunoguided surgery benefits for recurrent colorectal cancer. PMID: 9259962 Ref: [Probe-guided surgery of colorectal carcinoma]. PMID: 9273809 Ref: Cellular fibronectin concentration in the plasma of patients with malignant and benign diseases: a comparison with CA 19-9 and CEA. PMID: 9310245 Ref: Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma. PMID: 9329568 Ref: Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance. PMID: 9329569 Ref: [Follow up after potential curative surgery of colorectal cancer. Guidelines from the Norwegian Gastrointestinal Cancer Group]. PMID: 9340857 Ref: Histopathological and prognostic evaluation of immunohistochemical findings in colorectal cancer. PMID: 9342635 Ref: Oncogenic c-Ki-ras but not oncogenic c-Ha-ras up-regulates CEA expression and disrupts basolateral polarity in colon epithelial cells. PMID: 9346938 Ref: Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: lack of correlation. PMID: 9378556 Ref: [Role of imaging in abdominopelvic follow-up after resection of colorectal cancer]. PMID: 9378784 Ref: [Arterial infusion chemotherapy in pelvic space for advanced rectal cancer]. PMID: 9382505 Ref: [A case of multiple colonic liver metastases treated successfully with percutaneous isolated liver chemoperfusion using cisplatin]. PMID: 9382524 Ref: [A new two-part therapy for multiple bilobar liver metastases of colorectal cancer--treatment of one lobe with partial hepatectomy and the other with arterial chemotherapy]. PMID: 9382525 Ref: [A case of huge liver metastasis from colon cancer successfully treated by hepatic intraarterial infusion of low-dose 5-FU]. PMID: 9382526 Ref: Perspectives on oncologic imaging with radiolabeled antibodies. PMID: 9406694 Ref: Therapy for colon carcinoma xenografts with bispecific antibody-targeted, iodine-131-labeled bivalent hapten. PMID: 9406716 Ref: [After-care of colorectal carcinoma: what has efficacy?]. PMID: 9411673 Ref: Necrosis in 84 ovarian carcinomas: a morphologic study of primary versus metastatic colonic carcinoma with a selective immunohistochemical analysis of cytokeratin subtypes and carcinoembryonic antigen. PMID: 9421090 Ref: [Comparative study of the role of CA 19-9, CA 72-4 and CEA tumor antigens in the diagnosis of pancreatic cancer and other gastrointestinal malignant diseases]. PMID: 9432648 Ref: Metaplastic shadow cells in rectal adenocarcinoma: report of a case with immunohistochemical study. PMID: 9438008 Ref: The effect of colonoscopy on tumor markers. PMID: 9438630 Ref: Plasma sialic acid as a marker of the effect of the treatment on metastatic colorectal cancer. PMID: 9470809 Ref: Surveillance after colorectal cancer surgery. PMID: 9484923 Ref: Phosphorothioated antisense c-myc oligonucleotide inhibits the growth of human colon carcinoma cells. PMID: 9494542 Ref: CEA as a prognostic index in colorectal cancer. PMID: 9640796 Ref: Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen. PMID: 9815809 Ref: Biliary glycoprotein is overexpressed in human colon cancer cells with high metastatic potential. PMID: 9834361 Ref: Prognostic values of serum CA19-9 and CEA levels for colorectal cancer. PMID: 21590148 |
Ref: Preclinical characterization and in vivo imaging studies of an engineered recombinant technetium-99m-labeled metallothionein-containing anti-carcinoembryonic antigen single-chain antibody. PMID: 9443738 Ref: A predictive value of carcinoembryonic antigen in draining venous blood for colorectal cancer patients with postoperative hematogenous metastases. PMID: 9466050 Ref: Phase-I/II radio-immunotherapy study with Iodine-131-labeled anti-CEA monoclonal antibody F6 F(ab')2 in patients with non-resectable liver metastases from colorectal cancer. PMID: 9466665 Ref: Targeting strategy for gene delivery to carcinoembryonic antigen-producing cancer cells by retrovirus displaying a single-chain variable fragment antibody. PMID: 9472783 Ref: Resection of colorectal liver metastases: 25-year experience. PMID: 9494419 Ref: Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target. PMID: 9514045 Ref: Molecular mimicry of carcinoembryonic antigen by peptides derived from the structure of an anti-idiotype antibody. PMID: 9515808 Ref: Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. PMID: 9527052 Ref: Mice transgenic for human carcinoembryonic antigen as a model for immunotherapy. PMID: 9537250 Ref: The utility of monitoring carcinoembyronic antigen during systemic therapy for advanced colorectal cancer. PMID: 9538153 Ref: Shared tumor antigens in colorectal carcinoma and neuroendocrine tumors. PMID: 9544435 Ref: [Detection of hL6-mRNA: new possibilities in serologic tumor diagnosis of colorectal carcinomas]. PMID: 9556889 Ref: Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. PMID: 9563547 Ref: Protein kinase Calpha controls the adhesion but not the antiproliferative response of human colon carcinoma cells to transforming growth factor beta1: identification of two distinct branches of post-protein kinase Calpha adhesion signal pathway. PMID: 9564886 Ref: [Serum carcinoembryonic antigen doubling time in patients with recurrent gastrointestinal carcinoma and its relationship to tumor biology and life expectancy]. PMID: 9589054 Ref: Plasma D-dimer level in patients with colorectal cancer: its role as a tumor marker. PMID: 9590700 Ref: Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites. PMID: 9596273 Ref: Expression in cytotoxic T lymphocytes of a single-chain anti-carcinoembryonic antigen antibody. Redirected Fas ligand-mediated lysis of colon carcinoma. PMID: 9603473 Ref: Significance of local recurrence of rectal cancer as a local or disseminated disease. PMID: 9607539 Ref: Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reactions for carcinoembryonic antigen and cytokeratin 20. PMID: 9610661 Ref: Soluble CD44 and CD44v6 serum levels in patients with colorectal cancer are independent of tumor stage and tissue expression of CD44v6. PMID: 9625129 Ref: Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer. PMID: 9626470 Ref: Follow-up of colon cancer: detection of liver metastases: benefit and periodicity. PMID: 9629764 Ref: Selective expression of carcinoembryonic antigen promoter in cancer cell lines: targeting strategy for gene therapy in colorectal cancer. PMID: 9645743 Ref: Transcriptional regulation of the non-specific cross-reacting antigen gene, a member of the carcinoembryonic antigen gene family up-regulated in colorectal carcinomas. PMID: 9654079 Ref: Phase I study of E7010. PMID: 9654112 Ref: Serum carcinoembryonic antigen as a prognostic factor in resectable gastric cancer. PMID: 9660027 Ref: The value of tumor markers in colorectal cancer. PMID: 9670248 Ref: Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest x-ray, and colonoscopy. PMID: 9671067 Ref: Initial TPS serum level as an indicator of relapse and survival in colorectal cancer. PMID: 9677475 Ref: Leukocyte alkaline phosphatase, CA15-3, CA125, and CEA in cancer patients. PMID: 9678617 Ref: Gene therapy for colon cancer. PMID: 9684100 Ref: Value of endoscopic ultrasonography for assessment of patients presenting elevated tumor marker levels after surgery for colorectal cancers. PMID: 9693895 Ref: [Preoperative CEA level predicts outcomes of hepatic resection for liver metastases from colorectal cancer]. PMID: 9703845 Ref: [Clinical use of CEA in the management of colorectal cancer]. PMID: 9708003 Ref: Serum and tissue CEA in colorectal cancer: clinical relevance. PMID: 9708004 Ref: Colorectal cancer: morphologic variables related with carcinoembryonic antigen serum elevation (CEA). PMID: 9708005 Ref: The clinical significance of u-FCC, an antigen of anti-fucosylceramide antibody found in urine, in patients with gastric and colorectal carcinoma. PMID: 9708928 Ref: Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. PMID: 9712565 Ref: Orthotopic xenografts of human melanoma and colonic and ovarian carcinoma in sheep to evaluate radioimmunotherapy. PMID: 9716032 Ref: Radiologically placed hepatic artery catheter allows selection of patients with high-volume liver metastases for regional chemotherapy. PMID: 9727242 Ref: Prognostic markers in rectal carcinoma. PMID: 9730420 Ref: Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood. PMID: 9748132 Ref: [Follow-up after colorectal cancer. Undeserved neglect of CEA-analysis]. PMID: 9748821 Ref: Comparison of carcinoembryonic antigen promoter regions isolated from human colorectal carcinoma and normal adjacent mucosa to induce strong tumor-selective gene expression. PMID: 9754658 Ref: [Surgical treatment of pulmonary metastasis of colorectal cancer. Prognostic survival factors]. PMID: 9767880 Ref: Role of carcinoembryonic antigen in the management of advanced colorectal cancer. PMID: 9786312 Ref: Effect of the combined treatment with 5-fluorouracil, gamma-interferon or folinic acid on carcinoembryonic antigen expression in colon cancer cells. PMID: 9796980 Ref: Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer. PMID: 9823977 Ref: Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction. PMID: 9823981 Ref: Tributyrin induces growth inhibitory and differentiating effects on HT-29 colon cancer cells in vitro. PMID: 9824654 Ref: Radioimmunoguided surgery in colorectal cancer: a 6-year experience with four different technical solutions. PMID: 9829377 Ref: Radioimmunoguided surgery benefits in carcinoembryonic antigen-directed second-look surgery in the asymptomatic patient after curative resection of colorectal cancer. PMID: 9829384 Ref: A single-chain immunotoxin against carcinoembryonic antigen that suppresses growth of colorectal carcinoma cells. PMID: 9829749 Ref: Polynucleotide immunization of nonhuman primates against carcinoembryonic antigen. PMID: 9829759 Ref: Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen. PMID: 9829838 Ref: [Prognostic factors in colorectal adenocarcinoma]. PMID: 9835125 Ref: Modulation of carcinoembryonic antigen release by glucosylceramide--implications for HT29 cell differentiation. PMID: 9851714 Ref: Characteristics of two cancer cell lines derived from metastatic foci in liver and peritoneum of a patient with colon cancer. PMID: 9853557 Ref: Immunohistochemical localization of epithelial glycoprotein EGP-2 and carcinoembryonic antigen in normal colonic mucosa and colorectal tumors. PMID: 9854475 Ref: Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients. PMID: 9867150 Ref: Monitoring carcinoembryonic antigen in colorectal cancer: is it still useful? PMID: 9872539 Ref: Prolactin and colorectal cancer: is there a connection? PMID: 9923090 Ref: [Hepatic resections for primary and secondary malignant pathology of the liver: our experience]. PMID: 10021708 Ref: Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer. PMID: 10070308 Ref: OVX1 and CEA in patients with colon carcinoma, colon polyps and benign colon disorders. PMID: 10079388 Ref: Preoperative carbohydrate antigen 195 (CA195) and CEA serum levels as prognostic factors in patients with colorectal cancer. PMID: 10079391 Ref: Adhesion of colorectal carcinoma cells to the endothelium is mediated by cytokines from CEA stimulated Kupffer cells. PMID: 10211983 Ref: [Early postoperative intraperitoneal perfusion chemotherapy for advanced colorectal cancer]. PMID: 10921014 Ref: Gene therapy for human colorectal carcinoma using human CEA promoter contro led bacterial ADP-ribosylating toxin genes human CEA: PEA & DTA gene transfer. PMID: 11819328 Ref: Increased serum carcinoembryonic antigen levels as an early sign of medullary thyroid carcinoma. PMID: 15251732 |
Ref: Clinicopathological variables and p53 overexpression as a combined prognosticator for hematogenic recurrence in colorectal cancer. PMID: 9989413 Ref: Breast cancer imaging with radiolabeled antibodies. PMID: 9990682 Ref: [A case of multiple liver metastases showing good response by administration of carmofur alone in an aged patient with colorectal cancer]. PMID: 10065100 Ref: [Radioimmunoscintigraphy of colorectal cancer using the anti-CEA monoclonal antibody BW 431/26. Final results]. PMID: 10074212 Ref: Elevated serum levels of transforming growth factor-beta1 in patients with colorectal carcinoma: its association with tumor progression and its significant decrease after curative surgical resection. PMID: 10091729 Ref: [Thermo-chemotherapy using low-dose CPT-11 in a patient with local recurrence of rectal cancer]. PMID: 10097756 Ref: Indicators of recurrence following cryotherapy for hepatic metastases from colorectal cancer. PMID: 10100794 Ref: Tumor targeting with newly designed biparatopic antibodies directed against two different epitopes of the carcinoembryonic antigen (CEA). PMID: 10188732 Ref: Serum YKL-40 and colorectal cancer. PMID: 10188896 Ref: The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. PMID: 10202129 Ref: Influence of metastatic site as an additional predictor for response and outcome in advanced colorectal carcinoma. PMID: 10206296 Ref: Carcinoembryonic antigen: its value in the follow-up of patients with colorectal cancer. PMID: 10207736 Ref: Serum iron and ferritin levels in patients with colorectal cancer in relation to the size, site, and disease stage of cancer. PMID: 10213118 Ref: BR-MA, OM-MA, GI-MA and CEA: clinical evaluation using the IMMULITE analyzer. PMID: 10213919 Ref: [Monitoring colorectal cancer after surgical resection]. PMID: 10228469 Ref: Sialyl Tn antigen expression is associated with the prognosis of patients with advanced colorectal cancer. PMID: 10228794 Ref: Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver. PMID: 10228796 Ref: Multidrug-resistant phenotype influences the differentiation of a human colon carcinoma cell line. PMID: 10334913 Ref: The relationship between prognosis and CEA-dt after hepatic resection in patients with colorectal carcinomas. PMID: 10336810 Ref: Carcinoembryonic antigen gene and carcinoembryonic antigen expression in the liver metastasis of colorectal carcinoma. PMID: 10340466 Ref: Effective and safe gene therapy for colorectal carcinoma using the cytosine deaminase gene directed by the carcinoembryonic antigen promoter. PMID: 10341879 Ref: Radioimmunoluminography: a tool for relating tissue antigen concentration to clinical outcome. PMID: 10360677 Ref: Experience of 1446 rectal cancer patients in Korea and analysis of prognostic factors. PMID: 10367255 Ref: A thousand points of light or just dim bulbs? Radiolabeled antibodies and colorectal cancer imaging. PMID: 10370360 Ref: CEA and CA 19-9 as prognostic indexes in colorectal cancer. PMID: 10370636 Ref: Serological studies on CEA, CA 19-9, STn and SLX in colorectal cancer. PMID: 10370638 Ref: Combined therapy with radiofrequency thermal ablation and intra-arterial infusion chemotherapy for hepatic metastases from colorectal cancer. PMID: 10370669 Ref: Carcinoembryonic antigen (CEA)-specific T-cell activation in colon carcinoma induced by anti-CD3 x anti-CEA bispecific diabodies and B7 x anti-CEA bispecific fusion proteins. PMID: 10383154 Ref: Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases. PMID: 10390594 Ref: [Combination of 5'-DFUR and MMC for recurrent rectal cancer with pulmonary metastasis]. PMID: 10396327 Ref: Involvement of circulating CEA in liver metastases from colorectal cancers re-examined in a new experimental model. PMID: 10424738 Ref: Tumor specific CTL therapy for advanced cancer and development for cancer vaccine. PMID: 10429976 Ref: Labeled carcinoembryonic antigen antibodies excitable by infrared rays: a novel diagnostic method for micro cancers in the digestive tract. PMID: 10435358 Ref: Carcino-embryonic antigen may function as a chemo-attractant in colorectal-carcinoma cell lines. PMID: 10446457 Ref: Evaluation of an anti-carcinoembryonic monoclonal antibody suitable for immunoscintigraphy. PMID: 10454758 Ref: NuMA: evaluation of a new biomarker for the detection of low stage colorectal cancer. PMID: 10470167 Ref: Nuclear mitotic apparatus protein (NuMA) in benign and malignant diseases. PMID: 10470168 Ref: CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer. PMID: 10470173 Ref: CA 242 in comparison with established tumour markers in colorectal, pancreatic and lung cancer. PMID: 10470177 Ref: Comparison of carcinoembryonic antigen in tissue and serum with grade and stage of colon cancer. PMID: 10472328 Ref: [CEA, CA 19.9 and CA 195 in patients with colorectal carcinoma. ROC analysis]. PMID: 10481111 Ref: Clinico-pathological characteristics of colorectal cancer and serum anti-p53 antibodies. PMID: 10481530 Ref: Expression of high p53 levels in colorectal cancer: a favourable prognostic factor. PMID: 10487622 Ref: Carcinoembryonic antigen screening: pros and cons. PMID: 10528904 Ref: Immunoscintigraphy with 99Tcm-labelled monoclonal anti-CEA BW 431/26 antibodies in patients with suspected recurrent and metastatic colorectal carcinoma: two-year follow-up. PMID: 10533193 Ref: Pityriasis rubra pilaris with acantholysis and lichenoid histology. PMID: 10535583 Ref: Tumor angiogenesis predicts recurrence with normal serum carcinoembryonic antigen in advanced rectal carcinoma patients. PMID: 10554319 Ref: [Long partial response (PR) in a case of multiple liver metastasis from colon cancer effectively treated by continuous hepatic intra-arterial infusion chemotherapy]. PMID: 10560425 Ref: [A long-term surviving case of multiple metastatic liver tumors from rectal cancer treated with microwave coagulation therapy (MCT)]. PMID: 10560426 Ref: Tumor marker determination after orthotopic heart transplantation. PMID: 10561106 Ref: Clinical and immune responses in resected colon cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen. PMID: 10561367 Ref: CA 72-4 compared with CEA and CA 19-9 as a marker of some gastrointestinal malignancies. PMID: 10569140 Ref: [Preoperative levels of CEA and survival in patients with surgical treatment of colorectal carcinoma]. PMID: 10573645 Ref: Evaluation of the reverse transcriptase/polymerase chain reaction for carcinoembryonic antigen for the detection of breast cancer dissemination in bone marrow and peripheral blood. PMID: 10592099 Ref: [Positron-emission tomography with gamma camera in patients with colorectal and anal cancer. Preliminary results]. PMID: 10603755 Ref: Postoperative borderline elevated CEA predicts for earlier relapse in patients with rectal cancer receiving adjuvant postoperative therapy. PMID: 10606480 Ref: Analysis of the human carcinoembryonic antigen promoter core region in colorectal carcinoma-selective cytosine deaminase gene therapy. PMID: 10608354 Ref: [Surgical treatment of pulmonary metastases of colorectal cancers. 8-year survival and main prognostic factors]. PMID: 10612150 Ref: Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates. PMID: 10628305 Ref: The role of blood levels of soluble 53 kDa protein and CEA in monitoring colon cancer patients. PMID: 10628379 Ref: Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples. PMID: 10632355 Ref: [Detection of serum p53 antibodies in colorectal cancer patients and the clinical significance of postoperative monitoring]. PMID: 10635303 Ref: Detection of tumor cell contamination in peripheral blood by RT-PCR in gastrointestinal cancer patients. PMID: 10642939 Ref: Taking engineered anti-CEA antibodies to the clinic. PMID: 10648943 Ref: Clinical significance of carcinoembryonic antigen in colorectal malignancy. PMID: 10695415 Ref: Nonspecific cross-reacting antigen-50/90 (NCA-50/90) as a new tumor marker. PMID: 10697625 Ref: Carcinoembryonic antigen facilitates experimental metastasis through a mechanism that does not involve adhesion to liver cells. PMID: 10763913 Ref: The role of carcinoembryonic antigen monitoring in management of colorectal cancer. PMID: 11122815 Ref: [Evaluation of biliary CEA in the diagnosis of colorectal cancer with liver metastases]. PMID: 11776796 Ref: Enhanced CEA production associated with aspirin in a culture of CW-2 cells on some polymeric films. PMID: 19003147 |
Ref: CEA immunohistochemical localization is correlated with growth and metastasis of human gallbladder carcinoma. PMID: 10601548 Ref: Time-dependency of the prognostic effect of carcinoembryonic antigen and p53 protein in colorectal adenocarcinoma. PMID: 10618603 Ref: Quantification of micrometastases in lymph nodes of colorectal cancer using real-time fluorescence polymerase chain reaction. PMID: 10639572 Ref: Crystal structure of the anti-(carcinoembryonic antigen) single-chain Fv antibody MFE-23 and a model for antigen binding based on intermolecular contacts. PMID: 10677374 Ref: CaNa2EDTA for improvement of radioimmunodetection and radioimmunotherapy with 111In and 90Y-DTPA-anti-CEA MAbs in nude mice bearing human colorectal cancer. PMID: 10688120 Ref: Circulating p53 antibody in patients with colorectal cancer: relation to clinicopathologic features and survival. PMID: 10695624 Ref: Stromal CEA immunoreactivity is correlated with lymphatic invasion of human esophageal carcinoma. PMID: 10717234 Ref: American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. PMID: 10738234 Ref: Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer. PMID: 10761792 Ref: Prognostic significance of CEA and CA 19-9 in colorectal cancer in Kuwait. PMID: 10763141 Ref: Prognostic significance of circulating antibodies against carcinoembryonic antigen (anti-CEA) in patients with colon cancer. PMID: 10763959 Ref: Serum levels of interleukin-12 in patients with gastrointestinal cancer. PMID: 10769708 Ref: Resection of synchronous liver metastases from colorectal cancer. PMID: 10770561 Ref: Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience. PMID: 10770562 Ref: CA 125: a clinically useful tumor marker in the management of colorectal carcinoma metastatic to the liver in patients with normal carcinoembryonic antigen. PMID: 10776987 Ref: Staurosporine increases carcinoembryonic antigen expression in a human colon cancer cell line. PMID: 10789557 Ref: Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy. PMID: 10791201 Ref: Impact of 18F-FDG-positron emission tomography for decision making in colorectal cancer recurrences. PMID: 10796051 Ref: Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibody. PMID: 10815889 Ref: Regulatory effect of interleukin-4 and interleukin-13 on colon cancer cell adhesion. PMID: 10817509 Ref: Locally advanced rectal cancer: a multivariate analysis of outcome risk factors. PMID: 10861600 Ref: Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. PMID: 10862196 Ref: TA90-IC, a new marker for advanced colon cancer. PMID: 10864342 Ref: What's new with tumor markers for colorectal cancer? PMID: 10867451 Ref: High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment. PMID: 10880576 Ref: Helicobacter pylori: seroprevalence and colorectal cancer. PMID: 10892362 Ref: Carcinoembryonic antigen family of adhesion molecules in the cotton top tamarin (Saguinus oedipus). PMID: 10893441 Ref: Isolated splenic metastasis from colorectal carcinoma: a case report. PMID: 10895982 Ref: Radioimmunotherapy of colorectal cancer liver metastases: combination with radiotherapy. PMID: 10911919 Ref: Economic evaluation of colorectal cancer screening with fecal occult blood detection. PMID: 10927933 Ref: Combined radioimmunotherapy and radiotherapy of liver metastases from colorectal cancer: a feasibility study. PMID: 10928122 Ref: Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure. CPT-11 F205, F220, F221 and V222 study groups. PMID: 10945486 Ref: Induction of cytotoxic T cells and their antitumor activity in mice transgenic for carcinoembryonic antigen. PMID: 10946810 Ref: Microgravity culture reduces apoptosis and increases the differentiation of a human colorectal carcinoma cell line. PMID: 10949995 Ref: Significance of serum and tissue carcinoembryonic antigen for the prognosis of gastric carcinoma patients. PMID: 10951413 Ref: Cryotherapy for liver metastases. PMID: 10954187 Ref: The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer. PMID: 10958511 Ref: An entirely humanized CD3 zeta-chain signaling receptor that directs peripheral blood t cells to specific lysis of carcinoembryonic antigen-positive tumor cells. PMID: 10962448 Ref: Prognostic significance of reverse transcriptase-polymerase chain reaction measurement of carcinoembryonic antigen mRNA levels in tumor drainage blood and peripheral blood of patients with colorectal carcinoma. PMID: 10964326 Ref: Prognostic value of postoperative carcinoembryonic antigen concentration and extent of invasion of resection margins after hepatic resection for colorectal metastases. PMID: 10965835 Ref: Surgery for pulmonary metastases from colorectal carcinoma. PMID: 10969648 Ref: Regulation of tumour drug delivery by blood flow chronobiology. PMID: 10974637 Ref: Measurement of carcinoembryonic antigen in colonic effluent as a high-risk marker for colorectal carcinoma. PMID: 10975292 Ref: Applicability of carcinoembryonic antigen-specific monoclonal antibodies to radioimmunoguided surgery for human colorectal carcinoma. PMID: 10987293 Ref: The relationship between circulating sialyl Tn antigen and polypoid or nonpolypoid growth characteristics in colorectal cancer. PMID: 11003566 Ref: Rapid quantitative detection of carcinoembryonic antigen-expressing free tumor cells in the peritoneal cavity of gastric-cancer patients with real-time RT-PCR on the lightcycler. PMID: 11008202 Ref: Is (18)F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making? PMID: 11036130 Ref: FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma. PMID: 11037995 Ref: Hepatic sclerosing hemangioma mimicking a metastatic liver tumor: report of a case. PMID: 11039718 Ref: Impact of cytokeratin-20 and carcinoembryonic antigen mRNA detection by RT-PCR in regional lymph nodes of patients with colorectal cancer. PMID: 11044357 Ref: A clinical nomogram for predicting long-term survival in advanced colorectal cancer. PMID: 11044640 Ref: Does human melanoma express carcinoembryonic antigen? PMID: 11062726 Ref: Molecular detection of disseminated cancer cells in the peripheral blood and expression of sialylated antigens in colon cancers. PMID: 11064388 Ref: Can postoperative surveillance with serial CEA immunoscintigraphy detect resectable rectal cancer recurrence and potentially improve tumor-free survival? PMID: 11085731 Ref: [A successful case of preoperative intermittent hepatic arterial infusion of high-dose 5-FU and pharmacokinetic modulating chemotherapy against unresectable liver metastasis of colon cancer]. PMID: 11086423 Ref: [Case report--efficacy of short-term intraarterial 5-fluorouracil for liver metastasis from colorectal cancer]. PMID: 11086425 Ref: [Intra-arterial infusion therapy for unresectable liver metastasis of colorectal cancer]. PMID: 11086438 Ref: Added value of CEA scintigraphy in the detection of recurrence of rectal carcinoma. PMID: 11092488 Ref: Antibody-conjugated MHC class I tetramers can target tumor cells for specific lysis by T lymphocytes. PMID: 11093131 Ref: Follow-up in colorectal cancer: cost-effectiveness analysis of established and novel concepts. PMID: 11127527 Ref: The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccines. PMID: 11129322 Ref: Effect of 5-fluorouracil on carcinoembryonic antigen expression and shedding at clonal level in colon cancer cells. PMID: 11131650 Ref: [New therapeutic strategy against colon cancer based on a tumor-specific approach]. PMID: 11142164 Ref: Factors predictive of survival in patients with node-positive colorectal cancer in Taiwan. PMID: 11149009 Ref: 16. FDG-PET in the Detection of Recurrence in Colorectal Cancer Based on Rising CEA Level. Experience in 72 Patients. PMID: 11150773 Ref: Molecular detection of codon 12 K-RAS mutations in circulating DNA from serum of colorectal cancer patients. PMID: 11192825 Ref: NCCN Practice Guidelines for Colorectal Cancer. PMID: 11195411 Ref: Prognostic value of circulating sialyl Tn antigen in colorectal cancer patients. PMID: 11268468 Ref: Drug-induced modulation of carcinoembryonic antigen (CEA) expression in neoplastic cells from a patient with rectal cancer. PMID: 11277324 Ref: Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer. PMID: 11326645 Ref: Hepatic arterial infusion with oxaliplatin, folinic acid, and 5-fluorouracil in patients with hepatic metastases from colorectal cancer: role of carcino-embryonic antigen in assessment of response. PMID: 11326650 Ref: Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. PMID: 11326694 Ref: The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence. PMID: 11326702 Ref: Monoclonal antibody CIBCHTB1 defining an epitope on carcinoembryonic antigen (CEA). PMID: 11341176 Ref: Streptabody, a high avidity molecule made by tetramerization of in vivo biotinylated, phage display-selected scFv fragments on streptavidin. PMID: 11399324 Ref: Effect of marimastat on serum tumour markers in patients with colorectal cancer. PMID: 12678521 Ref: Low preoperative serum carcinoembryonic antigen concentration is a marker of good prognosis in patients undergoing cryotherapy for low volume hepatic metastases from colorectal cancer. PMID: 12678536 |
Ref: Quantitative relationship of the circulating tumor burden assessed by reverse transcription-polymerase chain reaction for cytokeratin 19 mRNA in peripheral blood of colorectal cancer patients with Dukes' stage, serum carcinoembryonic antigen level and tum PMID: 11121864 Ref: Prognostic value of serum sialyl Lewis(a), sialyl Lewis(x) and sialyl Tn antigens in blood from the tumor drainage vein of colorectal cancer patients. PMID: 11125284 Ref: Molecular characterization of colorectal neoplasia in translational research. PMID: 11151060 Ref: Acute-phase protein response, survival and tumour recurrence in patients with colorectal cancer. PMID: 11167877 Ref: Two-step targeting of xenografted colon carcinoma using a bispecific antibody and 188Re-labeled bivalent hapten: biodistribution and dosimetry studies. PMID: 11197965 Ref: CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease. PMID: 11237491 Ref: Is there a role for CEA in innate immunity in the colon? PMID: 11239789 Ref: Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer. PMID: 11266372 Ref: Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? PMID: 11274010 Ref: Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multipl PMID: 11289125 Ref: Role of carcinoembryonic antigen in the progression of colon cancer cells that express carbohydrate antigen. PMID: 11289155 Ref: Circulating sialyl Lewis(x), sialyl Lewis(a), and sialyl Tn antigens in colorectal cancer patients: multivariate analysis of predictive factors for serum antigen levels. PMID: 11291879 Ref: Pulmonary resection for metastases from colorectal cancer. PMID: 11296171 Ref: Determination of carcinoembryonic antigen in human sera by integrated bead-bed immunoassay in a microchip for cancer diagnosis. PMID: 11305654 Ref: Laparoscopic-assisted vs. open colectomy for colorectal cancer: influence on neoplastic cell mobilization. PMID: 11309650 Ref: Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET). PMID: 11313174 Ref: Colorectal carcinoma liver metastases: clinical significance of preoperative measurement of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels. PMID: 11317695 Ref: Detection of circulating tumor cells in patients with gastrointestinal tract cancer using RT-PCR and its clinical implications. PMID: 11322488 Ref: Functional differences between two morphologically distinct cell subpopulations within a human colorectal carcinoma cell line. PMID: 11323753 Ref: Sociodemographic differences in the receipt of colorectal cancer surveillance care following treatment with curative intent. PMID: 11329523 Ref: Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma. PMID: 11330579 Ref: Carcinoembryonic antigen in monitoring of response to systemic chemotherapy in patients with metastatic colorectal cancer. PMID: 11355325 Ref: Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases. PMID: 11360053 Ref: Increased serum level of sialyl Lewis(x) antigen in blood from the tumor drainage vein in patients with non-polypoid growth type of colorectal cancer. PMID: 11370835 Ref: Type-2 somatostatin receptor mRNA levels in breast and colon cancer determined by a quantitative RT-PCR assay based on dual label fluorogenic probe and the TaqMan technology. PMID: 11384768 Ref: Pretreatment clinical findings predict outcome for patients receiving preoperative radiation for rectal cancer. PMID: 11395234 Ref: Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation. PMID: 11396197 Ref: Follow-up after attempted curative surgery for colorectal cancer; postal survey of New Zealand surgeons' practice. PMID: 11400920 Ref: Survival, disease-free interval, and associated tumor features in patients with colon/rectal carcinomas and their resected intra-pulmonary metastases. PMID: 11404151 Ref: Relationship between tumour vascularity and circulating cancer cells in patients with colorectal carcinoma. PMID: 11417979 Ref: The carcinoembryonic antigen and its prognostic impact on immunocytologically detected intraperitoneal colorectal cancer cells. PMID: 11425064 Ref: [Clinical significance of micrometastasis to lymph nodes in gastrointestinal tract cancers]. PMID: 11432344 Ref: [Rapid quantitative detection of free cancer cells in the peritoneal cavity of gastric cancer patients with real-time RT-PCR, and its prognostic significance]. PMID: 11432345 Ref: Controlled ribozyme targeting demonstrates an antiapoptotic effect of carcinoembryonic antigen in HT29 colon cancer cells. PMID: 11448920 Ref: [Preoperative serum levels of the carcinoembryonic antigen (CEA) and prognosis in colorectal cancer]. PMID: 11470069 Ref: Pilot study of albendazole in patients with advanced malignancy. Effect on serum tumor markers/high incidence of neutropenia. PMID: 11474247 Ref: Immunobead RT-PCR versus regular RT-PCR amplification of CEA mRNA in peripheral blood. PMID: 11501748 Ref: Hydronephrosis associated with colorectal carcinoma: treatment and outcome. PMID: 11504520 Ref: Antibody targeting studies in a transgenic murine model of spontaneous colorectal tumors. PMID: 11517330 Ref: Surgical management of hepatic metastases from colorectal malignancies. PMID: 11521792 Ref: Technology evaluation: CEA-TRICOM, Therion Biologics Corp. PMID: 11525565 Ref: Carcinoembryonic antigen and CA19-9: implications of quantitative marker measurement in tissues for prognosis of colorectal cancer. PMID: 11531011 Ref: Butyrate and propionate downregulate ERK phosphorylation in HT-29 colon carcinoma cells prior to differentiation. PMID: 11535873 Ref: Detection of tumor cells in the portal and peripheral blood of patients with colorectal carcinoma using competitive reverse transcriptase-polymerase chain reaction. PMID: 11571740 Ref: [A case of intra-peritoneal recurrence of colon carcinoma that responded remarkably to combined therapy of low-dose leucovorin and 5-fluorouracil]. PMID: 11579643 Ref: [Tumor markers for colorectal cancer]. PMID: 11579645 Ref: Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup. PMID: 11602894 Ref: Follow-up after curative surgery for colorectal cancer. PMID: 11680046 Ref: [Diagnosis of the postoperative local recurrence of rectal cancer by FDG-PET--a case report]. PMID: 11708010 Ref: Prognostic value of carcinoembryonic antigen (CEA) in tumor tissue of patients with colorectal cancer. PMID: 11712806 Ref: A new mouse model for evaluating the immunotherapy of human colorectal cancer. PMID: 11731437 Ref: [Sensitivity, specificity and prognostic value of CEA in colorectal cancer: results of a Tunisian series and literature review]. PMID: 11774785 Ref: [Standards, options and recommendations for tumor markers in colorectal cancer]. PMID: 11792611 Ref: [Application of genetic diagnosis for colorectal cancer]. PMID: 11797394 Ref: The prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancer. PMID: 11819806 Ref: Granulocyte-macrophage-colony stimulating factor in patients with colorectal cancer. PMID: 11820563 Ref: [Expression of cytokeratin 7 and 20 in ovarian metastatic carcinomas]. PMID: 11866966 Ref: [Usefulness of preoperative assay CEA and CA 19-9 in colorectal cancer patients]. PMID: 11899841 Ref: Positron emission tomography for the evaluation of patients with colorectal cancer. PMID: 12445370 Ref: Systemic irinotecan or regional floxuridine chemotherapy prolongs survival after hepatic cryosurgery in patients with metastatic colon cancer refractory to 5-fluorouracil. PMID: 12445377 Ref: Immunoscintigraphy and intra-operative radioimmunodetection in the treatment of colorectal carcinoma. PMID: 12790934 Ref: Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma. PMID: 15503618 |
Ref: Carcinoembryonic antigen (CEA) presentation and specific T cell-priming by human dendritic cells transfected with CEA-mRNA. PMID: 11750849 Ref: Significance of postoperative adjuvant immunochemotherapy after curative resection of colorectal cancers: Association between host or tumor factors and survival. PMID: 11788909 Ref: Enhancement of colorectal tumor targeting using a novel biparatopic monoclonal antibody against carcinoembryonic antigen in experimental radioimmunoguided surgery. PMID: 11802220 Ref: Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery. PMID: 11846459 Ref: Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells. PMID: 11889075 Ref: Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation. PMID: 11896570 Ref: Serum total gangliosides and TA90-IC levels: novel immunologic markers in colorectal cancer. PMID: 11898807 Ref: Specific CEA-producing colorectal carcinoma cell killing with recombinant adenoviral vector containing cytosine deaminase gene. PMID: 11925606 Ref: CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer. PMID: 11941943 Ref: Predictors of short-term survival and progression to chemotherapy in patients with advanced colorectal cancer treated with 5-fluorouracil-based regimens. PMID: 11943891 Ref: CEA doubling time and CEA half-life in the prediction of recurrences after colorectal cancer surgery. PMID: 11948226 Ref: Usefulness of analytical CEA doubling time and half-life time for overlooked synchronous metastases in colorectal carcinoma. PMID: 11948229 Ref: High and selective expression of yeast cytosine deaminase under a carcinoembryonic antigen promoter-enhancer. PMID: 11956093 Ref: Prediction of postoperative survival by preoperative serum concentrations of anti-p53 compared to CEA, CA 50, CA 242 and conventional blood tests in patients with colorectal carcinoma. PMID: 11956598 Ref: [Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer]. PMID: 11957811 Ref: Human natural killer cell line modified with a chimeric immunoglobulin T-cell receptor gene leads to tumor growth inhibition in vivo. PMID: 11960290 Ref: Morphometric analysis of liver macrophages in patients with colorectal liver metastasis. PMID: 11964075 Ref: Inhibition of endogenous carcinoembryonic antigen (CEA) increases the apoptotic rate of colon cancer cells and inhibits metastatic tumor growth. PMID: 11964079 Ref: Follow-up of patients with colorectal cancer: numbers needed to test and treat. PMID: 11978524 Ref: Tumor marker CEA in monitoring of response to tegafur-uracil and folinic acid in patients with metastatic colorectal cancer. PMID: 11995458 Ref: Raltitrexed (tomudex) administration in patients failing multiple prior chemotherapy regimens in advanced colorectal cancer: a pilot study. PMID: 12003191 Ref: Improved tumor selectivity of radiolabeled peptides by receptor and antigen dual targeting in the neurotensin receptor model. PMID: 12009958 Ref: Pharmacological modulation of carcinoembryonic antigen in human cancer cells: studies with staurosporine. PMID: 12013504 Ref: Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI. PMID: 12029557 Ref: Granulocyte-colony stimulating factor (G-CSF) and macrophagecolony stimulating factor (M-CSF) in colorectal cancer patients. PMID: 12059074 Ref: Pulmonary resection for metastases from colorectal cancer: factors influencing prognosis. Twenty-year experience. PMID: 12062285 Ref: Quantitative detection of CEA expressing free tumor cells in the peripheral blood of colorectal cancer patients during surgery with real-time RT-PCR on a LightCycler. PMID: 12065095 Ref: Reversible dimer formation and stability of the anti-tumour single-chain Fv antibody MFE-23 by neutron scattering, analytical ultracentrifugation, and NMR and FT-IR spectroscopy. PMID: 12079338 Ref: Low serum leptin level in colon cancer patients without significant weight loss. PMID: 12088256 Ref: Relationship of the interleukin-1 system with neuroendocrine and exocrine markers in human colon cancer cell lines. PMID: 12096923 Ref: Positron emission tomography for evaluation of colorectal carcinoma. PMID: 12134365 Ref: [F-18 fluorodeoxyglucose positron emission tomography in colorectal carcinoma]. PMID: 12138655 Ref: Immunohistochemical detection of carcinoembryonic antigen in esophageal carcinomas: a comparison with other gastrointestinal neoplasms. PMID: 12168881 Ref: Arterial chemotherapy of 5-fluorouracil and mitomycin C in the treatment of liver metastases of colorectal cancer. PMID: 12174375 Ref: CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. PMID: 12174919 Ref: Primary colorectal carcinomas and their intrapulmonary metastases: clinical, glyco-, immuno- and lectin histochemical, nuclear and syntactic structure analysis with emphasis on correlation with period of occurrence of metastases and survival. PMID: 12193204 Ref: Tumour markers as early predictors of response to chemotherapy in advanced colorectal carcinoma. PMID: 12196369 Ref: [The rare manifestation of soft tissue metastasis in colorectal cancer]. PMID: 12202897 Ref: Identification of an interferon-gamma-inducible carcinoembryonic antigen (CEA) CD8(+) T-cell epitope, which mediates tumor killing in CEA transgenic mice. PMID: 12208761 Ref: Biliary carcinoembryonic antigen in the diagnosis of occult hepatic metastases from colorectal cancer. PMID: 12210019 Ref: Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients. PMID: 12231517 Ref: [Comparative study of CEA antibody scan and computed tomography scan in the follow-up of patients with colorectal cancer]. PMID: 12236910 Ref: Polarized distribution of carcinoembryonic antigen is associated with a tight junction molecule in human colorectal adenocarcinoma. PMID: 12237880 Ref: Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer. PMID: 12237895 Ref: [Prognostic importance of preoperative CEA in patients with colorectal cancer]. PMID: 12239755 Ref: Fluorescence endoscopy using a fluorescein-labeled monoclonal antibody against carcinoembryonic antigen in patients with colorectal carcinoma and adenoma. PMID: 12244502 Ref: FDG-PET improves the management of patients with suspected recurrence of colorectal cancer. PMID: 12352596 Ref: Lipid peroxidation as additional marker in patients with colorectal cancer. Results of a preliminary study. PMID: 12364818 Ref: Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry. PMID: 12377967 Ref: [Value of the preoperative carcinoembryonic antigen as an independent prognostic factor in cancer of the colon and rectum]. PMID: 12378215 Ref: Secondary colonic adenocarcinoma of the prostate histologically mimicking prostatic ductal adenocarcinoma. PMID: 12400988 Ref: Determination of histamine in the whole blood of colon cancer patients. PMID: 12401359 Ref: Serum soluble interleukin-2 receptor (IL-2R) and immunohistochemical staining of IL-2R/Tac antigen in colorectal cancer. PMID: 12402066 Ref: Flow cytometry correlates with RT-PCR for detection of spiked but not circulating colorectal cancer cells. PMID: 12405286 Ref: Expression profiling and interferon-beta regulation of liver metastases in colorectal cancer cells. PMID: 12405292 Ref: Radiologic imaging modalities in the diagnosis and management of colorectal cancer. PMID: 12418053 Ref: Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells. PMID: 12420218 Ref: Usefulness of FDG-positron emission tomography in diagnosing peritoneal recurrence of colorectal cancer. PMID: 12433608 Ref: [Radioimmunodetection of 188Re-labeled anti-carcinoembryonic antigen chimeric antibody in nude mice bearing human colon carcinoma]. PMID: 12452032 Ref: [Expression of tumor-associated antigen LEA and its significance for pathological diagnosis]. PMID: 12452070 Ref: Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer. PMID: 12454515 Ref: Soluble dipeptidyl peptidase IV (CD-26) in serum of patients with colorectal carcinoma. PMID: 12458328 Ref: [A case of locally extended rectal cancer responding to intra-arterial infusion therapy via the internal iliac artery]. PMID: 12484003 Ref: Protein epitopes in carcinoembryonic antigen. Report of the ISOBM TD8 workshop. PMID: 12499780 Ref: The preoperative assessment and postoperative surveillance of patients with colon and rectal cancer. PMID: 12507211 Ref: Serum tetranectin is an independent prognostic marker in colorectal cancer and weakly correlated with plasma suPAR, plasma PAI-1 and serum CEA. PMID: 12529016 Ref: [Significance of carcinoembryonic antigen levels in peritoneal washings in clinical analysis of patients with colorectal cancer]. PMID: 12557433 Ref: [Usefulness of CEA, CA 15-3 and CA 125 tumor markers in the differential diagnostics of peritoneal effusion]. PMID: 12557435 Ref: CEA and relapse after the operation of colorectal carcinoma. PMID: 12585359 Ref: [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms]. PMID: 12596691 Ref: [Comparative analysis of metastatic variants from the colorectal tumor cell line HT-29] PMID: 12601885 Ref: Differences in plasma gastrin, CEA, and CA 19-9 concentration in patients with proximal and distal colorectal cancer. PMID: 12622427 Ref: The role of proteomics in the diagnosis and outcome prediction in colorectal cancer. PMID: 12625789 Ref: Investigation into the usefulness and adverse events of CDDP, 5-fU and dl-leucovorin (PFL-therapy) for advanced colorectal cancer. PMID: 12627817 Ref: Detection of peritoneal micrometastases by reverse transcriptase-polymerase chain reaction targeting carcinoembryonic antigen and cytokeratin 20 in colon cancer patients. PMID: 12636102 Ref: Sentinel lymph node evaluation is technically feasible and may improve staging in colorectal cancer. PMID: 16093152 |
Ref: Radioimmunotherapy with 153Sm-CEA monoclonal antibody in nude mice bearing human colon carcinoma: an experimental study. PMID: 12527502 Ref: Elevated plasma gastrin, CEA, and CA 19-9 levels decrease after colorectal cancer resection. PMID: 12548418 Ref: Titration of serum p53 antibodies in 1,085 patients with various types of malignant tumors: a multiinstitutional analysis by the Japan p53 Antibody Research Group. PMID: 12548611 Ref: Regional delivery and selective expression of a high-activity yeast cytosine deaminase in an intrahepatic colon cancer model. PMID: 12566311 Ref: Treatment of colon and breast carcinoma cells with 5-fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA-A(*)02.01 restricted, CEA-peptide-specific cytotoxic T cells in vitro. PMID: 12584740 Ref: [Relationship between carcinoembryonic antigen and cyclooxygenase 2 expression and colorectal cancer]. PMID: 12600292 Ref: [Results of surgical treatment of pulmonary metastatic tumors and analysis of prognostic factors]. PMID: 12607246 Ref: Rectal carcinoma associated with pagetoid phenomenon. PMID: 12609793 Ref: [A case of advanced colon cancer responding to treatment with levofolinate combined with 5-fluorouracil]. PMID: 12610881 Ref: Analysis of clinical prognostic factors for survival and time to progression in patients with metastatic colorectal cancer treated with 5-fluorouracil-based chemotherapy. PMID: 12620142 Ref: Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. PMID: 12651195 Ref: Enhancement of radiation therapy by tumor necrosis factor alpha in human colon cancer using a bispecific antibody. PMID: 12654449 Ref: Enhanced production of carcinoembryonic antigen by CW-2 cells cultured on polymeric membranes immobilized with extracellular matrix proteins. PMID: 12661665 Ref: Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen. PMID: 12661896 Ref: T lymphocytes isolated from patients with advanced colorectal cancer are suitable for gene immunotherapy approaches. PMID: 12671714 Ref: Investigations for a multi-marker RT-PCR to improve sensitivity of disseminated tumor cell detection. PMID: 12680210 Ref: Molecular detection of disseminated tumor cells in the peripheral blood in patients with gastrointestinal cancer. PMID: 12684893 Ref: Platelet-activating factor activates mitogen-activated protein kinases, inhibits proliferation, induces differentiation and suppresses the malignant phenotype of human colon carcinoma cells. PMID: 12687020 Ref: Negative CEA values in metastatic colorectal carcinoma and the likelihood of complete chemotherapy response. PMID: 12699060 Ref: Immunostimulatory CpG oligonucleotides enhance the immune response of anti-idiotype vaccine that mimics carcinoembryonic antigen. PMID: 12700947 Ref: Colorectal cancer in young patients: characteristics and outcome. PMID: 12705353 Ref: Plasmid DNA encoding human carcinoembryonic antigen (CEA) adsorbed onto cationic microparticles induces protective immunity against colon cancer in CEA-transgenic mice. PMID: 12706680 Ref: Colonic tumor CEA, CSAp and MUC-1 expression following radioimmunotherapy or chemotherapy. PMID: 12743424 Ref: Intrinsic variability in the detection of micrometastases in lymph nodes for re-staging of colorectal cancer. effect of individual markers and tissue samples. PMID: 12763211 Ref: Hepatic resection for colorectal metastases to the liver: The National Cancer Centre/Singapore General Hospital experience. PMID: 12772523 Ref: Adenovirus-mediated prodrug-enzyme therapy for CEA-producing colorectal cancer cells. PMID: 12783317 Ref: [Standard technique of oncologic colorectal surgery]. PMID: 12815836 Ref: Real-time PCR (TaqMan PCR) quantification of carcinoembryonic antigen (CEA) mRNA in the peripheral blood of colorectal cancer patients. PMID: 12820382 Ref: Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers. PMID: 12820473 Ref: Weekly irinotecan in patients with metastatic colorectal cancer failing 5-fluorouracil-based chemotherapy: efficacy and prognostic factors. PMID: 12841660 Ref: Immunohistochemical analysis of resected clinical stage I pulmonary adenocarcinomas with high preoperative levels of serum carcinoembryonic antigen. PMID: 12842541 Ref: [Follow-up investigations in colorectal cancer]. PMID: 12845218 Ref: Use of the preoperative levels of CEA in patients with colorectal cancer. PMID: 12845969 Ref: Induction of human T lymphocyte cytotoxicity and inhibition of tumor growth by tumor-specific diabody-based molecules secreted from gene-modified bystander cells. PMID: 12847281 Ref: Biliary carcinoembryonic antigen levels in diagnosis of occult hepatic metastases from colorectal carcinoma. PMID: 12854170 Ref: Is there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma? PMID: 12865871 Ref: Follow-up strategies after curative resection of colorectal cancer. PMID: 12870136 Ref: Hepatic cryotherapy and regional chemotherapy with or without resection for liver metastases from colorectal carcinoma: how many are too many? PMID: 12872352 Ref: Differentiation of ovarian mucinous carcinoma and metastatic colorectal adenocarcinoma by immunostaining with beta-catenin. PMID: 12877730 Ref: Carcinoembryonic antigen-based vaccines. PMID: 12881810 Ref: Carcinoembryonic antigen to detect hepatic metastases of colorectal cancers. PMID: 12884096 Ref: Surgery for pulmonary metastases from colorectal cancer: the importance of prethoracotomy serum carcinoembryonic antigen as an indicator of prognosis. PMID: 12892459 Ref: Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNA. PMID: 12901279 Ref: [Preoperative CEA: prognostic significance in colorectal carcinoma]. PMID: 12903559 Ref: The relationship between circulating interleukin-6 and carcinoembryonic antigen in patients with colorectal cancer. PMID: 12926107 Ref: Association between serum carcinoembryonic antigen and endothelial cell adhesion molecules in colorectal cancer. PMID: 12931019 Ref: Serum levels of c-erbb-2 correlate with advanced stage and liver metastasis in colorectal cancer. PMID: 12943051 Ref: Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma. PMID: 12946793 Ref: Carcinoembryonic antigen and albumin predict survival in patients with advanced colon and rectal cancer. PMID: 12963652 Ref: Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. PMID: 14512395 Ref: Carcinoembryonic antigen elevation due to bowel sequestration with mucocele formation following colonic resection. PMID: 14521450 Ref: Follow-up of patients with curatively resected colorectal cancer: a practice guideline. PMID: 14529575 Ref: A phase II study of modified deGramont 5-fluorouracil, leucovorin, and oxaliplatin in previously treated patients with metastatic colorectal cancer. PMID: 14533439 Ref: Increased expression of CEA and MHC class I in colorectal cancer cell lines exposed to chemotherapy drugs. PMID: 14564514 Ref: [Surgical treatment of colorectal liver metastasis]. PMID: 14579759 Ref: [Prognostic significance and clinic utility of serum and immunohistochemical cathepsin B levels in colorectal cancer]. PMID: 14585038 Ref: Identification of a carcinoembryonic antigen binding protein on monocytes. PMID: 14592416 Ref: Coexpression of carcinoembryonic antigen and E-cadherin in colorectal adenocarcinoma with liver metastasis. PMID: 14592671 Ref: Surface expression of heterogeneous nuclear RNA binding protein M4 on Kupffer cell relates to its function as a carcinoembryonic antigen receptor. PMID: 14597422 Ref: Correlation between metastatic potential and variants from colorectal tumor cell line HT-29. PMID: 14606113 Ref: Irinotecan hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase II clinical study. PMID: 14606639 Ref: [Relationship between effectiveness of hepatic artery injection chemotherapy and serum VEGF]. PMID: 14619483 Ref: [Evaluation of liver metastasis of colorectal cancer following hepatic arterial infusion with degradable starch microspheres and adriamycin, mitomycin C as seen in changes in CEA at early stage of therapy]. PMID: 14619494 Ref: [A case of locally extended rectal carcinoma quickly responding to local intraarterial infusion therapy]. PMID: 14619530 Ref: [Detection of micrometastases of colorectal carcinoma in lymph nodes]. PMID: 14628649 Ref: Interleukin-1beta (IL-1beta) and IL-6 modulate insulin-like growth factor-binding protein (IGFBP) secretion in colon cancer epithelial (Caco-2) cells. PMID: 14656210 Ref: 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice. PMID: 14660722 Ref: Serum levels of tissue inhibitor of metalloproteinases-1 (TIMP-1) in colorectal cancer patients. PMID: 14669077 Ref: Aberrant crypt foci as microscopic precursors of colorectal cancer. PMID: 14669304 Ref: CD4(+) T cells from healthy subjects and colon cancer patients recognize a carcinoembryonic antigen-specific immunodominant epitope. PMID: 14679013 Ref: [Histopathology and tumor markers]. PMID: 14743744 Ref: Molecular detection of circulating cancer cells. Role in diagnosis, prognosis and follow-up of colon cancer patients. PMID: 14752222 Ref: Serum tumor markers may precede instrumental response to chemotherapy in patients with metastatic cancer. PMID: 14756546 Ref: Circulating vascular endothelial growth factor six months after primary surgery as a prognostic marker in patients with colorectal cancer. PMID: 14968945 Ref: Comparison of tumor M2-pyruvate kinase (tumor M2-PK), carcinoembryonic antigen (CEA), carbohydrate antigens CA 19-9 and CA 72-4 in the diagnosis of gastrointestinal cancer. PMID: 14981971 Ref: [Prognostic factors following liver resection for hepatic metastases from colorectal cancer]. PMID: 15029391 Ref: Colon cancer. Clinical practice guidelines in oncology. PMID: 19764149 Ref: Clinical Value of Whole Body F-18 FDG PET in The Management of Recurrent Colorectal Malignancy. PMID: 26680958 |
Ref: Long-term effect of 5-fluorouracil enhanced by intermittent administration of polysaccharide K after curative resection of colon cancer. A randomized controlled trial for 7-year follow-up. PMID: 13680286 Ref: Functional HLA-DR T cell epitopes of CEA identified in patients with colorectal carcinoma immunized with the recombinant protein CEA. PMID: 14605762 Ref: Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers. PMID: 14639606 Ref: Quantification of cytokeratin 20, carcinoembryonic antigen and guanylyl cyclase C mRNA levels in lymph nodes may not predict treatment failure in colorectal cancer patients. PMID: 14648708 Ref: Tumour-associated trypsin inhibitor, carcinoembryonic antigen and acute-phase reactant proteins CRP and alpha1-antitrypsin in patients with gastrointestinal malignancies. PMID: 14675563 Ref: Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma. PMID: 14716760 Ref: A bispecific antibody to enhance radiotherapy by tumor necrosis factor-alpha in human CEA-expressing digestive tumors. PMID: 14751531 Ref: Significance of postoperative adjuvant immunochemotherapy after curative resection of colorectal cancers: identification of responders incorporating the age factor. PMID: 14767513 Ref: Intratumoral vaccination and diversified subcutaneous/ intratumoral vaccination with recombinant poxviruses encoding a tumor antigen and multiple costimulatory molecules. PMID: 14871989 Ref: [A case of advanced colon cancer with peritoneal dissemination completely responding to TS-1]. PMID: 14997764 Ref: The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. PMID: 15007086 Ref: EIA versus RIA in detecting carcinoembryonic antigen level of patients with metastatic colorectal cancer. PMID: 15011849 Ref: Distributions in CEA doubling time differ in patients with recurrent colorectal carcinomas. PMID: 15011851 Ref: [Serum vascular endothelial growth factor levels in patients with colorectal cancer and its prognostic significance]. PMID: 15012886 Ref: Ki-67 and CEA expression as prognostic markers in Dukes' C colorectal cancer. PMID: 15050740 Ref: Soluble serum E-cadherin as a marker of tumour progression in colorectal cancer patients. PMID: 15065605 Ref: Clinical significance of preoperative serum sialic acid levels in colorectal cancer: utility in the detection of patients at high risk of tumor recurrence. PMID: 15077925 Ref: Clinical significance of serum gastrin levels in patients with colorectal cancer. PMID: 15077926 Ref: Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides. PMID: 15102666 Ref: Hepatic resection in stage IV colorectal cancer: prognostic predictors of outcome. PMID: 15103491 Ref: [Role of tumour markers in monitoring and follow-up of colorectal cancer patients]. PMID: 15105897 Ref: Host-oriented peptide evaluation using whole blood assay for generating antigen-specific cytotoxic T lymphocytes. PMID: 15154646 Ref: Regulation of cytokine production in carcinoembryonic antigen stimulated Kupffer cells by beta-2 adrenergic receptors: implications for hepatic metastasis. PMID: 15159029 Ref: Durable carcinoembryonic antigen (CEA)-specific humoral and cellular immune responses in colorectal carcinoma patients vaccinated with recombinant CEA and granulocyte/macrophage colony-stimulating factor. PMID: 15161680 Ref: [Clinical usefulness of urinary diacetylpolyamines as novel tumor markers]. PMID: 15164599 Ref: [The significance of urine di-acetyl spermine level as a cancer marker for colorectal cancer]. PMID: 15164601 Ref: Prognostic significance of microsatellite instability in sporadic colorectal cancer. PMID: 15175889 Ref: [CA 19.9 and HDL-cholesterol behaviour in a sporadic colorectal carcinoma sample]. PMID: 15176924 Ref: Molecular detection of APC, K- ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers. PMID: 15185002 Ref: A novel transgenic mouse model for immunological evaluation of carcinoembryonic antigen-based DNA minigene vaccines. PMID: 15199414 Ref: New approaches in the diagnostic procedure of malignant pleural effusions. PMID: 15201963 Ref: PET and PET-CT for evaluation of colorectal carcinoma. PMID: 15202102 Ref: Real time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA in patients with colorectal cancer. PMID: 15206965 Ref: Estimating the probability of cancer with several tumor markers in patients with colorectal disease. PMID: 15218297 Ref: Carcinoembryonic antigen induction of IL-10 and IL-6 inhibits hepatic ischemic/reperfusion injury to colorectal carcinoma cells. PMID: 15221959 Ref: Prognostic value of soluble P-selectin levels in colorectal cancer. PMID: 15221968 Ref: Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma. PMID: 15221991 Ref: Relationship between serum calcium and CA 19-9 levels in colorectal cancer. PMID: 15222030 Ref: Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma. PMID: 15223436 Ref: Cost and effectiveness of follow-up examinations in patients with colorectal cancer resected for cure in a French population-based study. PMID: 15239990 Ref: [Expression of estrogen receptor and progesterone receptor in colorectal cancer: a quantitative study]. PMID: 15248927 Ref: Correlation of vascular endothelial growth factor (VEGF) and CEA with clinicopathological variables in colorectal cancer patients. PMID: 15254661 Ref: Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice. PMID: 15256474 Ref: [Biomarkers for neoplasmas in digestive organs]. PMID: 15272578 Ref: Correlation of circulating tumor cells with tumor size and metastatic load in a spontaneous lung metastasis model. PMID: 15274304 Ref: Oxaliplatin hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase I-II clinical study. PMID: 15274406 Ref: Prolonged cytostatic tumor dormancy induced by serial exchange of chemotherapy in colorectal carcinoma. PMID: 15279063 Ref: Application of RT-PCR to clinical diagnosis of micrometastasis of colorectal cancer: A translational research study. PMID: 15289860 Ref: Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer. PMID: 15297402 Ref: Potential usefulness of detecting cyclooxygenase 2 messenger RNA in feces for colorectal cancer screening. PMID: 15300574 Ref: Prognostic and predictive molecular markers in colorectal carcinoma. PMID: 15330208 Ref: [Carcinoembryonic antigen (CEA) as an independent prognostic factor in colorectal carcinoma]. PMID: 15332370 Ref: [A case of hepatic metastasis from colon cancer successfully treated with 5-FU, levofolinate (l-LV) and low-dose CPT-11]. PMID: 15332552 Ref: [A successfully resected case of colorectal cancer with multiple liver metastases treated with systemic chemotherapy]. PMID: 15332553 Ref: [A case of liver metastasis of colon cancer responding remarkably to 5'-DFUR]. PMID: 15332554 Ref: [Gastrointestinal cancer]. PMID: 15332558 Ref: Carcinoembryonic antigen directed herpes viral oncolysis improves selectivity and activity in colorectal cancer. PMID: 15349105 Ref: [Application of serum protein pattern model in diagnosis of colorectal cancer]. PMID: 15355647 Ref: Quantification of colorectal cancer micrometastases in lymph nodes by nested and real-time reverse transcriptase-PCR analysis for carcinoembryonic antigen. PMID: 15355906 Ref: Transient CEA increase at start of oxaliplatin combination therapy for metastatic colorectal cancer. PMID: 15360055 Ref: Management of postoperative follow-up and surgical treatment for Krukenberg tumor from colorectal cancers. PMID: 15362750 Ref: Cost-effectiveness of two follow-up strategies for curative resection of colorectal cancer: comparative study using a Markov model. PMID: 15366746 Ref: [A case of a patient with solitary prostate metastasis of the colorectal carcinoma three years after abdominoperineal amputation of the rectum]. PMID: 15373203 Ref: [Significance of serum calcium levels in colorectal cancer]. PMID: 15382619 Ref: Detection of occult liver metastases in colorectal cancer by measurement of biliary carcinoembryonic antigen concentration: a prospective study. PMID: 15384059 Ref: [The optimal combination of serum tumor markers with bioinformatics in diagnosis of colorectal carcinoma]. PMID: 15476323 Ref: Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers. PMID: 15488142 Ref: Combined use of positive and negative immunomagnetic isolation followed by real-time RT-PCR for detection of the circulating tumor cells in patients with colorectal cancers. PMID: 15490093 Ref: [A case of rectal cancer with multiple liver and peritoneal metastases that responded dramatically to low-dose 5-FU plus LV and CDDP combination chemotherapy]. PMID: 15508457 Ref: Determination of carcinoembryonic antigen levels in peripheral and draining venous blood in patients with colorectal carcinoma. PMID: 15543380 Ref: [Metastatic cutaneous adenocarcinoma of unknown primary site. Case report]. PMID: 15543387 Ref: [Case report--Complete response of liver metastasis of rectal cancer after combination chemotherapy of CPT-11 + UFT-E]. PMID: 15553688 Ref: [A case of disseminated tumor from cecal cancer with survival for over 5 years after twice surgical resection and systemic chemotherapy]. PMID: 15553741 Ref: [A case of long-term survival after chemo-radiation for postoperative local recurrence of rectal cancer]. PMID: 15553742 Ref: [Expression and significance of survivin in colon cancer]. PMID: 15566647 Ref: Recombinant cancer vaccines based on viral vectors. PMID: 15603188 Ref: Plasma prolactin in patients with colorectal cancer. PMID: 15617576 Ref: Factors influencing outcome of surgery for stage I rectal cancer. PMID: 15640960 Ref: Serum cathepsin H as a potential prognostic marker in patients with colorectal cancer. PMID: 15646835 Ref: Which colorectal cancers are missed by double contrast barium enema? PMID: 15654524 Ref: Postoperative follow-up of patients with colorectal cancer: a combined evaluation of CT scan, colonoscopy and tumour markers. PMID: 15655619 Ref: Oncologic markers in patients with colorectal cancer after a complex therapy. PMID: 15658583 Ref: Cyclin E, p27 and mutant p53 do not predict the prognosis in AJCC stage II colorectal carcinomas. PMID: 15665575 Ref: Increased serum CA-15.3 levels in patients with megaloblastic anemia due to vitamin B12 deficiency. PMID: 15713991 Ref: Carcinoembryonic antigen promotes tumor cell survival in liver through an IL-10-dependent pathway. PMID: 16035616 Ref: (125)I-T84.66 scFv-human serum albumin PMID: 20641268 Ref: (111)In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-T84.66 minibody PMID: 20641400 Ref: Radioiodinated T84.66 minibody PMID: 20641489 Ref: (99m)Tc-Labeled anti-carcinoembryonic antigen monoclonal antibody CL-58 PMID: 20641529 Ref: (111)In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-T84.66 diabody PMID: 20641644 Ref: Alexa Fluor 488-conjugated anti-carcinoembryonic antigen monoclonal antibody PMID: 20641682 Ref: (64)Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-T84.66 scFv-human serum albumin PMID: 20641733 Ref: (131)I-NP-4 anti-CEA monoclonal antibody PMID: 20641780 Ref: 4-[(18)F]Fluorobenzoyl-T84.66 diabody PMID: 20641827 Ref: (99m)Tc-Arcitumomab PMID: 20641871 Ref: Radioiodinated anti-CEA monoclonal antibody NP-4 F(ab )2 fragment PMID: 20641898 Ref: (111)In-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-T84.66 scFv-human serum albumin PMID: 20641921 Ref: (99m)Tc(CO)3-Anti-carcinoembryonic antigen (CEA) humanized CEA5 graft nanobody PMID: 22855965 |
Ref: Management of the pelvic recurrence of rectal cancer with radiofrequency thermoablation: a case report and review of the literature. PMID: 15293064 Ref: Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer. PMID: 15510175 Ref: Serum laminin is an independent prognostic factor in colorectal cancer. PMID: 15592676 Ref: Cytokeratins and carcinoembryonic antigen in diagnosis, staging and prognosis of colorectal adenocarcinoma. PMID: 15655814 Ref: Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis. PMID: 15726622 Ref: Systematic follow-up after curative surgery for colorectal cancer in Norway: a population-based audit of effectiveness, costs, and compliance. PMID: 15749591 Ref: [Trial of outpatient anti-cancer chemotherapy with infusion of 5-FU and cisplatin for advanced gastric and colorectal cancers]. PMID: 15751631 Ref: Expression of the carcinoembryonic antigen gene is inhibited by SOX9 in human colon carcinoma cells. PMID: 15781631 Ref: [A case of bilateral multiple liver metastases with distant lymph node metastases due to rectal cancer successfully treated with hepatic arterial infusion (HAI) of levofolinate (l-LV)/5-fluorouracil (5-FU) and radiotherapy]. PMID: 15791825 Ref: [Urinary diacetylspermine: its analysis and performance as a novel tumor marker]. PMID: 15796045 Ref: Proteomic approaches in colon cancer: promising tools for new cancer markers and drug target discovery. PMID: 15807933 Ref: Plasma von Willebrand factor level as a prognostic indicator of patients with metastatic colorectal carcinoma. PMID: 15810086 Ref: Advantage of a residualizing iodine radiolabel in the therapy of a colon cancer xenograft targeted with an anticarcinoembryonic antigen monoclonal antibody. PMID: 15814655 Ref: Surface expression and CEA binding of hnRNP M4 protein in HT29 colon cancer cells. PMID: 15816515 Ref: Preclinical application of radioimmunoguided surgery using anti-carcinoembryonic antigen biparatopic antibody in the colon cancer. PMID: 15818040 Ref: Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer? PMID: 15820244 Ref: [Laboratory-immunology indicators according as prognostic factors of patients with colon and rectum cancer]. PMID: 15822675 Ref: N(1),N(12)-Diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers. PMID: 15837752 Ref: Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules. PMID: 15837756 Ref: Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3: results of a phase I study. PMID: 15864608 Ref: Correlation between serum CEA level and metabolic volume as determined by FDG PET in postoperative patients with recurrent colorectal cancer. PMID: 15909492 Ref: [Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer]. PMID: 15938925 Ref: Induction of antigen-specific CD4- and CD8-mediated T-cell responses by fusions of autologous dendritic cells and metastatic colorectal cancer cells. PMID: 15945098 Ref: Outcome of colorectal carcinoma in patients under 40 years of age. PMID: 15946138 Ref: Cleavage of carcinoembryonic antigen induces metastatic potential in colorectal carcinoma. PMID: 15958210 Ref: Combined effects of protein kinase inhibitors and 5-fluorouracil on CEA expression in human colon cancer cells. PMID: 15967383 Ref: Stem cell factor (SCF) and interleukin 3 (IL-3) in the sera of patients with colorectal cancer. PMID: 15986847 Ref: [Detection and clinical study of serum tumor markers in patients with colorectal cancer]. PMID: 15996321 Ref: Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response PMID: 16002679 Ref: Plasma gelatinase activity does not reflect disease activity after operation for colorectal cancer. PMID: 16015042 Ref: Adjuvant radiochemotherapy of stage II and III rectal adenocarcinoma: role of CEA and CA 19-9. PMID: 16033101 Ref: Combination of immunomagnetic enrichment with multiplex RT-PCR analysis for the detection of disseminated tumor cells. PMID: 16033103 Ref: Discordant quantitative detection of putative biomarkers in nodal micrometastases of colorectal cancer: biological and clinical implications. PMID: 16049286 Ref: Induction of mucosal and systemic immune responses against human carcinoembryonic antigen by an oral vaccine. PMID: 16061685 Ref: Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer PMID: 16061910 Ref: Patient surveillance after curative-intent surgery for rectal cancer. PMID: 16077933 Ref: Cutoff values of preoperative s-CEA levels for predicting survivals after curative resection of colorectal cancer. PMID: 16100455 Ref: Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. PMID: 16100946 Ref: Double-blind randomised trial comparing 5-fluorouracil plus leucovorin to placebo for metastatic colorectal carcinoma. PMID: 16108890 Ref: Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancer. PMID: 16115944 Ref: Preoperative serum levels of the carcinoembryonic antigen in hereditary non-polyposis colorectal cancer compared to levels in sporadic colorectal cancer. PMID: 16122885 Ref: False positive F-18 fluorodeoxyglucose combined PET/CT scans from suture granuloma and chronic inflammation: report of two cases and review of literature. PMID: 16123823 Ref: [Usefulness of evaluation of carcinoembryonic antigen (CEA) and soluble fragments of cytokeratin 18-th (TPS) in postoperative monitoring of patients with colorectal cancer]. PMID: 16124375 Ref: Expression of double-stranded RNA-activated protein kinase (PKR) and its prognostic significance in lymph node negative rectal cancer. PMID: 16148023 Ref: Radioimmunotherapy of carcinoma of colon with [131I]-labeled recombinant chimeric monoclonal antibodies to carcinoembryonic antigen. PMID: 16174444 Ref: Neoadjuvant therapy of rectal cancer using oral tegaful-uracil (UFT) plus concomitant radiotherapy--a case report. PMID: 16180702 Ref: Port site recurrence diagnosed by positron emission tomography after laparoscopic surgery for colon cancer. PMID: 16201091 Ref: Pretargeting of carcinoembryonic antigen-expressing cancers with a trivalent bispecific fusion protein produced in myeloma cells. PMID: 16203811 Ref: Detection of carcinoembryonic antigen messenger RNA-expressing cells in portal and peripheral blood during surgery does not influence relapse in colorectal cancer. PMID: 16244799 Ref: Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody. PMID: 16258537 Ref: [Follow-up of patients after curative surgery for colorectal cancer]. PMID: 16266577 Ref: Therapeutic advantage of pretargeted radioimmunotherapy using a recombinant bispecific antibody in a human colon cancer xenograft. PMID: 16278412 Ref: Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells. PMID: 16278414 Ref: Genetic and pathologic changes associated with lymphovascular invasion of colorectal adenocarcinoma. PMID: 16283485 Ref: Characteristic differences between patients who have undergone surgical treatment for lung metastasis or hepatic metastasis from colorectal cancer. PMID: 16311973 Ref: Clinicopathologic and prognostic significance of MMP-7 (matrilysin) expression in human rectal cancer. PMID: 16314344 Ref: [Five cases of locally advanced rectal cancer or local recurrence performed intra-arterial infusion chemotherapy via the internal iliac artery]. PMID: 16315919 Ref: Value of serum carbohydrate antigen 19-9 for predicting extrahepatic metastasis in patients with liver metastasis from colorectal carcinoma. PMID: 16334783 Ref: Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring. PMID: 16336453 Ref: Effective production of carcinoembryonic antigen by conversion of the membrane-bound into a recombinant secretory protein by site-specific mutagenesis. PMID: 16388317 Ref: Detection of circulating CEA-IgM complexes in early stage colorectal cancer. PMID: 16398401 Ref: Avidin-biotin system pretargeting radioimmunoimaging and radioimmunotherapy and its application in mouse model of human colon carcinoma. PMID: 16419157 Ref: A preclinical survey on the efficacy of lactandrate in the treatment of colon carcinoma. PMID: 17343334 Ref: Serum Alkaline Phosphatase Level as a Prognostic Tool in Colorectal Cancer: A Study of 105 patients. PMID: 19750205 Ref: Expressions of matrix metalloproteinase-7 and -9 and their prognostic significances in rectal cancer. PMID: 19956372 Ref: Preoperative evaluation and oncologic principles of colon cancer surgery. PMID: 20011299 |
Ref: Evidence for CEA release from human colon cancer cells by an endogenous GPI-PLD enzyme. PMID: 15893415 Ref: Start codon polymorphisms in the vitamin D receptor and colorectal cancer risk. PMID: 16019132 Ref: Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells. PMID: 16034561 Ref: CpG oligonucleotides enhance the tumor antigen-specific immune response of an anti-idiotype antibody-based vaccine strategy in CEA transgenic mice. PMID: 16044253 Ref: A recombinant anti-carcinoembryonic antigen immunoreceptor with combined CD3zeta-CD28 signalling targets T cells from colorectal cancer patients against their tumour cells. PMID: 16188919 Ref: Relationship between genetic alterations and prognosis in sporadic colorectal cancer. PMID: 16231316 Ref: Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancer. PMID: 16353185 Ref: Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer. PMID: 16391782 Ref: Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel. PMID: 16391796 Ref: Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD. PMID: 16403911 Ref: Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer. PMID: 16425302 Ref: Aberrant crypt foci. PMID: 16475686 Ref: Rectal cancer surgery in the elderly: a multivariate analysis of outcome risk factors. PMID: 16482596 Ref: Multiplex detection of surface molecules on colorectal cancers. PMID: 16485257 Ref: Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from colorectal cancer. PMID: 16495699 Ref: Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein. PMID: 16504122 Ref: Laparoscopic hepatic artery catheterization for regional chemotherapy: is this the best current option for liver metastatic disease? PMID: 16508811 Ref: Identification of mRNA markers for molecular staging of lymph nodes in colorectal cancer. PMID: 16510433 Ref: The antitumor effect of a novel differentiation inducer, 2, 2-Bis (4-(4-amino-3-hydroxyphenoxy) phenyl) adamantane (DPA), in combinatory therapy on human colon cancer. PMID: 16525652 Ref: Preparation of native and amplified tumour RNA for dendritic cell transfection and generation of in vitro anti-tumour CTL responses. PMID: 16530085 Ref: Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer. PMID: 16538413 Ref: Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests. PMID: 16600979 Ref: Irinotecan as a new agent for urachal cancer. PMID: 16601395 Ref: The diagnostic value of G-CSF measurement in the sera of colorectal cancer and adenoma patients. PMID: 16603145 Ref: Anemia and long-term outcome in adjuvant and neoadjuvant radiochemotherapy of stage II and III rectal adenocarcinoma: the Freiburg experience (1989-2002). PMID: 16609990 Ref: Guides for adjuvant treatment of colon cancer. TTD Group (Spanish Cooperative Group for Gastrointestinal Tumor Therapy). PMID: 16632423 Ref: Increased colon tumor susceptibility in azoxymethane treated CEABAC transgenic mice. PMID: 16632476 Ref: Individualizing chemotherapeutic treatment of colorectal cancer. PMID: 16641252 Ref: Prognostic significance of CEA levels and positive cytology in peritoneal washings in patients with colorectal cancer. PMID: 16684089 Ref: [Univariate and multivariate regression analyses of recurrence and metastasis of colon cancer after radical resection]. PMID: 16687080 Ref: Quantitative real-time RT-PCR detection for CEA, CK20 and CK19 mRNA in peripheral blood of colorectal cancer patients. PMID: 16691638 Ref: Arginase as a useful factor for the diagnosis of colorectal cancer liver metastases. PMID: 16711512 Ref: Severe hypothyroidism induced by thyroid metastasis of colon adenocarcinoma: a case report and review of the literature. PMID: 16714841 Ref: Implications of CEA and p53 overexpression in the poor prognosis of colorectal cancer. PMID: 16720924 Ref: [Risk factors for recurrence and metastasis after radical anterior resection for rectal cancer]. PMID: 16721679 Ref: Are pretreatment serum albumin and cholesterol levels prognostic tools in patients with colorectal carcinoma? PMID: 16733481 Ref: Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis. PMID: 16736329 Ref: Pattern of carcinoembryonic antigen drop after laparoscopic radiofrequency ablation of liver metastasis from colorectal carcinoma. PMID: 16736515 Ref: Hepatic arterial infusion of oxaliplatin and L-folinic acid-modulated 5-fluorouracil for colorectal cancer liver metastases. PMID: 16739329 Ref: Quantitative estimation of CEA and CK20 expression in tumour tissue of colorectal cancer and its liver metastases with reverse transcription and real-time PCR. PMID: 16739357 Ref: Biomarker selection for detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR. PMID: 16755296 Ref: [A patient with hepatic, pulmonary, and nodal metastases of colon cancer responding to CPT-11/TS-1 therapy]. PMID: 16770105 Ref: [Advanced rectal cancer in an older patient, in whom metastatic liver lesions were effectively controlled with oral UFT+LV and venous CPT-11 administration--case report]. PMID: 16770106 Ref: CEA monitoring in colorectal cancer. What you should know. PMID: 16773844 Ref: Regional micrometastasis of low rectal cancer in mesorectum: a study utilizing HE stain on whole-mount section and ISH analyses on tissue microarray. PMID: 16777689 Ref: Prognostic significance of CEA levels and detection of CEA mRNA in draining venous blood in patients with colorectal cancer. PMID: 16788936 Ref: Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer. PMID: 16804977 Ref: Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer. PMID: 16809030 Ref: Isolated metachronous splenic metastasis from synchronous colon cancer. PMID: 16824207 Ref: Can biliary carcinoembryonic antigen identify colorectal cancer patients with occult hepatic metastases? PMID: 16847713 Ref: Increase in both CEA and CA19-9 in sera is an independent prognostic indicator in colorectal carcinoma. PMID: 16847905 Ref: Antitumor activity of chimeric immunoreceptor gene-modified Tc1 and Th1 cells against autologous carcinoembryonic antigen-expressing colon cancer cells. PMID: 16856879 Ref: Nucleosomes in colorectal cancer patients during radiochemotherapy. PMID: 16864976 Ref: Assessment of management practices for colonic cancer in the Paris metropolitan area in 2002. PMID: 16885869 Ref: Preoperative carcinoembryonic antigen and albumin in predicting survival in patients with colon and rectal carcinomas. PMID: 16917399 Ref: RT-PCR and immunohistochemical evaluation of sentinel lymph nodes after in vivo mapping with Patent Blue V in colon cancer patients. PMID: 16938721 Ref: [Multivariate regressive analysis of prognosis of liver metastases from colorectal cancer]. PMID: 16965660 Ref: [Prognostic analysis of 220 colorectal cancer patients with synchronous liver metastases]. PMID: 16965661 Ref: [A case of rectal cancer with multiple liver metastases responding to TS-1]. PMID: 16969038 Ref: Strategies of follow-up for colorectal cancer: a survey of the American Society of Colon and Rectal Surgeons. PMID: 16969616 Ref: Value of carcinoembryonic antigen assay in predicting hepatic metastases, local recurrence, and survival after curative resection of colorectal cancer. PMID: 16998681 Ref: Urinary neopterin in patients with advanced colorectal carcinoma. PMID: 17013802 Ref: The role of carcinoembryonic antigen as a predictor of the need for preoperative computed tomography in colon cancer patients. PMID: 17058730 Ref: Unusual elevation of CEA in a patient with history of colon cancer. PMID: 17060406 Ref: ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. PMID: 17060676 Ref: Potential predictors of survival after surgery for colorectal cancer patients with synchronous unresectable liver metastases. PMID: 17089063 Ref: Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results. PMID: 17094403 Ref: Evaluation of the role of CT in the assessment of response to selective internal radiation therapy in patients with colorectal liver metastases. PMID: 17107529 Ref: Quantitative analysis of plasma DNA in colorectal cancer patients: a novel prognostic tool. PMID: 17108210 Ref: Multivariate analysis of prognostic determinants for colorectal cancer patients with high preoperative serum CEA levels: prognostic value of postoperative serum CEA levels. PMID: 17116621 Ref: Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer. PMID: 17145818 Ref: [Biomolecular prognostic factors in colorectal cancer]. PMID: 17190278 Ref: [A long-term survival case of liver and mediastinal LN metastases from colon cancer treated with intensive multimodal therapy]. PMID: 17212109 Ref: [The relationship between plasma level of VEGF or soluble Flt-1 and efficacy of hepatic arterial chemotherapy in patients with liver metastasis of colorectal cancer]. PMID: 17212123 Ref: Detection of cancer cells disseminated in bone marrow using real-time quantitative RT-PCR of CEA, CK19, and CK20 mRNA in patients with gastric cancer. PMID: 17235634 Ref: Establishment of serum protein pattern for screening colorectal cancer using SELDI-TOF-MS. PMID: 17285111 Ref: Prognostic value of carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content in colorectal cancer. PMID: 17652942 Ref: Solitary adrenal metastasis in a patient with sigmoid colon cancer; report of a case. PMID: 18175226 |
Ref: Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer. PMID: 16896992 Ref: p53 protein accumulation as a prognostic marker in sporadic colorectal cancer. PMID: 17021749 Ref: Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis. PMID: 17103264 Ref: Pulmonary resection for metastases from colorectal cancer: prognostic factors and survival. PMID: 17109105 Ref: Carcinoembryonic antigen (CEA) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial. PMID: 17174516 Ref: Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer. PMID: 17200912 Ref: Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer. PMID: 17211733 Ref: Clinical significance of large tenascin-C spliced variant as a potential biomarker for colorectal cancer. PMID: 17219282 Ref: Antibody response against neem leaf preparation recognizes carcinoembryonic antigen. PMID: 17276888 Ref: Induction of tumor-specific T-cell responses by vaccination with tumor lysate-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors. PMID: 17333181 Ref: Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen. PMID: 17363612 Ref: Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis. PMID: 17368603 Ref: Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. PMID: 17387743 Ref: Changes in disease pattern and treatment outcome of colorectal cancer: a review of 5,474 cases in 20 years. PMID: 17390145 Ref: Outcomes of hepatic artery infusion therapy for hepatic metastases from colorectal carcinoma after radiological placement of infusion catheters. PMID: 17399936 Ref: Multiple molecular markers as predictors of colorectal cancer in patients with normal perioperative serum carcinoembryonic antigen levels. PMID: 17406027 Ref: Utility of slot-blot-ELISA as a new, fast, and sensitive immunoassay for detection of carcinoembryonic antigen in the urine samples of patients with various gastrointestinal malignancies. PMID: 17424828 Ref: Hepatectomy and lung radiofrequency ablation for hepatic and subsequent pulmonary metastases from colorectal carcinoma. PMID: 17443735 Ref: Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer. PMID: 17457032 Ref: [A case of colon cancer resembling submucosal tumor with ossification]. PMID: 17485948 Ref: Carcinoembryonic antigen-stimulated THP-1 macrophages activate endothelial cells and increase cell-cell adhesion of colorectal cancer cells. PMID: 17487559 Ref: Comparative analysis of intraperitoneal minimal free cancer cells between colorectal and gastric cancer patients using quantitative RT-PCR: possible reason for rare peritoneal recurrence in colorectal cancer. PMID: 17487561 Ref: Detection of metastatic disease with sentinel lymph node dissection in colorectal carcinoma patients. PMID: 17490848 Ref: [A case of ascending colon cancer with enlarged metastatic lymph nodes around superior mesenteric arterial root that responded dramatically to S-1 and CPT-11 combination chemotherapy]. PMID: 17496457 Ref: Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. PMID: 17512720 Ref: [Rule of lymph node metastasis in colorectal cancer and its affecting factors]. PMID: 17520386 Ref: Tumour cell dissemination following endoscopic stent insertion. PMID: 17541987 Ref: [Effects of two different antigen-loading methods on the activity of dendritic cell vaccine for colorectal carcinoma cell inhibition in vitro]. PMID: 17545041 Ref: FDG-PET scan in patients with clinically and/or radiologically suspicious colorectal cancer recurrence but normal CEA. PMID: 17555577 Ref: Protein thiols and thiobarbituric acid reactive substance status in colon cancer patients. PMID: 17558909 Ref: Low TCR avidity and lack of tumor cell recognition in CD8(+) T cells primed with the CEA-analogue CAP1-6D peptide. PMID: 17564703 Ref: [Long survival of a colon cancer case with multiple liver metastases cured by multidisciplinary therapy]. PMID: 17565264 Ref: A small rise in CEA is sensitive for recurrence after surgery for colorectal cancer. PMID: 17573747 Ref: [Survival of patients with liver metastasis from colorectal cancer by different modes of therapy: a report of 363 cases]. PMID: 17575696 Ref: [Survival rates of patients with mucinous adenocarcinoma of the colorectum]. PMID: 17582971 Ref: Pre-clinical evaluation of a CEA DNA prime/protein boost vaccination strategy against colorectal cancer. PMID: 17587345 Ref: Predicting prognosis of rectal cancer patients with total mesorectal excision using molecular markers. PMID: 17589956 Ref: Hepatectomy for resectable colorectal cancer metastases--indicators of prognosis, definition of resectability, techniques and outcomes. PMID: 17606190 Ref: Results of a national survey among Dutch surgeons treating patients with colorectal carcinoma. Current opinion about follow-up, treatment of metastasis, and reasons to revise follow-up practice. PMID: 17608748 Ref: Combined use of preoperative 18F FDG-PET imaging and intraoperative gamma probe detection for accurate assessment of tumor recurrence in patients with colorectal cancer. PMID: 17634125 Ref: [Distal pancreatectomy for rectal metastatic adenocarcinoma 6 years after proctectomy]. PMID: 17646794 Ref: Tumor markers in patients with relapse of colorectal carcinoma. PMID: 17649792 Ref: Chemotherapy prescription patterns in colon cancer: a patterns-of-care survey in New Zealand. PMID: 17653254 Ref: [Value of fecal and blood adenomatous polyposis coli gene and K-ras gene mutation detection in colorectal neoplasm screening]. PMID: 17666342 Ref: Different forms of helper tolerance to carcinoembryonic antigen: ignorance and regulation. PMID: 17671139 Ref: [A case of local recurrence of colon cancer responding to chemotherapy with low-dose oxaliplatin, 5-FU and l-LV]. PMID: 17687216 Ref: Value of RT-PCR analysis of sentinel nodes in determining the pathological nodal status in colon cancer. PMID: 17695460 Ref: Rapid genetic diagnosis with transcription-reverse transcription concerted reaction system for peritoneal recurrence and survival in colorectal cancer patients. PMID: 17786336 Ref: Carcinoembryonic antigen (CEA) testing in colorectal cancer follow up: what do patients think? PMID: 17823231 Ref: Hyperthermic intraperitoneal chemoperfusion is an option for treatment of peritoneal carcinomatosis in children. PMID: 17848227 Ref: MMP-1 (collagenase-1) expression in primary colorectal cancer and its metastases. PMID: 17852862 Ref: [Prognostic study of preoperative serum levels of CEA and CA 19-9 in colorectal cancer]. PMID: 17876139 Ref: Correlation of CK-20-positive cells in peripheral venous blood with serum CEA levels in patients with colorectal carcinoma. PMID: 17914651 Ref: Construction of humanized carcinoembryonic antigen specific single chain variable fragment and mitomycin conjugate. PMID: 17963306 Ref: Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. PMID: 17967307 Ref: Preparation, characterization, and biological evaluation of a streptavidin-chimeric t84.66 conjugate for antibody pretargeting. PMID: 17979568 Ref: Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases. PMID: 17991322 Ref: Free circulating DNA as possible tumour marker in colorectal cancer. PMID: 18024018 Ref: Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection. PMID: 18043108 Ref: Colorectal hyperplasia and dysplasia due to human carcinoembryonic antigen (CEA) family member expression in transgenic mice. PMID: 18159236 Ref: [A case of refractory inguinal lymphorrhea cured by lipiodol lymphangiography]. PMID: 18219932 Ref: Carcinoembryonic antigen and patterns of recurrence after curative resection of the colorectal cancer. PMID: 18251140 Ref: The effects of surgical margin and edge cryotherapy after liver resection for colorectal cancer metastases. PMID: 18333223 Ref: Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas. PMID: 18334831 Ref: Natural fluorescence spectroscopy of human blood plasma in the diagnosis of colorectal cancer: feasibility study and preliminary results. PMID: 18338491 Ref: Significance of CEA and VEGF as Diagnostic Markers of Colorectal Cancer in Lebanese Patients. PMID: 18665243 Ref: The role of postoperative surveillance in colorectal cancer. PMID: 20011206 |
Ref: Prognostic factors after preoperative irradiation and surgery for locally advanced rectal cancer. PMID: 17614249 Ref: Caspase-3 activity, response to chemotherapy and clinical outcome in patients with colon cancer. PMID: 17805550 Ref: Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. PMID: 17882491 Ref: Isolated splenic metastasis from colorectal cancer: report of a case. PMID: 17939014 Ref: Isolated paraaortic lymph-node recurrence after the curative resection of colorectal carcinoma. PMID: 17963247 Ref: New insights into the role of age and carcinoembryonic antigen in the prognosis of colorectal cancer. PMID: 18026187 Ref: Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responses. PMID: 18060404 Ref: Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer. PMID: 18070184 Ref: Abberant crypt foci -- importance in colorectal carcinogenesis and expression of p53 and mdm2: a changing concept. PMID: 18080767 Ref: [A case of metastasis to the diaphragm from ascending colon cancer]. PMID: 18195546 Ref: Metastatic human colonic carcinoma: molecular imaging with pretargeted SPECT and PET in a mouse model. PMID: 18227543 Ref: Tumor markers in staging and prognosis of colorectal carcinoma. PMID: 18237252 Ref: Faecal ribosomal protein L19 is a genetic prognostic factor for survival in colorectal cancer. PMID: 18266979 Ref: Biodistribution and tumor imaging of an anti-CEA single-chain antibody-albumin fusion protein. PMID: 18312824 Ref: Increased basolateral sorting of carcinoembryonic antigen in a polarized colon carcinoma cell line after cholesterol depletion-Implications for treatment of inflammatory bowel disease. PMID: 18330942 Ref: [A successfully resected case of colorectal cancer with multiple liver metastases treated with FOLFIRI after failure of mFOLFOX6]. PMID: 18347406 Ref: Targeted killing of colorectal cancer cell lines by a humanised IgG1 monoclonal antibody that binds to membrane-bound carcinoembryonic antigen. PMID: 18349843 Ref: Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. PMID: 18362931 Ref: The prevalence of iron deficiency anemia and its clinical implications in patients with colorectal carcinoma. PMID: 18364262 Ref: Compliance, attitudes and barriers to post-operative colorectal cancer follow-up. PMID: 18373578 Ref: Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow. PMID: 18375392 Ref: Yield of routine imaging after curative colorectal cancer treatment. PMID: 18411580 Ref: Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas. PMID: 18426738 Ref: Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer. PMID: 18435490 Ref: Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence? PMID: 18440486 Ref: Profiling tumor-associated autoantibodies for the detection of colon cancer. PMID: 18451234 Ref: [Clinicopathological analysis of synchronous hepatic metastases from colorectal cancer]. PMID: 18478460 Ref: Genetic construction, expression, and characterization of a single chain anti-CEA antibody fused to cytosine deaminase from yeast. PMID: 18497986 Ref: Community compliance with carcinoembryonic antigen: follow-up of patients with colorectal cancer. PMID: 18501071 Ref: The role of half-life of carcinoembryonic antigen (CEA) in prognosis prediction of colorectal cancer patients with preoperatively elevated CEA. PMID: 18570735 Ref: Combined effects of 5-fluorouracil, folinic acid and oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy. PMID: 18577244 Ref: Metastatic tumor doubling time is an independent predictor of intrapulmonary recurrence after pulmonary resection of solitary pulmonary metastasis from colorectal cancer. PMID: 18577868 Ref: [Adnexal tumors after surgical treatment of colorectal cancer]. PMID: 18592863 Ref: Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients. PMID: 18613372 Ref: Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer. PMID: 18616803 Ref: The application of C12 biochip in the diagnosis and monitoring of colorectal cancer: systematic evaluation and suggestion for improvement. PMID: 18626164 Ref: Clinical case report and literature review: metachronous colorectal splenic metastases. PMID: 18628076 Ref: Diminishing impact of preoperative carcinoembryonic antigen (CEA) in prognosis of Dukes' C colorectal cancer. PMID: 18630484 Ref: Negative serum carcinoembryonic antigen has insufficient accuracy for excluding recurrence from patients with Dukes C colorectal cancer: analysis with likelihood ratio and posttest probability in a follow-up study. PMID: 18633674 Ref: Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer. PMID: 18665430 Ref: Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse. PMID: 18670822 Ref: Splenic infarct as a diagnostic pitfall in radiology. PMID: 18688130 Ref: Risk factors for local recurrence of middle and lower rectal carcinoma after curative resection. PMID: 18720544 Ref: Receipt of guideline-recommended follow-up in older colorectal cancer survivors : a population-based analysis. PMID: 18780338 Ref: [Study on clinicopathological correlations between metabolic syndrome and colorectal carcinoma]. PMID: 18785568 Ref: Carcinoma obstruction of the left colon and long-term prognosis. PMID: 18795674 Ref: Clinicopathological features and the value of differential Cytokeratin 7 and 20 expression in resolving diagnostic dilemmas of ovarian involvement by colorectal adenocarcinoma and vice-versa. PMID: 18801162 Ref: Modification of CEA with both CRT and TAT PTD induces potent anti-tumor immune responses in RNA-pulsed DC vaccination. PMID: 18812201 Ref: Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9. PMID: 18813812 Ref: Evaluation of the lateral sentinel node by indocyanine green for rectal cancer based on micrometastasis determined by reverse transcriptase-polymerase chain reaction. PMID: 18813813 Ref: Doubling time of carcinoembryonic antigen is a significant prognostic factor after the surgical resection of locally recurrent rectal cancer. PMID: 18818499 Ref: Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients. PMID: 18845519 Ref: Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer. PMID: 18846401 Ref: Tumour-associated transcripts and EGFR deletion variants in colorectal cancer in primary tumour, metastases and circulating tumour cells. PMID: 18936523 Ref: Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer. PMID: 18937231 Ref: [Expression of human pituitary tumor transforming gene 1 in colorectal cancer detected with real-time fluorescent quantitative PCR and its clinical significance]. PMID: 19000457 Ref: Metastatic colorectal cancer to a primary thyroid cancer. PMID: 19014453 Ref: Intrarectal vaccination with recombinant vaccinia virus expressing carcinoembronic antigen induces mucosal and systemic immunity and prevents progression of colorectal cancer. PMID: 19018004 Ref: The usefulness of immunohistochemistry in sporadic colorectal cancer. PMID: 19050802 Ref: [Multivisceral resection in locally advanced colorectal cancer: analysis of associated humoral and clinical factors]. PMID: 19062487 Ref: [A case of advanced sigmoid colon cancer with peritoneal dissemination responding to FOLFOX4 therapy]. PMID: 19098417 Ref: [Serum anti-p53 antibodies and CEA in monitoring of recurrences of colorectal cancer]. PMID: 19839520 Ref: Study of endothelin-1 and vascular endothelial growth factor in patients with cancer colon. PMID: 20424651 |
Ref: Mutant p53 protein in the serum of patients with colorectal cancer: Correlation with the level of carcinoembryonic antigen and serum epidermal growth factor receptor. PMID: 16632243 Ref: Prognostic factors in survival of colorectal cancer patients after surgery. PMID: 18462239 Ref: Comparison of carcinoembryonic antigen prognostic value in serum and tumour tissue of patients with colorectal cancer. PMID: 18513194 Ref: Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer. PMID: 18619834 Ref: Preoperative investigations for metastatic staging of colon and rectal cancer across multiple centres--what is current practice? PMID: 18624816 Ref: Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist. PMID: 18672360 Ref: Factors associated with anastomotic recurrence after total mesorectal excision in rectal cancer patients. PMID: 18937260 Ref: A therapeutic cancer vaccine targeting carcinoembryonic antigen in intestinal carcinomas. PMID: 18937552 Ref: Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer. PMID: 18942720 Ref: Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases. PMID: 18987915 Ref: A herpes oncolytic virus can be delivered via the vasculature to produce biologic changes in human colorectal cancer. PMID: 19018254 Ref: A phase I study of hyperthermic isolated hepatic perfusion with oxaliplatin in the treatment of unresectable liver metastases from colorectal cancer. PMID: 19034580 Ref: Added value of combined gene and protein expression of CK20 and CEA in non-macroscopically involved lymph nodes of colorectal cancer. PMID: 19074466 Ref: Clinical significance of chicken ovalbumin upstream promoter-transcription factor II expression in human colorectal cancer. PMID: 19082449 Ref: Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery. PMID: 19101093 Ref: Characterization of genetically modified T-cell receptors that recognize the CEA:691-699 peptide in the context of HLA-A2.1 on human colorectal cancer cells. PMID: 19118044 Ref: Tissue specific cytotoxicity of colon cancer cells mediated by nanoparticle-delivered suicide gene in vitro and in vivo. PMID: 19118047 Ref: Laparoscopic resection of extraperitoneal rectal cancer: a comparative analysis with open resection. PMID: 19118433 Ref: Lung metastases from colorectal cancer: surgical resection and prognostic factors. PMID: 19136273 Ref: Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer. PMID: 19140877 Ref: Prognostic value of CEA and CA 19-9 tumor markers combined with cytology from peritoneal fluid in colorectal cancer. PMID: 19189191 Ref: Clinical significance of tumor markers and an emerging perspective on colorectal cancer. PMID: 19200256 Ref: Detection of serum gastric cancer-associated MG7-Ag from gastric cancer patients using a sensitive and convenient ELISA method. PMID: 19235597 Ref: [Prognostic factors after resection of colorectal cancer liver metastases]. PMID: 19239935 Ref: Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy. PMID: 19259690 Ref: Potent induction of B- and T-cell immunity against human carcinoembryonic antigen-expressing tumors in human carcinoembryonic antigen transgenic mice mediated by direct lentivector injection. PMID: 19276164 Ref: [A case of ascending colon cancer with local recurrence responding completely to alternating modified-FOLFOX6 and FOLFIRI regimens(modified-FIREFOX regimen)]. PMID: 19295282 Ref: Changes in plasma TIMP-1 levels after resection for primary colorectal cancer. PMID: 19331135 Ref: A phase I study of a combination of yttrium-90-labeled anti-carcinoembryonic antigen (CEA) antibody and gemcitabine in patients with CEA-producing advanced malignancies. PMID: 19351765 Ref: A simple scoring system based on clinical features to predict locally advanced rectal cancers. PMID: 19367434 Ref: Serum proteomics using mass spectrometry. PMID: 19381950 Ref: High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer. PMID: 19384300 Ref: Claudin-1 protein is a major factor involved in the tumorigenesis of colorectal cancer. PMID: 19414319 Ref: The prognostic impact of the number of lymph nodes retrieved after neoadjuvant chemoradiotherapy with mesorectal excision for rectal cancer. PMID: 19418495 Ref: Analysis of factors associated with outcome in patients undergoing isolated hepatic perfusion for unresectable liver metastases from colorectal center. PMID: 19434456 Ref: Prognostic value of carcinoembryonic antigen distribution in tumor tissue of colorectal carcinoma. PMID: 19466306 Ref: Persistent high postoperative carcinoembryonic antigen in colorectal cancer patients--is it important? PMID: 19488584 Ref: Clinical significance of microvessel count in patients with metastatic liver cancer originating from colorectal carcinoma. PMID: 19495885 Ref: Identification of Cystatin SN as a novel tumor marker for colorectal cancer. PMID: 19513549 Ref: Factors predicting survival in surgical palliative resection of stage IV colorectal cancer. PMID: 19536056 Ref: Liver perfusion with dynamic multidetector-row computed tomography as an objective method to evaluate the efficacy of chemotherapy in patients with colorectal cancer. PMID: 19559351 Ref: Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection. PMID: 19565285 Ref: Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients. PMID: 19569242 Ref: Utility of serum preoperative carcinoemberyonic antigen in colorectal cancer patients. PMID: 19579599 Ref: The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer. PMID: 19581858 Ref: Novel functional profiling approach combining reverse phase protein microarrays and human 3-D ex vivo tissue cultures: expression of apoptosis-related proteins in human colon cancer. PMID: 19609961 Ref: Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level. PMID: 19629600 Ref: Elevated carcinoembryonic antigen and sarcoidosis masquerading as metastatic colon cancer. PMID: 19632934 Ref: Pulmonary resection for metastases from colorectal carcinoma. PMID: 19635733 Ref: Detection of epithelial cells by RT-PCR targeting CEA, CK20, and TEM-8 in colorectal carcinoma patients using OncoQuick density gradient centrifugation system. PMID: 19645077 Ref: Prognostic value of postoperative CEA clearance in rectal cancer patients with high preoperative CEA levels. PMID: 19657698 Ref: In vitro evaluation of histone deacetylase inhibitors as combination agents for colorectal cancer. PMID: 19661311 Ref: CEA in activated macrophages. New diagnostic possibilities for tumor markers in early colorectal cancer. PMID: 19661342 Ref: Factors influencing survival after complete resection of pulmonary metastases from colorectal cancer. PMID: 19672932 Ref: Sensitive digital quantification of DNA methylation in clinical samples. PMID: 19684580 Ref: Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment. PMID: 19691850 Ref: [Video-assisted thoracic surgery for pulmonary metastasis of colorectal cancer]. PMID: 19692764 Ref: Differential expression of the LOX family genes in human colorectal adenocarcinomas. PMID: 19724858 Ref: [Multivariate analysis of clinicopathologic factors correlated with pathological complete response following preoperative radiotherapy in rectal adenocarcinoma]. PMID: 19728907 Ref: [Risk factors related to lymph node metastases after neoadjuvant therapy for locally advanced rectal cancer]. PMID: 19728908 Ref: [Efficacy and prognostic analysis on surgical resection of pulmonary metastasis from colorectal cancer]. PMID: 19742336 Ref: F-18 FDG PET detection of a medullary thyroid carcinoma in a patient with metastatic colonic cancer; literature review. PMID: 19744643 Ref: Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection. PMID: 19757443 Ref: Carcinoembryonic antigen screening: how far should we go? PMID: 19787171 Ref: Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma. PMID: 19795327 Ref: A strategy for blood biomarker amplification and localization using ultrasound. PMID: 19805109 Ref: Diagnosis and management of local and locoregional recurrence of colorectal carcinoma. PMID: 19827341 Ref: Relationship between peripheral and mesenteric serum levels of CEA and CA 242 with staging and histopathological variables in colorectal adenocarcinoma. PMID: 19851695 Ref: Surveillance approaches among colorectal cancer survivors after curative-intent. PMID: 19942831 Ref: Serum homocysteine, cholesterol, retinol, alpha-tocopherol, glycosylated hemoglobin and inflammatory response during therapy with bevacizumab, oxaliplatin, 5-fluorouracil and leucovorin. PMID: 20032440 Ref: [Switching to direct intrahepatic arterial infusion of 5-FU after a progression of liver metastases from colorectal carcinoma treated with systemic infusion of FOLFOX]. PMID: 20037315 Ref: [A case of liver metastasis of rectal cancer demonstrating complete response for more than two years to mFOLFOX6]. PMID: 20037356 Ref: [A case of ascending colon cancer successfully treated for synchronous liver metastases with mFOLFOX6 after a resection of the primary tumor]. PMID: 20037364 Ref: [A case of surgical approach to the recurrence of the para-aortic lymph nodes after resection of rectal cancer]. PMID: 20037371 Ref: En bloc resection for right colon cancer directly invading duodenum or pancreatic head. PMID: 20046421 Ref: [Significance of the TPS cytokeratin marker in the postoperative follow up of colorectal carcinoma patients]. PMID: 20055296 Ref: [A preliminary study on construction of targeting double suicide gene therapy vector pcDNA3.1 (-) Cp-CD-TK]. PMID: 20067103 Ref: Outcomes of total pelvic exenteration for colorectal cancer. PMID: 20214208 Ref: Surveillance after curative resection of colorectal cancer. PMID: 21037815 Ref: Titration of serum CEA, p53 antibodies and CEA-IgM complexes in patients with colorectal cancer. PMID: 21475853 |
Ref: Over-expression of human kallikrein 11 is associated with poor prognosis in patients with low rectal carcinoma. PMID: 19184568 Ref: Prognostic factors in survival of colorectal cancer patients with synchronous liver metastasis. PMID: 19508508 Ref: HERG1 gene expression as a specific tumor marker in colorectal tissues. PMID: 19577877 Ref: Construction, expression and characterization of a dual cancer-specific fusion protein targeting carcinoembryonic antigen in intestinal carcinomas. PMID: 19686851 Ref: Krukenberg tumors of colorectal origin: a dismal outcome--experience of a tertiary center. PMID: 19705132 Ref: The -174 G/C polymorphism in interleukin-6 (IL-6) promoter region is associated with serum IL-6 and carcinoembryonic antigen levels in patients with colorectal cancers in Taiwan. PMID: 19728052 Ref: Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection. PMID: 19800178 Ref: Survival benefit from ovarian metastatectomy in colorectal cancer patients with ovarian metastasis: a retrospective analysis. PMID: 19820936 Ref: Short disease-free interval is a significant risk factor for intrapulmonary recurrence after resection of pulmonary metastases in colorectal cancer. PMID: 19843115 Ref: Stent or surgery for incurable obstructive colorectal cancer: an individualized decision. PMID: 19859722 Ref: The impact of carcinoembryonic antigen flare in patients with advanced colorectal cancer receiving first-line chemotherapy. PMID: 19861580 Ref: Knockdown of peroxisome proliferator-activated receptor-beta induces less differentiation and enhances cell-fibronectin adhesion of colon cancer cells. PMID: 19935699 Ref: Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody. PMID: 19953093 Ref: Radioimmunotherapy of human colon cancer xenografts with 131I-labeled anti-CEA monoclonal antibody. PMID: 20078028 Ref: A novel prognostic index in colorectal cancer defined by serum carcinoembryonic antigen and plasma tissue inhibitor of metalloproteinases-1. PMID: 20095885 Ref: A comparative study of protein expression in primary colorectal cancer and synchronous hepatic metastases: the significance of matrix metalloproteinase-1 expression as a predictor of liver metastasis. PMID: 20095886 Ref: First alert for recurrence during follow-up after potentially curative resection for colorectal carcinoma: CA 19-9 should be included in surveillance programs. PMID: 20100688 Ref: Colorectal cancer: response to sunitinib in a heavily pretreated colorectal cancer patient. PMID: 20110784 Ref: Amperometric immunosensor for carcinoembryonic antigen in colon cancer samples based on monolayers of dendritic bipodal scaffolds. PMID: 20112971 Ref: Pulmonary metastasectomy in colorectal cancer: a systematic review and quantitative synthesis. PMID: 20118336 Ref: Preoperative carcinoembryonic antigen level as an independent prognostic factor in potentially curative colon cancer. PMID: 20119979 Ref: Pretargeted radioimmunoscintigraphy in patients with primary colorectal cancer using a bispecific anticarcinoembryonic antigen CEA X anti-di-diethylenetriaminepentaacetic acid F(ab')2 antibody. PMID: 20127959 Ref: Factors that contribute to faecal cyclooxygenase-2 mRNA expression in subjects with colorectal cancer. PMID: 20145612 Ref: Serum cellular apoptosis susceptibility protein is a potential prognostic marker for metastatic colorectal cancer. PMID: 20150437 Ref: Changes in soluble CEA and TIMP-1 levels during adjuvant chemotherapy for stage III colon cancer. PMID: 20150641 Ref: [Multiple liver metastases due to sigmoid colon cancer successfully treated by degradable starch microspheres (DSM)-TAE, radiofrequency ablation therapy, and Uzel/UFT]. PMID: 20154497 Ref: [A case of complete response after treatment with UFT and leucovorin for synchronous multiple liver metastases of rectal cancer]. PMID: 20154498 Ref: Lead time of carcinoembryonic antigen elevation in the postoperative follow-up of colorectal cancer did not affect the survival rate after recurrence. PMID: 20162425 Ref: Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen. PMID: 20173157 Ref: The diagnostic value of indeterminate lung lesions on staging chest computed tomographies in patients with colorectal cancer. PMID: 20175945 Ref: Successful long-term management of a patient with late-stage metastatic colorectal cancer treated with panitumumab. PMID: 20189054 Ref: [A case of colon cancer with multiple liver metastases responding ot S-1 as third-line treatment following FOLFIRI and FOLFOX]. PMID: 20210032 Ref: Efficient co-transduction of adenoviral vectors encoding carcinoembryonic antigen and survivin into dendritic cells by the CAR-TAT adaptor molecule enhance anti-tumor immunity in a murine colorectal cancer model. PMID: 20211203 Ref: Survival in surgical palliative resection of stage IV colorectal cancer: short term results in a single institution. PMID: 20212413 Ref: Performance of FDG PET/CT in postoperative colorectal cancer patients with a suspected recurrence and a normal CEA level. PMID: 20216474 Ref: Clinical significance of CEA and CA19-9 in postoperative follow-up of colorectal cancer. PMID: 20217258 Ref: [Expression and its significance of retinoic acid receptor-beta in colorectal cancer]. PMID: 20302734 Ref: [Significance of CEA to predict the effect of chemotherapy with bevacizumab]. PMID: 20332684 Ref: Serum sE-selectin levels and carcinoembryonic antigen mRNA-expressing cells in peripheral blood as prognostic factors in colorectal cancer patients. PMID: 20336782 Ref: Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations. PMID: 20364373 Ref: Development of a multimarker assay for early detection of ovarian cancer. PMID: 20368574 Ref: Transient carcinoembryonic antigen elevations during adjuvant chemotherapy for colorectal cancer reflect the burden of residual micrometastatic disease. PMID: 20378505 Ref: HLA-A*0201-restricted CEA-derived peptide CAP1 is not a suitable target for T-cell-based immunotherapy. PMID: 20386466 Ref: Advantages of the AMDL-ELISA DR-70 (FDP) assay over carcinoembryonic antigen (CEA) for monitoring colorectal cancer patients. PMID: 20391025 Ref: Utility or futility of prognostic scoring systems for colorectal liver metastases in an era of advanced multimodal therapy. PMID: 20413243 Ref: [A case of fluoropyrimidine-resistant recurrent colon cancer successfully treated with weekly administration of irinotecan]. PMID: 20414034 Ref: [A case of metachronous multiple lung metastases and intraabdominal lymph node metastases of rectal cancer responding to S-1]. PMID: 20414035 Ref: Characteristics and risk factors for colorectal cancer recurrence. PMID: 20414929 Ref: Inadequate quality of surveillance after curative surgery for colon cancer. PMID: 20429036 Ref: [Clinical pathologic factors predicting tumor response after preoperative neoadjuvant therapy for rectal cancer]. PMID: 20450606 Ref: [The trends in clinical characteristics of colon cancer in last two decades]. PMID: 20450656 Ref: [TSST-1 regulated synergistically by 5HRE and CEAp activates lymphocytes to kill CEA-positive tumor cells specifically]. PMID: 20487641 Ref: Phase II study of pre-operative radiotherapy with capecitabine and oxaliplatin for rectal cancer and carcinoembryonic antigen as a predictor of pathological tumour response. PMID: 20515578 Ref: Expression of cortactin correlates with a poor prognosis in patients with stages II-III colorectal adenocarcinoma. PMID: 20532661 Ref: Expression of 2 transcripts of NGX6 gene in colorectal cancer and the correlation with carcinoembryonic antigen. PMID: 20543461 Ref: [Pre-operative sera levels of CEA and CA19-9 and tissular distribution of tumor marker CA19-9 in colorectal carcinoma: correlation with morphological features of neoplasia]. PMID: 20549100 Ref: The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients. PMID: 20556397 Ref: [Familial adenomatous polyposis: a follow-up of the extracolonic manifestations]. PMID: 20578576 Ref: Repeat resection of pulmonary metastasis is beneficial for patients with colorectal carcinoma. PMID: 20582543 Ref: Pancreatic metastasis from colon carcinoma nine years after a hemicolectomy managed by distal pancreatectomy. A review of the literature regarding the role and outcome of pancreatic resection for colorectal metastasis. PMID: 20601814 Ref: Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen. PMID: 20604972 Ref: Predictive value of cancer stem-like cells and cancer-associated genetic markers for peritoneal recurrence of colorectal cancer in patients after curative surgery. PMID: 20616575 Ref: Preoperative plasma TIMP-1 is an independent prognostic indicator in patients with primary colorectal cancer: a prospective validation study. PMID: 20619633 Ref: [Clinical multivariate regression analysis of local recurrence following curative surgery for rectal cancer]. PMID: 20646650 Ref: [A case successfully treated with multidisciplinary treatment against recurrence of lateral lymph node and liver for rectal cancer]. PMID: 20647735 Ref: Does serum carcinoembryonic antigen elevation in patients with postoperative stage II colorectal cancer indicate recurrence? Comparison with stage III. PMID: 20648586 Ref: Evaluating the utility of N1,N12-diacetylspermine and N1,N8-diacetylspermidine in urine as tumor markers for breast and colorectal cancers. PMID: 20655890 Ref: An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer. PMID: 20679728 Ref: RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker. PMID: 20682997 Ref: Influence of obesity on the serum carcinoembryonic antigen value in patients with colorectal cancer. PMID: 20729287 Ref: Serological diagnostic factors for liver metastasis in patients with colorectal cancer. PMID: 20731024 Ref: Biomolecular markers as determinants of patients selection for adjuvant chemotherapy of sporadic colorectal cancers. PMID: 20737746 Ref: A combination of serum markers for the early detection of colorectal cancer. PMID: 20798228 Ref: Prognostic significance of response to preoperative radiotherapy, lymph node metastasis, and CEA level in patients undergoing total mesorectal excision of rectal cancer. PMID: 20809426 Ref: Medullary carcinoma of the large intestine: a population based analysis. PMID: 20811712 Ref: One step nucleic acid amplification (OSNA) - a new method for lymph node staging in colorectal carcinomas. PMID: 20819209 Ref: [Usefulness of evaluation of soluble fragment cytokeratin 18, carcinoembryonic antigen and gastrointestinal carcinoma-associated antigen in diagnostic of patients with colorectal cancer]. PMID: 20842828 Ref: Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients. PMID: 20849596 Ref: Is circulating D-dimer level a better prognostic indicator than CEA in resectable colorectal cancer? Our experience on 199 cases. PMID: 20878623 Ref: Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. PMID: 20880178 Ref: Carcinoembryonic antigen interacts with TGF-{beta} receptor and inhibits TGF-{beta} signaling in colorectal cancers. PMID: 20889724 Ref: Prognosis of colorectal cancer with liver metastasis: value of a prognostic index. PMID: 20945037 Ref: [A case of high CEA colon cancer responding to neoadjuvant chemotherapy with FOLFIRI]. PMID: 20948272 Ref: The severity of neural invasion is a crucial prognostic factor in rectal cancer independent of neoadjuvant radiochemotherapy. PMID: 21037435 Ref: FcgammaR polymorphisms and clinical outcome in colorectal cancer patients receiving passive or active antibody treatment. PMID: 21042730 Ref: Disappearing adrenal masses. PMID: 21046476 Ref: Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies. PMID: 21115931 Ref: Chemoradiation-induced changes in serum CEA and plasma TIMP-1 in patients with locally advanced rectal cancer. PMID: 21115936 Ref: [Prognostic analysis of 77 cases of rectal cancer with synchronous liver metastases]. PMID: 21122418 Ref: Multiple myeloma presenting as CEA-producing rectal cancer. PMID: 21139949 Ref: Morphofunctional malignancy grading is a valuable prognostic factor for colorectal cancer. PMID: 21140080 Ref: Significance of Follow-up in Detection of Pulmonary Metastasis of Colorectal Cancer. PMID: 21152232 Ref: Multiplex RT-PCR-based detections of CEA, CK20 and EGFR in colorectal cancer patients. PMID: 21157973 Ref: Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report. PMID: 21161947 Ref: Intensive risk-adjusted follow-up with the CEA, TPA, CA19.9, and CA72.4 tumor marker panel and abdominal ultrasonography to diagnose operable colorectal cancer recurrences: effect on survival. PMID: 21173292 Ref: Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients. PMID: 21187495 Ref: [Non-invasive imaging tools in colorectal cancer]. PMID: 21197735 Ref: [Comparison of pathologic and clinical characteristics of young and old patients with advanced rectal cancer after neoadjuvant radiotherapy]. PMID: 21211254 Ref: [Efficacy of short-term high volume (6 g of 5-FU in a week) hepatic arterial infusion for synchronous diffuse liver metastases of sigmoid colon cancer with over 40 thousand ng/mL of CEA of ascites]. PMID: 21224565 Ref: [A case of lung metastases of colon cancer demonstrating complete response for more than five years after treatment with UFT]. PMID: 21224629 Ref: [A case of ovarian metastasis from colon cancer successfully treated with multidisciplinary therapy]. PMID: 21224633 Ref: [Roles of hepatectomy for colorectal liver metastases with necrotic foci caused by prior anti-cancer therapies]. PMID: 21224642 Ref: [Pseudo-Meigs' syndrome caused by ovarium metastasis from colorectal cancer]. PMID: 21224649 Ref: [Hepatic arterial infusion chemotherapy with oxaliplatin in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure]. PMID: 21224650 Ref: [A case of lateral lymph node metastasis of submucosal rectal cancer]. PMID: 21224661 Ref: [Successfully resected an isolated extraperitoneal metastasis of sigmoid colon cancer--a case report]. PMID: 21224666 Ref: Assessment of novel combinations of biomarkers for the detection of colorectal cancer. PMID: 21263188 Ref: [Follow-up after curative surgery for colorectal cancer: impact of positron emission tomography - computed tomography (PET/CT)]. PMID: 21263760 Ref: [Evaluation of neoadjuvant chemo-radiotherapy with locally advanced rectal cancer by comparing tumour volume before and after treatment]. PMID: 21351419 Ref: Clinical significance of genetic variations in the PI3K/PTEN/AKT/mTOR pathway in Korean patients with colorectal cancer. PMID: 21412012 Ref: [Surveillance of patients after colonoscopic polypectomy and curative resection of colorectal cancer]. PMID: 21568065 Ref: Do all locally advanced rectal cancers require radiation? A review of literature in the modern era. PMID: 22811804 Ref: Negative prognostic factors in colorectal carcinoma: An analysis of 448 patients. PMID: 23133256 Ref: The potential of carcinoembryonic antigen, p53, Ki-67 and glutathion Stransferase-pi as clinico-histopathological markers for colorectal cancer. PMID: 23554611 |
Ref: To be or not to be: significance of lymph nodes on pretreatment CT in predicting survival of rectal cancer patients. PMID: 19853396 Ref: Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer. PMID: 20373053 Ref: Cytokeratin 20 and vascular endothelial growth factor as molecular markers in Egyptian patients with colorectal cancer. PMID: 20395351 Ref: Serum sHLA-G levels: a useful indicator in distinguishing colorectal cancer from benign colorectal diseases. PMID: 20473865 Ref: S100B protein expressions as an independent predictor of early relapse in UICC stages II and III colon cancer patients after curative resection. PMID: 20628824 Ref: No association of the hypoxia-inducible factor-1alpha gene polymorphisms with survival in patients with colorectal cancer. PMID: 20635169 Ref: No association of the eNOS gene polymorphisms with survival in patients with colorectal cancer. PMID: 20706876 Ref: Hyperfibrinogenemia after preoperative chemoradiotherapy predicts poor response and poor prognosis in rectal cancer. PMID: 20809424 Ref: Loss of E-cadherin and MUC2 expressions correlated with poor survival in patients with stages II and III colorectal carcinoma. PMID: 20865330 Ref: The metabolic response using 18F-fluorodeoxyglucose-positron emission tomography/computed tomography and the change in the carcinoembryonic antigen level for predicting response to pre-operative chemoradiotherapy in patients with rectal cancer. PMID: 21040991 Ref: The intraportal injection model for liver metastasis: advantages of associated bioluminescence to assess tumor growth and influences on tumor uptake of radiolabeled anti-carcinoembryonic antigen antibody. PMID: 21116205 Ref: Risk factors for the development of metachronous liver metastasis in colorectal cancer patients after curative resection. PMID: 21153819 Ref: Identification of biomarkers to improve diagnostic sensitivity of sporadic colorectal cancer in patients with low preoperative serum carcinoembryonic antigen by clinical proteomic analysis. PMID: 21185818 Ref: Low preoperative serum albumin in colon cancer: a risk factor for poor outcome. PMID: 21190025 Ref: A Phase I safety study of plasmid DNA immunization targeting carcinoembryonic antigen in colorectal cancer patients. PMID: 21195077 Ref: Magnetic electrochemiluminescent Fe3O4/CdSe-CdS nanoparticle/polyelectrolyte nanocomposite for highly efficient immunosensing of a cancer biomarker. PMID: 21207584 Ref: A case of mucoid carcinoma of the sigmoid colon with features of a submucosal tumor. PMID: 21212599 Ref: Primary acantholytic squamous cell carcinoma of the cecum: a case report. PMID: 21223553 Ref: The role of carcinoembryonic antigen after neoadjuvant chemoradiotherapy in patients with rectal cancer. PMID: 21228676 Ref: Identification of SEC61beta and its autoantibody as biomarkers for colorectal cancer. PMID: 21255561 Ref: Isolated splenic metastasis from colorectal cancer. PMID: 21258837 Ref: Novel Carcinoembryonic-Antigen-(CEA)-Specific Pretargeting System to Assess Tumor Cell Viability after Irradiation of Colorectal Cancer Cells. PMID: 21271227 Ref: Clinical utility of serum tumor markers in the diagnosis of malignant intestinal occlusion. A prospective observational study. PMID: 21279957 Ref: Prognostic role of carcinoembryonic antigen is influenced by microsatellite instability genotype and stage in locally advanced colorectal cancers. PMID: 21301835 Ref: Determination of N(1),N(1)(2)-diacetylspermine in urine: a novel tumor marker. PMID: 21318886 Ref: Analysis of factors associated with prognosis after colorectal cancer resection in 174 Chinese elderly patients. PMID: 21327532 Ref: Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse. PMID: 21343933 Ref: Molecular profiling of colon tumors: the search for clinically relevant biomarkers of progression, prognosis, therapeutics, and predisposition. PMID: 21347779 Ref: Scan? Cure? Sure! PMID: 21349952 Ref: Clinical significance of circulating galectins as colorectal cancer markers. PMID: 21369702 Ref: Local calprotectin production in colorectal cancer and polyps--active neutrophil recruitment in carcinogenesis. PMID: 21380506 Ref: Prognostic value of tumor response to neoadjuvant therapy in rectal carcinoma. PMID: 21383559 Ref: C-stage in colon cancer: implications of carcinoembryonic antigen biomarker in staging, prognosis, and management. PMID: 21421861 Ref: Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. PMID: 21422427 Ref: Prognostic factors in colorectal cancer evolution. PMID: 21424077 Ref: A gene signature distinguishing CD133hi from CD133- colorectal cancer cells: essential role for EGR1 and downstream factors. PMID: 21436631 Ref: Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PMID: 21445232 Ref: Isolation of carcinoembryonic antigen N-terminal domains (N-A1) from soluble aggregates. PMID: 21458574 Ref: What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis : imaging for recurrent colorectal cancer. PMID: 21468765 Ref: Survivin isoforms and clinicopathological characteristics in colorectal adenocarcinomas using real-time qPCR. PMID: 21472129 Ref: Penile metastasis from adenocarcinoma of the prostate in a patient with colorectal carcinoma. PMID: 21489365 Ref: Multicentre study of liver metastases from colorectal cancer in pathological livers. PMID: 21492331 Ref: Clinical significance of pre- to post-chemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection. PMID: 21537868 Ref: Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer. PMID: 21538056 Ref: [Associated risk factors of peritoneal metastasis in colorectal cancer]. PMID: 21538265 Ref: MTSS1 overexpression correlates with poor prognosis in colorectal cancer. PMID: 21562916 Ref: Quantitative analysis of TEM-8 and CEA tumor markers indicating free tumor cells in the peripheral blood of colorectal cancer patients. PMID: 21573768 Ref: Factors that influence survival in unresectable metastatic or locally advanced colorectal cancer. PMID: 21573902 Ref: Right colon cancer presenting as hemorrhagic shock. PMID: 21607161 Ref: Type IV collagen as a tumour marker for colorectal liver metastases. PMID: 21620632 Ref: Carcinoembryonic antigen level can be overestimated in metabolic syndrome. PMID: 21655061 Ref: Radioimmunoscintigraphy of colorectal carcinomas with 99mTc-labelled antibodies. PMID: 21661394 Ref: Prognostic value of preoperative CEA and CA 19-9 levels in patients with colorectal cancer. PMID: 21661403 Ref: Comprehensive immunological analyses of colorectal cancer patients in the phase I/II study of quickly matured dendritic cell vaccine pulsed with carcinoembryonic antigen peptide. PMID: 21681375 Ref: Phase I clinical trial of the (131)I-labeled anticarcinoembryonic antigen CIGB-M3 multivalent antibody fragment. PMID: 21711100 Ref: Circulating tumour markers can define patients with normal colons, benign polyps, and cancers. PMID: 21712823 Ref: Correlation between TBARS levels and glycolytic enzymes: the importance to the initial evaluation of clinical outcome of colorectal cancer patients. PMID: 21715128 Ref: Role of carcinoembryonic antigen, magnetic resonance imaging, and positron emission tomography-computed tomography in the evaluation of patients with suspected local recurrence of colorectal cancer. PMID: 21724118 Ref: 18F-FDG PET-CT in evaluation of postoperative colorectal cancer patients with rising CEA level. PMID: 21760561 Ref: High expression of testes-specific protease 50 is associated with poor prognosis in colorectal carcinoma. PMID: 21765952 Ref: Colorectal carcinoma: nucleosomes, carcinoembryonic antigen and ca 19-9 as apoptotic markers; a comparative study. PMID: 21787404 Ref: Toward standardized high-throughput serum diagnostics: multiplex-protein array identifies IL-8 and VEGF as serum markers for colon cancer. PMID: 21807963 Ref: Circulating antibodies to carcinoembryonic antigen related to improved recurrence-free survival of patients with colorectal carcinoma. PMID: 21819716 Ref: Outcome of surgical resection for recurrent pulmonary metastasis from colorectal carcinoma. PMID: 21824604 Ref: Comparison of clinicopathological features and hRad21 expression between telomerase-dependent and telomerase-independent colorectal cancer. PMID: 21830390 Ref: Lactic acidosis and colon cancer: oncologic emergency? PMID: 21855042 Ref: Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclide. PMID: 21858527 Ref: Assessing compliance with national comprehensive cancer network guidelines for elderly patients with stage III colon cancer: the Fox Chase Cancer Center Partners' initiative. PMID: 21859563 Ref: [Surgical treatment and prognostic factors for obstructing left colorectal cancer]. PMID: 21866457 Ref: The efficacy of gemcitabine as salvage treatment in patients with refractory advanced colorectal cancer (CRC): a single institution experience. PMID: 21868546 Ref: MHC class II genotype- and MHC class I and II phenotype-related parameters in sporadic colorectal cancer. PMID: 21874254 Ref: Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer. PMID: 21875276 Ref: Carcinoembryonic antigen (CEA) and its receptor hnRNP M are mediators of metastasis and the inflammatory response in the liver. PMID: 21901530 Ref: Peripheral blood guanylyl cyclase c (GCC) expressions are associated with prognostic parameters and response to therapy in colorectal cancer patients. PMID: 21901559 Ref: Accuracy of monitoring serum carcinoembryonic antigen levels in postoperative stage III colorectal cancer patients is limited to only the first postoperative year. PMID: 21922357 Ref: Multianalyte immunoassay chip for detection of tumor markers by chemiluminescent and colorimetric methods. PMID: 21928078 Ref: Preoperative carcinoembryonic antigen elevation in colorectal cancer. PMID: 21937372 Ref: [Role of carcinoembryonic antigen and cyclooxygenase-2 in the study of molecule incisal edge for colorectal cancer]. PMID: 22030784 Ref: The clinical value of von Willebrand factor in colorectal carcinomas. PMID: 22046486 Ref: Usefulness of CEA concentration measurement and classic colonoscopy in follow-up after radical treatment of colorectal cancer. PMID: 22166547 Ref: [A case of transverse colon cancer without a recurrence lesion after five years from resection of hepatic metastasis]. PMID: 22202361 Ref: [A case of lung metastases after surgery for colon cancer demonstrating complete response for more than six years after treatment with UFT/LV]. PMID: 22202433 Ref: Analysis of the RUNX3 gene methylation in serum DNA from esophagus squamous cell carcinoma, gastric and colorectal adenocarcinoma patients. PMID: 22234069 Ref: Detection of serum anti-P53 antibodies from patients with colorectal cancer in China using a combination of P53- and phage-ELISA: correlation to clinical parameters. PMID: 22393964 Ref: Isolated splenic metastasis from colorectal carcinoma in a high risk patient: a case report. PMID: 22397278 Ref: Liver metastases in Egyptian patients with colorectal cancer: incidence and clinico-pathological predictors. PMID: 22435152 Ref: Pathologic response of primary rectal cancer to oxaliplatin-based chemotherapy. PMID: 22654573 Ref: Detection and Clinical Significance of DLC1 Gene Methylation in Serum DNA from Colorectal Cancer Patients. PMID: 23359753 Ref: Biomarkers in advanced colorectal cancer: challenges in translating clinical research into practice. PMID: 24212785 Ref: Predictive factors of the response of rectal cancer to neoadjuvant radiochemotherapy. PMID: 24212803 Ref: The Role of High Frequency Dynamic Threshold (HiDT) Serum Carcinoembryonic Antigen (CEA) Measurements in Colorectal Cancer Surveillance: A (Revisited) Hypothesis Paper. PMID: 24212811 |
Ref: Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer. PMID: 21618511 Ref: Regulation of carcinoembryonic antigen release from colorectal cancer cells. PMID: 21725636 Ref: Factors predicting oncologic outcomes in patients with fewer than 12 lymph nodes retrieved after curative resection for colon cancer. PMID: 21837680 Ref: Identification and assessment of new biomarkers for colorectal cancer with serum N-glycan profiling. PMID: 21853445 Ref: Increased serum level of Nup88 protein is associated with the development of colorectal cancer. PMID: 21863385 Ref: The effect of artificial neural network model combined with six tumor markers in auxiliary diagnosis of lung cancer. PMID: 21882004 Ref: Lymphovascular invasion is a significant prognosticator in rectal cancer patients who receive preoperative chemoradiotherapy followed by total mesorectal excision. PMID: 21935746 Ref: Down-regulation of HLA-A mRNA in peripheral blood mononuclear cell of colorectal cancer. PMID: 21947186 Ref: Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients. PMID: 22006279 Ref: Prognostic significance of perioperative change of CEA level in colorectal patients when pre-operative level is normal. PMID: 22024225 Ref: The relationship between heart rate variability and time-course of carcinoembryonic antigen in colorectal cancer. PMID: 22070982 Ref: The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer. PMID: 22071131 Ref: Phase I clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma. PMID: 22072399 Ref: Reevaluation of serum p53 antibody as a tumor marker in colorectal cancer patients. PMID: 22075664 Ref: DNA topoisomerase II alpha: a favorable prognostic factor in colorectal caner. PMID: 22076611 Ref: Prognostic models for outcome following liver resection for colorectal cancer metastases: A systematic review. PMID: 22079259 Ref: Influence of non-alcoholic fatty liver disease on the prognosis in patients with colorectal cancer. PMID: 22133576 Ref: Activated macrophages containing tumor marker in colon carcinoma: immunohistochemical proof of a concept. PMID: 22134871 Ref: No correlation between pretreatment serum CEA levels and tumor volume in locally advanced rectal cancer patients. PMID: 22137981 Ref: Intra-hepatic arterioportal shunt mimicking a metastatic liver tumor: report of a case. PMID: 22143359 Ref: Regulatory T-cell-mediated inhibition of antitumor immune responses is associated with clinical outcome in patients with liver metastasis from colorectal cancer. PMID: 22159472 Ref: Suppression of tumour-specific CD4(+) T cells by regulatory T cells is associated with progression of human colorectal cancer. PMID: 22207629 Ref: Panitumumab in patients with KRAS wild-type colorectal cancer after progression on cetuximab. PMID: 22210091 Ref: DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy. PMID: 22213216 Ref: Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation Therapy. PMID: 22216763 Ref: Prognostic value of plasmatic tumor M2 pyruvate kinase and carcinoembryonic antigen in the survival of colorectal cancer patients. PMID: 22231432 Ref: Management of obstructive colorectal cancer: evaluation of preoperative bowel decompression using ileus tube drainage. PMID: 22237900 Ref: Flt3 ligand enhances anti-tumor effects of antibody therapeutics. PMID: 22245429 Ref: Quantum-dot-based biosensor for simultaneous detection of biomarker and therapeutic drug: first steps toward an assay for quantitative pharmacology. PMID: 22245799 Ref: Free peritoneal tumor cells detection in gastric and colorectal cancer patients. PMID: 22258756 Ref: Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients. PMID: 22267181 Ref: Diffusion-weighted MRI in rectal cancer: apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness. PMID: 22271382 Ref: Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women. PMID: 22277732 Ref: Brain metastasis from colorectal cancer: prognostic factors and survival. PMID: 22287384 Ref: Enhancement of anti-murine colon cancer immunity by fusion of a SARS fragment to a low-immunogenic carcinoembryonic antigen. PMID: 22304896 Ref: Prognostic value of the lymph node ratio in stage III colorectal cancer. PMID: 22313594 Ref: Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983). PMID: 22314329 Ref: Combined modality therapy for rectal cancer: the relative value of posttreatment versus pretreatment CEA as a prognostic marker for disease recurrence. PMID: 22327251 Ref: Determination of circulating tumor cells for prediction of recurrent colorectal cancer progression. PMID: 22328299 Ref: [Huge unresectable multiple hepatic metastases of rectum cancer responding to combined therapy with FOLFIRI +bevacizumab - a case report]. PMID: 22333652 Ref: Recent advances in active specific cancer vaccine treatment for colorectal cancer. PMID: 22339221 Ref: Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer. PMID: 22351690 Ref: Prognostic role of methylated free circulating DNA in colorectal cancer. PMID: 22362391 Ref: The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels. PMID: 22367859 Ref: Phase II trial of concomitant neoadjuvant chemotherapy with oxaliplatin and capecitabine and intensity-modulated radiotherapy (IMRT) in rectal cancer. PMID: 22371167 Ref: Induction of IgM, IgA and IgE antibodies in colorectal cancer patients vaccinated with a recombinant CEA protein. PMID: 22382876 Ref: Evaluation of the use of decision-support software in carcino-embryonic antigen (CEA)-based follow-up of patients with colorectal cancer. PMID: 22390356 Ref: Simultaneous multianalyte immunoassay measurement of five serum tumor markers in the detection of colorectal cancer. PMID: 22399621 Ref: Multivariate Analysis of the Survival Rate for Treatment Modalities in Incurable Stage IV Colorectal Cancer. PMID: 22413080 Ref: Divergent roles of CD44 and carcinoembryonic antigen in colon cancer metastasis. PMID: 22415308 Ref: Factors influencing oncological outcomes in patients who develop pulmonary metastases after curative resection of colorectal cancer. PMID: 22426271 Ref: Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis. PMID: 22426691 Ref: Cost-effectiveness analysis of postoperative surveillance protocols following radical surgery for colorectal cancer. PMID: 22442906 Ref: Comparison of radiofrequency ablation and resection for hepatic metastasis from colorectal cancer. PMID: 22460570 Ref: An RNA aptamer that binds carcinoembryonic antigen inhibits hepatic metastasis of colon cancer cells in mice. PMID: 22465431 Ref: Postherapeutic follow-up of colorectal cancer patients treated with curative intent. PMID: 22480117 Ref: The predictive value of preoperative carcinoembryonic antigen level in the prognosis of colon cancer. PMID: 22481066 Ref: Improved activation toward primary colorectal cancer cells by antigen-specific targeting autologous cytokine-induced killer cells. PMID: 22481963 Ref: The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer. PMID: 22487741 Ref: C-reactive protein is associated with distant metastasis of T3 colorectal cancer. PMID: 22493378 Ref: Diagnostic significance of serum HMGB1 in colorectal carcinomas. PMID: 22496788 Ref: Unnecessary surgery can be avoided by judicious use of PET/CT scanning in colorectal cancer patients. PMID: 22552946 Ref: The quantitative analysis by stem-loop real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer. PMID: 22562822 Ref: Role of serum carcinoembryonic antigen in the detection of colorectal cancer before and after surgical resection. PMID: 22563201 Ref: Clinical characteristics and disease outcome of UICC stages I-III colorectal cancer patients at Siriraj Hospital. PMID: 22574549 Ref: Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen. PMID: 22576063 Ref: Utility of cell-free tumour DNA for post-surgical follow-up of colorectal cancer patients. PMID: 22593440 Ref: Infiltration of colorectal carcinoma by S100+ dendritic cells and CD57+ lymphocytes as independent prognostic factors after radical surgical treatment. PMID: 22593500 Ref: Relevance of histone marks H3K9me3 and H4K20me3 in cancer. PMID: 22593510 Ref: Preoperative thrombocytosis is associated with survival after surgery for colorectal cancer. PMID: 22623286 Ref: The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels. PMID: 22644560 Ref: Multidisciplinary management of colorectal cancer enhances access to multimodal therapy and compliance with National Comprehensive Cancer Network (NCCN) guidelines. PMID: 22645076 Ref: [Influence of tumor size on the prognosis in patients with colon cancer]. PMID: 22648846 Ref: Pulmonary recurrence predominates after combined modality therapy for rectal cancer: an original retrospective study. PMID: 22664562 Ref: Quality of care along the cancer continuum: does receiving adequate lymph node evaluation for colon cancer lead to comprehensive postsurgical care? PMID: 22683070 Ref: [A case of advanced colon cancer with peritoneal dissemination effectively treated with modified FOLFOX6 chemotherapy]. PMID: 22705700 Ref: Influence of surgical manipulation and surgical modality on the molecular detection of circulating tumor cells from colorectal cancer. PMID: 22708097 Ref: Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients. PMID: 22735902 Ref: Serum M2-pyruvate kinase: A promising non-invasive biomarker for colorectal cancer mass screening. PMID: 22737276 Ref: Prognostic factors affecting recurrence and survival in patients with locally advanced rectal cancer. PMID: 22740208 Ref: Carcinoembryonic antigen and carbohydrate antigen 19-9 are prognostic predictors of colorectal cancer with unresectable liver metastasis. PMID: 22740990 Ref: Possibility of sandwiched liver surgery with molecular targeting drugs, cetuximab and bevacizumab on colon cancer liver metastases: a case report. PMID: 22747970 Ref: [Postoperative morbidity and mortality factors after laparoscopic resection for colon cancer in octogenarians]. PMID: 22748477 Ref: Cancer chemotherapy reduces plasma total polyphenols and total antioxidants capacity in colorectal cancer patients. PMID: 22772457 Ref: The clinical usefulness of urinary N(1),N(12)-diacetylspermine (DiAcSpm) levels as a tumor marker in patients with colorectal cancer. PMID: 22783374 Ref: Evaluation of carcinoembryonic antigen (CEA), epidermal growth factor receptor (EGFR), epithelial cell adhesion molecule EpCAM (GA733-2), and carbohydrate antigen 19-9 (CA 19-9) levels in colorectal cancer patients and correlation with clinicopathological PMID: 22783573 Ref: [The chemotherapy with mFOLFOX6 for advanced colon cancer was effective for gastric cancer - a case report]. PMID: 22790053 Ref: [A case report of advanced mucinous adenocarcinoma of the transverse colon with peritoneal dissemination effectively treated by multidisciplinary approach with a focus on FOLFOX4 therapy combined with panitumumab]. PMID: 22790058 Ref: A novel serum metabolomics-based diagnostic approach for colorectal cancer. PMID: 22792336 Ref: High levels of serum VEGF and TIMP-1 are correlated with colon cancer liver metastasis and intrahepatic recurrence after liver resection. PMID: 22807974 Ref: Serum amino acid profiles and their alterations in colorectal cancer. PMID: 22833708 Ref: Serum carcinoembryonic antigen measurement, abdominal contrast-enhanced computed tomography, and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of colorectal cancer recurrence: a correlative study. PMID: 22842225 Ref: The Glasgow prognostic score is valuable for colorectal cancer with both synchronous and metachronous unresectable liver metastases. PMID: 22844378 Ref: Factors that influence survival in colorectal cancer with synchronous distant metastasis. PMID: 22901720 Ref: K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy. PMID: 22909976 Ref: Management of colorectal cancer patients after resection of liver metastases: can we offer a tailored treatment? PMID: 22911546 Ref: [Human carcinoembryonic antigen family proteins, structure and function]. PMID: 22922152 Ref: Identification of patients with high-risk for pulmonary metastases after curative resection of colorectal cancer. PMID: 22934451 Ref: A novel multiplex-protein array for serum diagnostics of colon cancer: a case-control study. PMID: 22954206 Ref: Evaluation of predictive markers for patients with advanced colorectal cancer. PMID: 22974092 Ref: Utility of 18-fluorodeoxyglucose positron emission/computed tomography in the management of recurrent colorectal cancer. PMID: 22989147 Ref: Significance of ELF3 mRNA expression for detection of lymph node metastases of colorectal cancer. PMID: 22993316 Ref: Expression of p53 and Ki-67 as prognostic factors for survival of men with colorectal cancer. PMID: 22993345 Ref: Clinical significance of serial serum carcinoembryonic antigen values for treating rectal cancer with preoperative chemoradiotherapy. PMID: 22993707 Ref: High serum levels of both carcinoembryonic antigen and carbohydrate antigen 19-9 in a patient with sigmoid colon cancer without metastasis. PMID: 23037201 Ref: Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers. PMID: 23049919 Ref: Anti-CEA loaded maghemite nanoparticles as a theragnostic device for colorectal cancer. PMID: 23055733 Ref: Dermokine expression in intraductal papillary-mucinous neoplasm and invasive pancreatic carcinoma. PMID: 23060565 Ref: Utility of low dose (18)F-FDG PET-CT in patients with suspected colorectal carcinoma recurrence in conventional diagnostic methods. PMID: 23067526 Ref: Serum peptidome patterns of colorectal cancer based on magnetic bead separation and MALDI-TOF mass spectrometry analysis. PMID: 23091368 Ref: [Analysis of factors associated with lateral lymph node metastasis in mid and low rectal cancer]. PMID: 23099907 Ref: In vitro autoradiography of carcinoembryonic antigen in tissue from patients with colorectal cancer using multifunctional antibody TF2 and (67/68Ga)-labeled haptens by pretargeting. PMID: 23133809 Ref: Depth of mesorectal extension has prognostic significance in patients with T3 rectal cancer. PMID: 23135579 Ref: A case of multiple primary malignancies and investigation of family history. PMID: 23162625 Ref: Suppression of reactive oxygen species develops lymph node metastasis in colorectal cancer. PMID: 23169181 Ref: The prognostic role of disseminated tumor cells detected in peripheral blood and bone marrow of colorectal cancer. PMID: 23178553 Ref: Concordance with ASCO guidelines for surveillance after colorectal cancer treatment: a population-based analysis. PMID: 23181004 Ref: Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer. PMID: 23209692 Ref: Evaluation of laparoscopic resection of colorectal carcinoma from the viewpoint of molecular biology. PMID: 23255996 Ref: [A patient with unresectable progressive advanced rectal cancer maintained in a state of remission by using combination therapy]. PMID: 23267933 Ref: [Clinical significance of serum anti-p53 antibody measurement for colorectal cancer]. PMID: 23268012 Ref: [The clinical significance of serum anti-p53 antibody as a monitoring marker in colorectal cancer]. PMID: 23268013 Ref: The application of current diagnostic protocols of patients with colon cancer in preparation for therapy. PMID: 23378690 Ref: Prognostic factors of local recurrence and survival after curative rectal cancer surgery: a single institution experience. PMID: 23390833 Ref: Nutritional status and systemic inflammatory activity of colorectal patients on symbiotic supplementation. PMID: 23411802 Ref: Neoadjuvant oral vs. infusional chemoradiotherapy on locally advanced rectal cancer: Prognostic factors. PMID: 24416533 Ref: Hepatic resection margin predicts survival in colorectal cancer with hepatic metastasis. PMID: 26388907 Ref: Differing Serum Cea in Primary and Recurrent Rectal Cancer - A Reflection of Histology? PMID: 29147281 |
Ref: T cell responses against microsatellite instability-induced frameshift peptides and influence of regulatory T cells in colorectal cancer. PMID: 22729559 Ref: Co-existence of cyclin D1 and vascular endothelial growth factor protein expression is a poor prognostic factor for UICC stage I-III colorectal cancer patients after curative resection. PMID: 22926658 Ref: DC vaccine therapy combined concurrently with oral capecitabine in metastatic colorectal cancer patients. PMID: 22945335 Ref: Predictive value of vascular endothelial growth factor overexpression in early relapse of colorectal cancer patients after curative resection. PMID: 22961433 Ref: Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer. PMID: 22975639 Ref: Prognostic factors after pulmonary metastasectomy for colorectal cancer and rationale for determining surgical indications: a retrospective analysis. PMID: 23001087 Ref: Transient therapy-related surge in serum tumor biomarkers: characterizing behavior and postulating its biologic role. PMID: 23040007 Ref: Elevated preoperative carcinoembryonic antigen (CEA) and Ki67 is predictor of decreased survival in IIA stage colon cancer. PMID: 23052808 Ref: Prognostic factors in patients undergoing complete resection of pulmonary metastases of colorectal cancer: a multi-institutional cumulative follow-up study. PMID: 23085967 Ref: Laparoscopic surgery minimizes the surgical manipulation of isolated tumor cells leading to decreased metastasis compared to open surgery for colorectal cancer. PMID: 23104554 Ref: KiSS-1 methylation and protein expression patterns contribute to diagnostic and prognostic assessments in tissue specimens for colorectal cancer. PMID: 23132294 Ref: Detection of circulating tumor cells in peripheral blood of colorectal cancer patients without distant organ metastases. PMID: 23150200 Ref: Impact of a dedicated cancer center surveillance program on guideline adherence for patients with stage II and III colorectal cancer. PMID: 23153862 Ref: Surveillance after resection for colorectal cancer. PMID: 23184361 Ref: The influence of metastatic site on the expression of CEA and cellular localization of beta-catenin in colorectal cancer. PMID: 23216017 Ref: Response to neoadjuvant therapy in patients with early age-of-onset rectal cancer. PMID: 23222281 Ref: Clinical features and prognostic factors of bone metastases from colorectal cancer. PMID: 23224335 Ref: An optimal mRNA marker for OSNA (One-step nucleic acid amplification) based lymph node metastasis detection in colorectal cancer patients. PMID: 23293371 Ref: Aneuploidy and elevated CEA indicate an increased risk for metachronous metastasis in colorectal cancer. PMID: 23296402 Ref: Evaluation of alpha 1-antitrypsin and the levels of mRNA expression of matrix metalloproteinase 7, urokinase type plasminogen activator receptor and COX-2 for the diagnosis of colorectal cancer. PMID: 23300952 Ref: Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer. PMID: 23307251 Ref: Clinical significance of CA19-9 in the follow-up of colorectal cancer patients with elevated preoperative serum CA19-9. PMID: 23321120 Ref: Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting. PMID: 23322207 Ref: Clinical value of immunoscintigraphy in the rectal carcinomas: immunoscintigraphy of rectal carcinomas. PMID: 23340231 Ref: Cytotoxicity of lymphocytes activated by superantigen toxic-shock-syndrome toxin-1 against colorectal cancer LoVo cells. PMID: 23340976 Ref: Preoperative carcinoembryonic antibody is predictive of distant metastasis in pathologically T1 colorectal cancer after radical surgery. PMID: 23372362 Ref: Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: a systematic review and meta-analysis. PMID: 23407908 Ref: Serum tumor markers and PET/CT imaging for tumor recurrence detection. PMID: 23420146 Ref: Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery. PMID: 23452434 Ref: Pelvic peritonectomy without intraperitoneal chemotherapy for localized peritoneal carcinomatosis. PMID: 23482769 Ref: Expression of survivin and its four splice variants in colorectal cancer and its clinical significances. PMID: 23494669 Ref: Artificial neural networks--a method for prediction of survival following liver resection for colorectal cancer metastases. PMID: 23514791 Ref: [Tumor markers in colorectal cancer]. PMID: 23522321 Ref: Predictive value of apparent diffusion coefficient in evaluation of colorectal carcinoma hepatic metastases' response to radiofrequency ablation. PMID: 23526807 Ref: Systematic review and quality assessment of cost-effectiveness analysis of pharmaceutical therapies for advanced colorectal cancer. PMID: 23548649 Ref: Reappraisal of pretreatment carcinoembryonic antigen in patients with rectal cancer receiving preoperative chemoradiotherapy. PMID: 23549007 Ref: [Prognostic factors affecting the surgical treatment of metastatic lung tumor from colorectal cancer]. PMID: 23575178 Ref: Downregulation of ATP-binding cassette subfamily C member 4 increases sensitivity to neoadjuvant radiotherapy for locally advanced rectal carcinoma. PMID: 23575399 Ref: The clinical significance of preoperative serum levels of carbohydrate antigen 19-9 in colorectal cancer. PMID: 23577318 Ref: Preoperative plasma hyperfibrinogenemia is predictive of poor prognosis in patients with nonmetastatic colon cancer. PMID: 23612884 Ref: Serum carbohydrate antigen 19-9 as an indicator of liver metastasis in colorectal carcinoma cases. PMID: 23621260 Ref: Gamma-glutamyl transpeptidase level is a novel adverse prognostic indicator in human metastatic colorectal cancer. PMID: 23621885 Ref: Large variation between hospitals in follow-up for colorectal cancer in southern Netherlands. PMID: 23624873 Ref: Are high initial CEA and CA 19-9 levels associated with the presence of K-ras mutation in patients with metastatic colorectal cancer? PMID: 23625655 Ref: Normalization of serum p53 antibody levels in patients after curative resection for colorectal cancer. PMID: 23645779 Ref: Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer. PMID: 23645782 Ref: Clinical prediction of pathological complete response after preoperative chemoradiotherapy for rectal cancer. PMID: 23652742 Ref: A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer. PMID: 23657083 Ref: Microfluidic bead-based multienzyme-nanoparticle amplification for detection of circulating tumor cells in the blood using quantum dots labels. PMID: 23663673 Ref: Receipt of recommended surveillance among colorectal cancer survivors: a systematic review. PMID: 23677524 Ref: Preoperative carcinoembryonic antigen as an outcome predictor in colon cancer. PMID: 23681672 Ref: Incidence of primary colorectal cancer from colonoscopy examinations in patients presenting with liver mass. PMID: 23682528 Ref: [Analysis of risk factors for pulmonary metastasis after curative resection of colorectal cancer]. PMID: 23696405 Ref: Clinical validity of tissue carcinoembryonic antigen expression as ancillary to serum carcinoembryonic antigen concentration in patients curatively resected for colorectal cancer. PMID: 23711333 Ref: Circulating methylated septin 9 nucleic Acid in the plasma of patients with gastrointestinal cancer in the stomach and colon. PMID: 23730408 Ref: CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer. PMID: 23739192 Ref: Elevation of preoperative s-CEA concentration in stage IIA colorectal cancer can also be a high risk factor for stage II patients. PMID: 23760586 Ref: Factors predicting long-term survival in colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen. PMID: 23765330 Ref: Serum sAPRIL: a potential tumor-associated biomarker to colorectal cancer. PMID: 23792260 Ref: [Comparison of local immune microenvironment between liver-metastasis colorectal cancer and non-liver-metastasis colorectal cancer]. PMID: 23801208 Ref: The correlation between the levels of tissue inhibitor of metalloproteinases 1 in plasma and tumour response and survival after preoperative radiochemotherapy in patients with rectal cancer. PMID: 23801910 Ref: Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer. PMID: 23818348 Ref: D-dimer is a marker of response to chemotherapy in patients with metastatic colorectal cancer. PMID: 23818351 Ref: Drug-resistant colon cancer cells produce high carcinoembryonic antigen and might not be cancer-initiating cells. PMID: 23818760 Ref: Apparent diffusion coefficient as a non-invasive predictor of treatment response and recurrence in locally advanced rectal cancer. PMID: 23830776 Ref: F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer. PMID: 23846517 Ref: Individualized Cutoff Value of the Preoperative Carcinoembryonic Antigen Level is Necessary for Optimal Use as a Prognostic Marker. PMID: 23862128 Ref: Prognostic significance of the decreased rate of perioperative serum carcinoembryonic antigen level in the patients with colon cancer after a curative resection. PMID: 23862129 Ref: [Successful treatment of a patient using mFOLFOX6 after laparoscopic surgery for rectal cancer with peritoneal dissemination]. PMID: 23863744 Ref: [Analysis of prognostic factors after radical resection in 628 patients with stage II or III colon cancer]. PMID: 23880003 Ref: Expression and significance of TSGF, CEA and AFP in patients before and after radical surgery for colon cancer. PMID: 23886200 Ref: Role of carcinoembryonic antigen as a marker for colorectal liver metastases. PMID: 23888604 Ref: Physician follow-up and observation of guidelines in the post treatment surveillance of colorectal cancer. PMID: 23889952 Ref: Identification of kininogen-1 as a serum biomarker for the early detection of advanced colorectal adenoma and colorectal cancer. PMID: 23894665 Ref: Circulating midkine in malignant and non-malignant colorectal diseases. PMID: 23899719 Ref: Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system. PMID: 23926437 Ref: Predictive value of serum CEA, CA19-9 and CA125 in diagnosis of colorectal liver metastasis in Chinese population. PMID: 23933921 Ref: Clinical implication of additional selective lateral lymph node excision in patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy. PMID: 23943283 Ref: 18F-FDG PET/CT superior to serum CEA in detection of colorectal cancer and its recurrence. PMID: 23993799 Ref: Predictive value of ERCC1, ERCC2, and XRCC1 overexpression for stage III colorectal cancer patients receiving FOLFOX-4 adjuvant chemotherapy. PMID: 23996617 Ref: Diagnostic Accuracy of Elevated Serum Carcinoembryonic Antigen for Recurrence in Postoperative Stage II Colorectal Cancer Patients: Comparison With Stage III. PMID: 24032116 Ref: The management of the advanced colorectal cancer: management of the pulmonary metastases. PMID: 24102011 Ref: The advantage of circulating tumor cells over serum carcinoembryonic antigen for predicting treatment responses in rectal cancer. PMID: 24106900 Ref: Detection of serological biomarkers by proximity extension assay for detection of colorectal neoplasias in symptomatic individuals. PMID: 24107468 Ref: Simultaneous detection of four biomarkers with one sensing surface based on redox probe tagging strategy. PMID: 24120163 Ref: Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy. PMID: 24149180 Ref: Circulating tumor cells are associated with diffuse spread in stage IV colorectal cancer patients. PMID: 24153154 Ref: Prognostic significance of serum carcinoembryonic antigen normalization on survival in rectal cancer treated with preoperative chemoradiation. PMID: 24155677 Ref: Multiplexed VeraCode bead-based serological immunoassay for colorectal cancer. PMID: 24161315 Ref: Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer. PMID: 24215576 Ref: Prognostic factors for disease-free survival after preoperative chemotherapy followed by curative resection in patients with colorectal cancer harboring hepatic metastasis: a single-institute, retrospective analysis in Asia. PMID: 24217184 Ref: C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery. PMID: 24222151 Ref: [A case wherein bevacizumab/XELOX combination therapy was remarkably effective for the treatment of extensive dissemination in advanced colon cancer, and the primary lesion could be resected]. PMID: 24231712 Ref: Comparative serum proteomic analysis of serum diagnosis proteins of colorectal cancer based on magnetic bead separation and maldi-tof mass spectrometry. PMID: 24289627 Ref: [A case of local recurrence of rectal carcinoma 10 years after initial surgery]. PMID: 24335376 Ref: Comparative study of CEA and CA19-9 in esophageal, gastric and colon cancers individually and in combination (ROC curve analysis). PMID: 24379990 Ref: [Analysis of the eligibility of elderly colorectal cancer patients for adjuvant chemotherapy combined with polysaccharide K]. PMID: 24393859 Ref: Immunohistochemistry: A diagnostic aid in differentiating primary epithelial ovarian tumors and tumors metastatic to the ovary. PMID: 24455652 Ref: Carcinoembryonic antigen levels in the peripheral and mesenteric venous blood of patients with rectal carcinoma. PMID: 24474227 Ref: Investigation of free cancer cells in peripheral blood using CEA mRNA expression in perioperative colorectal cancer patients. PMID: 24649226 Ref: Association between carcinoembryonic antigen, carbohydrate antigen 19-9 and body mass index in colorectal cancer patients. PMID: 24649265 Ref: Carcinoembryonic antigen elevation in post-hepatectomy patients with colorectal cancer liver metastasis indicates recurrence with high accuracy. PMID: 24719930 Ref: Clinical Usefulness of Serum CYFRA 21-1 in Patients with Colorectal Cancer. PMID: 24900105 Ref: Synthesis and biological investigations of a ZnPc-antiCEA bioconjugate for imaging of colorectal cancer. PMID: 25328375 Ref: [A comparative analysis of colorectal carcinoma cell lines that differ in metastatic potential]. PMID: 25509104 Ref: Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma. PMID: 25568506 Ref: [Immunoassay of nine serological tumor markers on hydrogel-based microchip]. PMID: 25696931 |
Ref: [Recurrent colorectal liver metastases: who benefits from a second hepatic resection?]. PMID: 23846538 Ref: Prognostic value of pretreatment level of carcinoembryonic antigen on tumour downstaging and early occurring metastasis in locally advanced rectal cancer following neoadjuvant radiotherapy (30 Gy in 10 fractions). PMID: 23848511 Ref: Combined preoperative CEA and CD44v6 improves prognostic value in patients with stage I and stage II colorectal cancer. PMID: 23860725 Ref: Usefulness of serum p53 antibody measurement in colorectal cancer: an examination of 1384 primary colorectal cancer patients. PMID: 23975589 Ref: Assessment of aggressiveness of rectal cancer using 3-T MRI: correlation between the apparent diffusion coefficient as a potential imaging biomarker and histologic prognostic factors. PMID: 24005562 Ref: Total number of lymph nodes harvested is associated with better survival in stages II and III colorectal cancer. PMID: 24048680 Ref: Prognostic factors for peritoneal carcinomatosis originating from colorectal cancer: an analysis of 921 patients from a multi-institutional database. PMID: 24077999 Ref: Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. PMID: 24122750 Ref: Autologous dendritic cell based adoptive immunotherapy of patients with colorectal cancer-A phase I-II study. PMID: 24163303 Ref: The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma. PMID: 24242212 Ref: Panitumumab monotherapy as a second-line treatment in metastasised colorectal cancer: a single centre experience. PMID: 24246276 Ref: Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model. PMID: 24249594 Ref: Follow-up after curative resection of colorectal cancer. PMID: 24271157 Ref: Carcinoembryonic antigen expression level as a predictive factor for response to 5-fluorouracil in colorectal cancer. PMID: 24293105 Ref: Influence of family history on survival in patients with colon and rectal cancer. PMID: 24304621 Ref: Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors. PMID: 24332554 Ref: A scoring system to predict inferior mesenteric artery lymph node metastasis and prognostic value of its involvement in rectal cancer. PMID: 24337892 Ref: Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapy. PMID: 24370352 Ref: Increased miR-449a expression in colorectal carcinoma tissues is inversely correlated with serum carcinoembryonic antigen. PMID: 24396489 Ref: Current approaches and challenges for monitoring treatment response in colon and rectal cancer. PMID: 24396496 Ref: Clinical tumour size and nodal status predict pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer. PMID: 24420737 Ref: [A case of advanced sigmoid colon cancer with metastases in the liver and the paraaortic lymph nodes successfully treated with 5-FU/l-LV and FOLFOX4 followed by S-1 leading to long-term complete response]. PMID: 24423964 Ref: Rising CEA levels in a patient with colon carcinoma: metachronous medullary thyroid cancer. PMID: 24425322 Ref: Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. PMID: 24430319 Ref: Role of paxillin in colorectal carcinoma and its relationship to clinicopathological features. PMID: 24451945 Ref: Successful fluorescence-guided surgery on human colon cancer patient-derived orthotopic xenograft mouse models using a fluorophore-conjugated anti-CEA antibody and a portable imaging system. PMID: 24494971 Ref: Impact of the post/preoperative serum CEA ratio on the survival of patients with rectal cancer. PMID: 24504847 Ref: Expression of matrix metalloproteinases 2, 7 and 9 in patients with colorectal cancer. PMID: 24516991 Ref: Assessment of the value of carcinoembryonic antigen reduction ratio as a prognosis factor in rectal cancer. PMID: 24524862 Ref: Clinical significance of serum ADP-ribosylation and NAD glycohydrolase activity in patients with colorectal cancer. PMID: 24535779 Ref: [Diagnosis of colorectal cancer by measurement of tumor markers]. PMID: 24597351 Ref: A Case of Long-term Survival after Curative Resection for Synchronous Solitary Adrenal Metastasis from Rectal Cancer. PMID: 24639864 Ref: Prediction of response to preoperative chemoradiotherapy in patients with locally advanced rectal cancer. PMID: 24647108 Ref: The role of RCAS1 as a biomarker in diagnosing CRC and monitoring tumor recurrence and metastasis. PMID: 24652591 Ref: Translating clinical research of Molecular Biology into a personalized, multidisciplinary approach of colorectal cancer patients. PMID: 24653752 Ref: Does CEA and CA 19-9 combined increase the likelihood of 18F-FDG in detecting recurrence in colorectal patients with negative CeCT? PMID: 24681767 Ref: Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells. PMID: 24686242 Ref: Clinical significance of combined testing of YKL-40 with CEA in Chinese colorectal cancer patients. PMID: 24697115 Ref: Circulating exosomal microRNAs as biomarkers of colon cancer. PMID: 24705249 Ref: Identification of a circulating microRNA signature for colorectal cancer detection. PMID: 24709885 Ref: Prognostic and predictive value of cathepsin X in serum from colorectal cancer patients. PMID: 24725597 Ref: Selenium-binding protein 1 is associated with the degree of colorectal cancer differentiation and is regulated by histone modification. PMID: 24737289 Ref: Prognostic factors for metastatic colorectal cancer after first-line chemotherapy with FOLFOX-4 or FOLFIRI regimen. PMID: 24755745 Ref: The availability of computed tomography for pulmonary staging in colorectal cancer. PMID: 24783181 Ref: Evaluating the significance of expression of CEA mRNA and levels of CEA and its related proteins in colorectal cancer patients. PMID: 24783267 Ref: Rapidly derived colorectal cancer cultures recapitulate parental cancer characteristics and enable personalized therapeutic assays. PMID: 24797403 Ref: Cell-free DNA blood levels in colorectal cancer patients do not correlate with mismatch repair-proficiency. PMID: 24815837 Ref: Peripheral Foxp3+ regulatory T cells and natural killer group 2, member D expression levels in natural killer cells of patients with colorectal cancer. PMID: 24819058 Ref: The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer. PMID: 24823671 Ref: Sensitivity of Symptomatology Versus Diagnostic Procedures and Concentration of CEA and CA19-9 in the Early Detection of Colorectal Cancer. PMID: 24825931 Ref: Role of beta1-Integrin in Colorectal Cancer: Case-Control Study. PMID: 24851215 Ref: The diagnostics of colorectal cancer. PMID: 24876814 Ref: Up-regulation of CNDP2 facilitates the proliferation of colon cancer. PMID: 24885395 Ref: Correlation between expression of miR-155 in colon cancer and serum carcinoembryonic antigen level and its contribution to recurrence and metastasis forecast. PMID: 24888652 Ref: The correlation between serum VEGF levels and known prognostic risk factors in colorectal carcinoma. PMID: 24901122 Ref: Evaluation of peritoneal CEA levels following colorectal cancer surgery. PMID: 24910092 Ref: Value of (1)(8)F-FDG PET-CT in surveillance of postoperative colorectal cancer patients with various carcinoembryonic antigen concentrations. PMID: 24914384 Ref: Short- and mid-term outcomes after early surgical training in laparoscopic colorectal cancer surgery: trainees' performance has no negative impact. PMID: 24919163 Ref: False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. PMID: 24925201 Ref: Postoperative serum methylation levels of TAC1 and SEPT9 are independent predictors of recurrence and survival of patients with colorectal cancer. PMID: 24925595 Ref: [Control of recurrence with CEA and CT after colon cancer operation]. PMID: 24934047 Ref: Differences in carcinoembryonic antigen levels between colon and rectal cancer. PMID: 24940506 Ref: Multiphoton imaging of tumor biomarkers with conjugates of single-domain antibodies and quantum dots. PMID: 24941465 Ref: CEA monitoring in colorectal cancer is not a waste of time. PMID: 24944045 Ref: [Diagnostic capability of carcinoembryonic antigen elevation]. PMID: 24948443 Ref: [Predictive factors associated with pathologic complete response after neoadjuvant chemoradiotherapy in rectal cancer]. PMID: 24953361 Ref: [Sensitivity study on preoperative individual concomitant radiochemotherapy for rectal cancer]. PMID: 24953363 Ref: [Clinical significance of the detection of serum neutrophil gelatinase-associated lipocalin in human colorectal cancer]. PMID: 24953369 Ref: The role of preoperative serum levels for Dickkopf-related protein 1 as a potential marker of tumor invasion in patients with stage II and III colon cancer. PMID: 24992617 Ref: If you have an active vagus nerve, cancer stage may no longer be important. PMID: 25001652 Ref: A circumferential resection margin of 1 mm is a negative prognostic factor in rectal cancer patients with and without neoadjuvant chemoradiotherapy. PMID: 25003288 Ref: Colorectal carcinoma in first decade of life: our experience. PMID: 25005910 Ref: Evaluation of prognostic significance of circulating tumor cells detection in rectal cancer patients treated with preoperative radiotherapy: prospectively collected material data. PMID: 25006584 Ref: Detection of circulating tumor cells in patients with locally advanced rectal cancer undergoing neoadjuvant therapy followed by curative surgery. PMID: 25008360 Ref: Prognostic significance of preoperative fibrinogen in patients with colon cancer. PMID: 25024612 Ref: Evaluation of preoperative serum markers for individual patient prognosis in stage I-III rectal cancer. PMID: 25027407 Ref: In the era of total mesorectal excision: adjuvant radiotherapy may be unnecessary for pT3N0 rectal cancer. PMID: 25052511 Ref: A predictive model for evaluating responsiveness to pemetrexed treatment in patients with advanced colorectal cancer. PMID: 25081726 Ref: Diagnostic and prognostic significance of different mucin expression, preoperative CEA, and CA-125 in colorectal carcinoma: A clinicopathological study. PMID: 25097424 Ref: Recurrence patterns after resection of liver metastases from colorectal cancer. PMID: 25103010 Ref: Colonoscopy as a method of choice in the diagnosis of colorectal cancer. PMID: 25132707 Ref: Prognostic value of preoperative D-dimer and carcinoembryonic antigen levels in patients undergoing intended curative resection for colorectal cancer: a prospective cohort study. PMID: 25147006 Ref: Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer. PMID: 25157833 Ref: Reversed polarity of the glandular epithelial cells in micropapillary carcinoma of the large intestine and the EMA/MUC1 immunostain. PMID: 25158820 Ref: Beclin 1 expression is closely linked to colorectal carcinogenesis and distant metastasis of colorectal carcinoma. PMID: 25196438 Ref: Low expression of RSK4 predicts poor prognosis in patients with colorectal cancer. PMID: 25197367 Ref: A monoclonal antibody against neem leaf glycoprotein recognizes carcinoembryonic antigen (CEA) and restricts CEA expressing tumor growth. PMID: 25198527 Ref: Clinical significance of carcinoembryonic antigen expression of acellular mucin pools after preoperative chemoradiotherapy of rectal carcinoma. PMID: 25203146 Ref: Combination of antibody targeting and PTD-mediated intracellular toxin delivery for colorectal cancer therapy. PMID: 25204286 Ref: Cognitive function and fatigue after diagnosis of colorectal cancer. PMID: 25214544 Ref: Discovery of melanotransferrin as a serological marker of colorectal cancer by secretome analysis and quantitative proteomics. PMID: 25216327 Ref: Prediction of survival in patients with unresectable colorectal liver metastases. PMID: 25222579 Ref: Radioimmunoimaging of liver metastases with PET using a 64Cu-labeled CEA antibody in transgenic mice. PMID: 25226518 Ref: Circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimens. PMID: 25256831 Ref: Apparent Diffusion Coefficient (ADC) value: a potential imaging biomarker that reflects the biological features of rectal cancer. PMID: 25303288 Ref: Association between carcinoembryonic antigen levels and the applied value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative recurrent and metastatic colorectal cancer. PMID: 25364443 Ref: [(1)(8)F-FDG PET/CT. Its correlation with carcinoembryonic antigen in patients with colorectal carcinoma]. PMID: 25375281 Ref: Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancer. PMID: 25406793 Ref: Analysis of stage and clinical/prognostic factors for colon and rectal cancer from SEER registries: AJCC and collaborative stage data collection system. PMID: 25412391 Ref: Development of antibody functionalized magnetic nanoparticles for the immunoassay of carcinoembryonic antigen: a feasibility study for clinical use. PMID: 25424410 Ref: Treatment and multivariate analysis of colorectal cancer with liver metastasis. PMID: 25436344 Ref: CA 19-9 as a marker in addition to CEA to monitor colorectal cancer. PMID: 25442815 Ref: CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomas. PMID: 25484061 Ref: [Plasma DNA measurement as a biomarker of cancer]. PMID: 25518072 Ref: Genomic profiling of patient-derived colon cancer xenograft models. PMID: 25526474 Ref: Predictors of recurrence after a first hepatectomy for colorectal cancer liver metastases: a retrospective analysis. PMID: 25528650 Ref: [Detection of transforming growth factor-beta1 in colorectal cancer and its clinical significance]. PMID: 25537904 Ref: Zinc-alpha-2-glycoprotein: a candidate biomarker for colon cancer diagnosis in Chinese population. PMID: 25561225 Ref: Transanal endoscopic microsurgery for early rectal cancer: single center experience. PMID: 25561999 Ref: The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer. PMID: 25693941 Ref: Predictive value of tissue inhibitor of metalloproteinases-1 and carcinoembryonic antigen plasma levels in response to chemotherapy in patients with metastatic colorectal cancer. PMID: 25709652 Ref: [Resection of a left obturator lymph node recurrence five years five months after surgery for rectal cancer]. PMID: 25731272 Ref: [A case report of the use of laparoscopic surgery to remove an adrenal tumor following resection of sigmoid colon cancer]. PMID: 25731277 Ref: [A case of carcinoma arising in a diverticulum of the transverse colon]. PMID: 25731294 Ref: [Irradiation with carbon ions for locally recurrent rectal cancer]. PMID: 25731305 Ref: [A case of rectal cancer treated with aggressive surgery for liver and anal metastases]. PMID: 25731333 Ref: [A case of metastatic colon carcinoma following curative resection for advanced gastric cancer associated with metastases to the liver and gallbladder]. PMID: 25731544 Ref: Importance of the Postoperative Carcinoembryonic Antigen Level during Follow-Up after Curative Resection in Patients with Liver Metastatic Colorectal Carcinoma. PMID: 26158154 Ref: Study on the Therapeutic Benefit on Lactoferrin in Patients with Colorectal Cancer Receiving Chemotherapy. PMID: 27350986 |
Ref: Association of serum levels of CEA, CA199, CA125, CYFRA21-1 and CA72-4 and disease characteristics in colorectal cancer. PMID: 24875250 Ref: The frequency of Th17 and Th22 cells in patients with colorectal cancer at pre-operation and post-operation. PMID: 25026244 Ref: Clinical significance of thrombocytosis before preoperative chemoradiotherapy in rectal cancer: predicting pathologic tumor response and oncologic outcome. PMID: 25145505 Ref: SALL4 as a new biomarker for early colorectal cancers. PMID: 25156818 Ref: Value of CT, FDG PET-CT and serum tumor markers in staging recurrent colorectal cancer. PMID: 25213271 Ref: The comparison of miR-155 with computed tomography and computed tomography plus serum amyloid A protein in staging rectal cancer. PMID: 25261908 Ref: Incidental focal uptake in colorectal location on oncologic (1)(8)FDG PET and PET/CT studies: histopathological findings and clinical significances. PMID: 25263718 Ref: Detection of carcinoembryonic antigen mRNA in peritoneal lavage by the transcription-reverse transcription concerted method indicates poor prognosis in patients with stage II and III colon cancer. PMID: 25311262 Ref: Clinicopathologic features and oncologic outcomes of colorectal cancer patients with extremely high carcinoembryonic antigen. PMID: 25367182 Ref: The prognostic role of baseline CEA and CA 19-9 values and their time-dependent variations in advanced colorectal cancer patients submitted to first-line therapy. PMID: 25374062 Ref: The role of fibrinogen as a predictor in preoperative chemoradiation for rectal cancer. PMID: 25384698 Ref: Alcohol, carcinoembryonic antigen processing and colorectal liver metastases. PMID: 25427914 Ref: A loss of antitumor therapeutic activity of CEA DNA vaccines is associated with the lack of tumor cells' antigen presentation to Ag-specific CTLs in a colon cancer model. PMID: 25449428 Ref: Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials. PMID: 25465185 Ref: Long-term outcomes after surgical resection of pulmonary metastases from colorectal cancer. PMID: 25499475 Ref: An elevated preoperative serum carbohydrate antigen 19-9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancer. PMID: 25512077 Ref: Sol-gel chemistry in biosensing devices of electrical transduction: application to CEA cancer biomarker. PMID: 25547969 Ref: Oncologic impact of pathologic response on clinical outcome after preoperative chemoradiotherapy in locally advanced rectal cancer. PMID: 25553320 Ref: Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform. PMID: 25575824 Ref: Positive postoperative CEA is a strong predictor of recurrence for patients after resection for colorectal liver metastases. PMID: 25582745 Ref: Concordance of Carcinoembryonic Antigen Ratio and Response Evaluation Criteria in Solid Tumors as Prognostic Surrogate Indicators of Metastatic Colorectal Cancer Patients Treated with Chemotherapy. PMID: 25586242 Ref: Serum YKL-40 in risk assessment for colorectal cancer: a prospective study of 4,496 subjects at risk of colorectal cancer. PMID: 25597749 Ref: TIMP-1 and CEA as biomarkers in third-line treatment with irinotecan and cetuximab for metastatic colorectal cancer. PMID: 25608838 Ref: Functional TP53 mutations have no impact on response to cytotoxic agents in metastatic colon cancer. PMID: 25609485 Ref: Serum 25-hydroxy vitamin D and survival in advanced colorectal cancer: a retrospective analysis. PMID: 25646565 Ref: Up-regulation of miR-592 correlates with tumor progression and poor prognosis in patients with colorectal cancer. PMID: 25661360 Ref: Intracellular Acidosis Promotes Mitochondrial Apoptosis Pathway: Role of EMMPRIN Down-regulation via Specific Single-chain Fv Intrabody. PMID: 25663946 Ref: Assessing the prognostic value of preoperative carcinoembryonic antigen-specific T-cell responses in colorectal cancer. PMID: 25669203 Ref: CEA-targeted nanoparticles allow specific in vivo fluorescent imaging of colorectal cancer models. PMID: 25694062 Ref: Nomogram including pretherapeutic parameters for prediction of survival after SIRT of hepatic metastases from colorectal cancer. PMID: 25721320 Ref: Expression of aquaporin-1, aquaporin-3, and aquaporin-5 correlates with nodal metastasis in colon cancer. PMID: 25721378 Ref: Human cervical cancer oncogene-1 over expression in colon cancer and its clinical significance. PMID: 25785079 Ref: Role of blood tumor markers in predicting metastasis and local recurrence after curative resection of colon cancer. PMID: 25785084 Ref: A case of recurrent Cronkhite-Canada syndrome containing colon cancer. PMID: 25785317 Ref: Circulating tumor cell levels are elevated in colorectal cancer patients with high tumor burden in the liver. PMID: 25785486 Ref: The anticancer effect of (1S,2S,3E,7E,11E)-3,7,11, 15-cembratetraen-17,2-olide(LS-1) through the activation of TGF-beta signaling in SNU-C5/5-FU, fluorouracil-resistant human colon cancer cells. PMID: 25786063 Ref: Surveillance after neoadjuvant therapy in advanced rectal cancer with complete clinical response can have comparable outcomes to total mesorectal excision. PMID: 25787162 Ref: D-dimer and international normalized ratio (INR) are correlated with tumor markers and disease stage in colorectal cancer patients. PMID: 25792472 Ref: Outcomes of Therasphere Radioembolization for Colorectal Metastases. PMID: 25795047 Ref: Tumor marker analyses in patients with brain metastases: patterns of practice and implications for survival prediction research. PMID: 25801247 Ref: Personalized treatment for patients with colorectal cancer: role of biomarkers. PMID: 25808438 Ref: Clinical follow-up does not improve survival after resection of stage I-III colorectal cancer: A cohort study. PMID: 25827817 Ref: Factors influencing response to neoadjuvant chemoradiation and outcomes in rectal cancer patients: tertiary Indian cancer hospital experience. PMID: 25830035 Ref: Factors affecting prognosis in metastatic colorectal cancer patients. PMID: 25854399 Ref: Normalization of CEA Levels Post-Neoadjuvant Therapy is a Strong Predictor of Pathologic Complete Response in Rectal Cancer. PMID: 25859755 Ref: betaig-h3 CORRELATES WITH RELATED FACTORS OF PERITONEAL METASTASIS OF GASTRIC CANCER. PMID: 25864756 Ref: Preoperative carcinoembryonic antigen and prognosis of colorectal cancer. An independent prognostic factor still reliable. PMID: 25875542 Ref: One-Stage Colectomy with Intraoperative Colonic Irrigation for Acute Left-Sided Malignant Colonic Obstruction. PMID: 25877736 Ref: Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial. PMID: 25884448 Ref: Circulating Oxidized Low-Density Lipoproteins and Antibodies against Oxidized Low-Density Lipoproteins as Potential Biomarkers of Colorectal Cancer. PMID: 25918520 Ref: Trends and predictors of resection of the primary tumor for patients with stage IV colorectal cancer. PMID: 25919984 Ref: Clinical Application of Serum Tumor Abnormal Protein (TAP) in Colorectal Cancer Patients. PMID: 25921156 Ref: Clinical complete response (cCR) after neoadjuvant chemoradiotherapy and conservative treatment in rectal cancer. Findings from the ACCORD 12/PRODIGE 2 randomized trial. PMID: 25921382 Ref: Serum GRObeta: a potential tumor-associated biomarker for colorectal cancer. PMID: 25932198 Ref: Preoperative serum markers for individual patient prognosis in stage I-III colon cancer. PMID: 25953265 Ref: Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer. PMID: 25956394 Ref: Serum Angiopoietin-like Protein 2 Improves Preoperative Detection of Lymph Node Metastasis in Colorectal Cancer. PMID: 25964566 Ref: A novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes' stages A-D colorectal cancers. PMID: 25987887 Ref: The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy. PMID: 25994571 Ref: Long-term Outcomes of Laparoscopic versus Open Surgery for Rectal Cancer: A Single-center Retrospective Analysis. PMID: 25998973 Ref: [Individualized therapy of synchronous ovarian and colon cancers with lymph]. PMID: 26027602 Ref: Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples. PMID: 26035703 Ref: Microinvasion of liver metastases from colorectal cancer: predictive factors and application for determining clinical target volume. PMID: 26040515 Ref: Growth inhibitory effect of adenovirus-mediated tissue-targeted expression of ribosomal protein L23 on human colorectal carcinoma cells. PMID: 26044651 Ref: Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer. PMID: 26045799 Ref: Correlation of CEA but not CA 19-9 as serum biomarkers of disease activity in a case of metastatic rectal adenocarcinoma. PMID: 26047368 Ref: Specific Colon Cancer Cell Cytotoxicity Induced by Bacteriophage E Gene Expression under Transcriptional Control of Carcinoembryonic Antigen Promoter. PMID: 26053394 Ref: A Low Lymphocyte-to-Monocyte Ratio Predicts Unfavorable Prognosis in Pathological T3N0 Rectal Cancer Patients Following Total Mesorectal Excision. PMID: 26078791 Ref: Trends in surveillance for resected colorectal cancer, 2001-2009. PMID: 26079928 Ref: Poor nutritional status before and during chemotherapy leads to worse prognosis in unresectable advanced or recurrent colorectal cancer. PMID: 26081995 Ref: Effect of Incorporation of Pretreatment Serum Carcinoembryonic Antigen Levels Into AJCC Staging for Colon Cancer on 5-Year Survival. PMID: 26083632 Ref: Stage-dependent changes of preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in colorectal cancer. PMID: 26104767 Ref: Comparison of non-schistosomal rectosigmoid cancer and schistosomal rectosigmoid cancer. PMID: 26109809 Ref: The Prognostic Role of Para-Aortic Lymph Nodes in Patients with Colorectal Cancer: Is It Regional or Distant Disease? PMID: 26115511 Ref: Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury. PMID: 26130065 Ref: Associations between tumor markers and the risk of colorectal polyp recurrence in Chinese people. PMID: 26131265 Ref: Diagnostic relevance of autoantibody detection against inhibitors of apoptosis proteins in colon cancer and colon adenoma. PMID: 26137273 Ref: Glycomic profiling of carcinoembryonic antigen isolated from human tumor tissue. PMID: 26157355 Ref: Practice Guideline for the Surveillance of Patients After Curative Treatment of Colon and Rectal Cancer. PMID: 26163950 Ref: Intensified follow-up in colorectal cancer patients using frequent Carcino-Embryonic Antigen (CEA) measurements and CEA-triggered imaging: Results of the randomized "CEAwatch" trial. PMID: 26184850 Ref: Inhibition of CEA release from epithelial cells by lipid A of Gram-negative bacteria. PMID: 26208386 Ref: KRAS Status as an Independent Prognostic Factor for Survival after Yttrium-90 Radioembolization Therapy for Unresectable Colorectal Cancer Liver Metastases. PMID: 26210240 Ref: Prognostic Effect of Pretreatment Serum Carcinoembryonic Antigen Level: A Useful Tool for Prediction of Distant Metastasis in Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision. PMID: 26252304 Ref: Diagnostic value of (18)F-FDG PET/CT as first choice in the detection of recurrent colorectal cancer due to rising CEA. PMID: 26263901 Ref: Clinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer. PMID: 26268466 Ref: Rectal cancer patients after neoadjuvant radiotherapy (30Gy/10f) with negative lymph node may not benefit from postoperative adjuvant chemotherapy: a retrospective study. PMID: 26278877 Ref: Serum anti-p53 antibody as a tumour marker for colorectal cancer screening. PMID: 26284124 Ref: [Colorectal cancer surgery with curative intent: what surveillance?]. PMID: 26298903 Ref: Carcinoembryonic antigen has prognostic value for tumor downstaging and recurrence in rectal cancer after preoperative chemoradiotherapy and curative surgery: A multi-institutional and case-matched control study of KROG 14-12. PMID: 26303015 Ref: MAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomas. PMID: 26342024 Ref: Influence of the DCC gene on proliferation and carcinoembryonic antigen expression in the human colorectal cancer cell line SW1116. PMID: 26345965 Ref: [Retrospective analysis of 856 cases with stage 0 to III rectal cancer underwent curative surgery combined modality therapy]. PMID: 26359071 Ref: Analysis of colorectal cancer glyco-secretome identifies laminin beta-1 (LAMB1) as a potential serological biomarker for colorectal cancer. PMID: 26359947 Ref: Overall Survival of Stage III Colon Cancer with Only One Lymph Node Metastasis Is Independently Predicted by Preoperative Carcinoembryonic Antigen Level and Lymph Node Sampling Status. PMID: 26381396 Ref: [Analysis of treatment and prognostic factors in colorectal cancer liver metastasis]. PMID: 26404693 Ref: [Expression and clinical significance of G protein-coupled receptor 31 in colorectal cancer tissue]. PMID: 26404694 Ref: Preoperative Lower Body Mass Index Correlates with Poorer Prognosis in Patients Undergoing Curative Laparoscopic Surgery for Colorectal Cancer. PMID: 26408737 Ref: [A CASE OF SOLITARY ADRENAL TUMOR METASTASIZED FROM RECTAL CANCER]. PMID: 26419076 Ref: Prognostic Factors after Liver Resection for Colorectal Liver Metastasis. PMID: 26421789 Ref: Predictors of Pathologic Complete Response After Neoadjuvant Treatment for Rectal Cancer: A Multicenter Study. PMID: 26433487 Ref: Prognostic Nutritional Index Predicts Severe Complications, Recurrence, and Poor Prognosis in Patients With Colorectal Cancer Undergoing Primary Tumor Resection. PMID: 26445177 Ref: The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation. PMID: 26451609 Ref: Surgical Specimens of Colorectal Cancer Fixed with PAXgene Tissue System Preserve High-Quality RNA. PMID: 26484572 Ref: [Analysis of risk factors associate with lymph node metastasis of T1 and T2 rectal cancer]. PMID: 26499148 Ref: Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy. PMID: 26501807 Ref: A Higher Frequency of CD14+ CD169+ Monocytes/Macrophages in Patients with Colorectal Cancer. PMID: 26509874 Ref: Reporting of the circumferential tumour margin involvement and preoperative levels of carcinoembryonic antigen as prognostic risk factors in colorectal cancer patients. PMID: 26526512 Ref: Blood-based Biomarkers at Large Bowel Endoscopy and Prediction of Future Malignancies. PMID: 26526637 Ref: Molecular pathological epidemiology of colorectal cancer in Chinese patients with KRAS and BRAF mutations. PMID: 26530529 Ref: Detection of AKR1B10 in Peripheral Blood by Anti-AKR1B10-Conjugated CdTe/CdS Quantum Dots. PMID: 26554246 Ref: The Trend of CEACAM3 Blood Expression as Number Index of the CTCs in the Colorectal Cancer Perioperative Course. PMID: 26556959 Ref: Elevated CA19-9 as the Most Significant Prognostic Factor in Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy. PMID: 26559251 Ref: Predictors of Pathologic Complete Response in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation. PMID: 26559272 Ref: Prognostic value of regulator of G-protein signaling 6 in colorectal cancer. PMID: 26653562 Ref: Blood CEA levels for detecting recurrent colorectal cancer. PMID: 26661580 Ref: Predictors of Complete Response and Disease Recurrence Following Chemoradiation for Rectal Cancer. PMID: 26734570 Ref: Prognostic significance of Glasgow prognostic score in patients with stage II colorectal cancer. PMID: 26770545 Ref: [The Different Indications and Treatment Effect between Preoperative Chemotherapy and Preoperative Radiotherapy for Advanced Rectal Cancer]. PMID: 26805068 Ref: [A Case of Ascending Colon Cancer with Extra Iliac Lymph Node Metastases]. PMID: 26805282 Ref: [A Case of Abdominal Wall Hernia Rupture during Bevacizumab Treatment]. PMID: 26805294 Ref: [A Case of Bladder Adenocarcinoma with Rectal Metastasis]. PMID: 26805326 Ref: Clinical significance of serum claudin-1 and claudin-7 levels in patients with colorectal cancer. PMID: 26807230 Ref: Combined assays for serum carcinoembryonic antigen and microRNA-17-3p offer improved diagnostic potential for stage I/II colon cancer. PMID: 26807240 Ref: Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients. PMID: 26823815 Ref: The Significance of Combined Measurement of p53 Antibody and other Tumor Markers for Colorectal Cancer after Curative Resection. PMID: 26897942 Ref: New Prognostic Indicator is Useful for Predicting the Survival of Patients with Unresectable Advanced Colorectal Cancer. PMID: 26902016 Ref: Potential Prognostic Impact of Baseline CEA Level and Surgery of Primary Tumor Among Patients with Synchronous Stage IV Colorectal Cancer: A Large Population Based Study. PMID: 27217664 |
Ref: Feasibility of mesorectal vascular invasion in predicting early distant metastasis in patients with stage T3 rectal cancer based on rectal MRI. PMID: 26017737 Ref: [Prognostic value of preoperative carcinoembryogenic antigen: Is it useful in all stages of colorectal cancer?]. PMID: 26117267 Ref: Prognostic Factors for Survival after Resection of Pulmonary Metastases from Colorectal Carcinoma. PMID: 26289631 Ref: Prognostic factors for patients with stage II colon cancer: results of a prospective study. PMID: 26474869 Ref: Predictive value of blood lipid association with response to neoadjuvant chemoradiotherapy in colorectal cancer. PMID: 26531721 Ref: Watch and Wait?--Elevated Pretreatment CEA Is Associated with Decreased Pathological Complete Response in Rectal Cancer. PMID: 26546119 Ref: Is there a survival benefit from increased intensity of CEA monitoring after primary resection of colorectal cancer? PMID: 26560023 Ref: A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma. PMID: 26578734 Ref: Reply to: Is there survival benefit from increased intensity for CEA monitoring after primary resection of colorectal cancer? PMID: 26585466 Ref: NIK- and IKKbeta-binding protein promotes colon cancer metastasis by activating the classical NF-kappaB pathway and MMPs. PMID: 26596835 Ref: Management of resectable colorectal lung metastases. PMID: 26659389 Ref: The diagnostic accuracy of carcinoembryonic antigen to detect colorectal cancer recurrence - A systematic review. PMID: 26700203 Ref: Epithelial but not stromal expression of collagen alpha-1(III) is a diagnostic and prognostic indicator of colorectal carcinoma. PMID: 26741506 Ref: Study on colorectal cancer presentation, treatment and follow-up. PMID: 26744064 Ref: The association between preoperative serum CEA concentrations and synchronous liver metastasis in colorectal cancer patients. PMID: 26756614 Ref: Cost-effectiveness of a carcinoembryonic antigen (CEA) based follow-up programme for colorectal cancer (the CEA Watch trial). PMID: 26757353 Ref: Evaluating the Prognostic Role of Elevated Preoperative Carcinoembryonic Antigen Levels in Colon Cancer Patients: Results from the National Cancer Database. PMID: 26759308 Ref: Significance of histologic tumor grade in rectal cancer treated with preoperative chemoradiotherapy followed by curative surgery: A multi-institutional retrospective study. PMID: 26763136 Ref: Video-Assisted Thoracoscopic Pulmonary Metastasectomy in Patients with Colorectal Cancer: A Recent 10-Year Single-Institution Experience. PMID: 26830908 Ref: Micrometastasis Volume in Lymph Nodes Determines Disease Recurrence Rate of Stage II Colorectal Cancer: A Prospective Multicenter Trial. PMID: 26831719 Ref: TNMF versus TNM in staging of colorectal cancer. PMID: 26836283 Ref: Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patients. PMID: 26837580 Ref: Predictors of circumferential resection margin involvement in surgically resected rectal cancer: A retrospective review of 23,464 patients in the US National Cancer Database. PMID: 26906328 Ref: A predictive nomogram improved diagnostic accuracy and interobserver agreement of perirectal lymph nodes metastases in rectal cancer. PMID: 26910373 Ref: Increased serological cancer-associated biomarker levels at large bowel endoscopy and risk of subsequent primary cancer (dagger). PMID: 26918701 Ref: Three-year monitoring of serum p53 antibody during chemotherapy and surgery for stage IV rectal cancer. PMID: 26919859 Ref: Repeat pulmonary resection for recurrent lung metastases from colorectal cancer: an analysis of prognostic factors. PMID: 26920721 Ref: Clinicopathological characteristics and prognosis of schistosomal colorectal cancer. PMID: 26922912 Ref: Correlation of the Serum Level of Carcinoembryonic Antigen and Prolactin with Different Stages of Colorectal Carcinoma According to Dukes' Staging. PMID: 26931251 Ref: [The effect of patterns of recurrence after radical resection of rectal cancer on long-term survival after recurrence]. PMID: 26932856 Ref: Short-term Outcomes of an Extralevator Abdominoperineal Resection in the Prone Position Compared With a Conventional Abdominoperineal Resection for Advanced Low Rectal Cancer: The Early Experience at a Single Institution. PMID: 26962531 Ref: Prognosis Can Be Predicted More Accurately Using Pre- and Postchemoradiotherapy Carcinoembryonic Antigen Levels Compared to Only Prechemoradiotherapy Carcinoembryonic Antigen Level in Locally Advanced Rectal Cancer Patients Who Received Neoadjuvant Chemor PMID: 26962798 Ref: Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy. PMID: 26976996 Ref: Multiplex determination of serological signatures in the sera of colorectal cancer patients using hydrogel biochips. PMID: 26992329 Ref: Comparative study of tumor markers in patients with colorectal carcinoma before and after chemotherapy. PMID: 27004218 Ref: Systematic review: brain metastases from colorectal cancer--Incidence and patient characteristics. PMID: 27037031 Ref: Increased Free Circulating DNA Integrity Index as a Serum Biomarker in Patients with Colorectal Carcinoma. PMID: 27039817 Ref: Different risk factors for advanced colorectal neoplasm in young adults. PMID: 27053853 Ref: Overexpression of Anillin (ANLN) is correlated with colorectal cancer progression and poor prognosis. PMID: 27062703 Ref: Predictive Value of CEA for Survival in Stage I Rectal Cancer: a Population-Based Propensity Score-Matched Analysis. PMID: 27067235 Ref: Pretreatment magnetic resonance imaging of regional lymph nodes with carcinoembryonic antigen in prediction of synchronous distant metastasis in patients with rectal cancer. PMID: 27070083 Ref: Association of pretreatment serum carcinoembryonic antigen levels with chemoradiation-induced downstaging and downsizing of rectal cancer. PMID: 27073681 Ref: Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical Outcomes. PMID: 27091407 Ref: Dynamic assessment of carcinoembryonic antigen in the first month after liver resection for colorectal liver metastases as a rapid-recurrence predictor. PMID: 27100029 Ref: Mutational Profiles Reveal an Aberrant TGF-beta-CEA Regulated Pathway in Colon Adenomas. PMID: 27100181 Ref: [Association of preoperative platelet count with the prognosis of patients with colorectal cancer]. PMID: 27113174 Ref: Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study. PMID: 27116012 Ref: [Analysis of clinical predictive factors of pathologic complete response after neoadjuvant chemoradiotherapy in rectal cancer]. PMID: 27122460 Ref: Development and Clinical Validation of a Blood Test Based on 29-Gene Expression for Early Detection of Colorectal Cancer. PMID: 27126992 Ref: ZKSCAN3 Facilitates Liver Metastasis of Colorectal Cancer Associated with CEA-expressing Tumor. PMID: 27127149 Ref: Can clinical factors be used as a selection tool for an organ-preserving strategy in rectal cancer? PMID: 27142064 Ref: Comparative evaluation of oncologic outcomes in colon cancer. PMID: 27142903 Ref: Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor. PMID: 27149134 Ref: Hydroxylated collagen peptide in urine as biomarker for detecting colorectal liver metastases. PMID: 27186406 Ref: Quantitative real-time detection of carcinoembryonic antigen (CEA) from pancreatic cyst fluid using 3-D surface molecular imprinting. PMID: 27193921 Ref: High copy number of mitochondrial DNA predicts poor prognosis in patients with advanced stage colon cancer. PMID: 27197581 Ref: [Analysis of the factors in the disease-free interval of metachronous pulmonary metastasis from rectal cancer]. PMID: 27215527 Ref: Charting a course through the CEAs: diagnosis and management of medullary thyroid cancer. PMID: 27230389 Ref: Relation between Carcinoembryonic Antigen Levels in Colon Cancer Tissue and Serum Carcinoembryonic Antigen Levels at Initial Surgery and Recurrence. PMID: 27260164 Ref: Detection of Biomarkers with Solid-Phase Proximity Ligation Assay in Patients with Colorectal Cancer. PMID: 27267845 Ref: Comparative expression patterns and diagnostic efficacies of SR splicing factors and HNRNPA1 in gastric and colorectal cancer. PMID: 27282379 Ref: Pattern of tumour growth of the primary colon cancer predicts long-term outcome after resection of liver metastases. PMID: 27306604 Ref: The Prognostic Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Colorectal Cancer. PMID: 27307087 Ref: HOTAIRM1 as a potential biomarker for diagnosis of colorectal cancer functions the role in the tumour suppressor. PMID: 27307307 Ref: The impact of body mass index on oncological outcomes in colorectal cancer patients with curative intent. PMID: 27402104 Ref: Analysis of circulating tumor cells in colorectal cancer liver metastasis patients before and after cryosurgery. PMID: 27415969 Ref: Exosomes from human colorectal cancer induce a tumor-like behavior in colonic mesenchymal stromal cells. PMID: 27418137 Ref: An Optically-Transparent Aptamer-Based Detection System for Colon Cancer Applications Using Gold Nanoparticles Electrodeposited on Indium Tin Oxide. PMID: 27420059 Ref: A Simple Scoring System Predicting the Survival Time of Patients with Bone Metastases after RT. PMID: 27438606 Ref: Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system. PMID: 27439702 Ref: Expression of MCRS1 and MCRS2 and their correlation with serum carcinoembryonic antigen in colorectal cancer. PMID: 27446248 Ref: Elevated Level of Serum Carcinoembryonic Antigen (CEA) and Search for a Malignancy: A Case Report. PMID: 27446768 Ref: Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer. PMID: 27459628 Ref: Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Colorectal Cancer. PMID: 27466527 Ref: The clinical impact of ICOS signal in colorectal cancer patients. PMID: 27467961 Ref: Carcinoembryonic Antigen Expression and Resistance to Radiation and 5-Fluorouracil-Induced Apoptosis and Autophagy. PMID: 27478804 Ref: Tumor markers used in monitoring the tumor recurrence in patients with colorectal cancer. PMID: 27547057 Ref: Reverse Fluorescence Enhancement and Colorimetric Bimodal Signal Readout Immunochromatography Test Strip for Ultrasensitive Large-Scale Screening and Postoperative Monitoring. PMID: 27547984 Ref: Postoperative carcinoembryonic antigen level has a prognostic value for distant metastasis and survival in rectal cancer patients who receive preoperative chemoradiotherapy and curative surgery: a retrospective multi-institutional analysis. PMID: 27553616 Ref: A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment. PMID: 27558635 Ref: Are there recognized prognostic factors for patients undergoing pulmonary metastasectomy for colorectal carcinoma? PMID: 27572615 Ref: Contrast-enhanced ultrasound improves accurate identification of appendiceal mucinous adenocarcinoma in an old patient: A case report. PMID: 27583883 Ref: Identification of long noncoding RNAs as potential novel diagnosis and prognosis biomarkers in colorectal cancer. PMID: 27591862 Ref: Different clinical characteristics in sporadic young-age onset colorectal cancer. PMID: 27631240 Ref: D-Dimer and Carcinoembryonic Antigen Levels: Useful Indicators for Predicting the Tumor Stage and Postoperative Survival. PMID: 27651789 Ref: Time to lowest postoperative carcinoembryonic antigen level is predictive on survival outcome in rectal cancer. PMID: 27658525 Ref: Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection. PMID: 27664887 Ref: Blood Measurement of Carcinoembryonic Antigen Level for Detecting Recurrence of Colorectal Cancer. PMID: 27673308 Ref: Evaluation of antibody level against Fusobacterium nucleatum in the serological diagnosis of colorectal cancer. PMID: 27678333 Ref: Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls. PMID: 27683121 Ref: Circulating and tissue galectin-1 and galectin-3 in colorectal carcinoma: association with clinicopathological parameters, serum CEA, IL-17 and IL23. PMID: 27685917 Ref: [Prognostic value of preoperative carcinoembryonic antigen level in patients with stage I-III colorectal cancer]. PMID: 27687665 Ref: High preoperative serum CA19-9 level is predictive of poor prognosis for patients with colorectal liver oligometastases undergoing hepatic resection. PMID: 27722895 Ref: Late sacral recurrence of rectal cancer treated by heavy ion radiotherapy: a case report. PMID: 27726113 Ref: A cross-sectional study comparing a blood test for methylated BCAT1 and IKZF1 tumor-derived DNA with CEA for detection of recurrent colorectal cancer. PMID: 27726312 Ref: Prognostic risk factors in patients with bone metastasis from colorectal cancer. PMID: 27734341 Ref: Pseudo-Meigs' syndrome due to ovarian metastases from colon cancer: a case report and review of the literature. PMID: 27734419 Ref: Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging. PMID: 27742904 Ref: CD133+CD54+CD44+ circulating tumor cells as a biomarker of treatment selection and liver metastasis in patients with colorectal cancer. PMID: 27764803 Ref: [Predictive value of Glasgow prognostic score in patients with colorectal cancer undergoing laparoscopic radical resection]. PMID: 27781250 Ref: The CEA-/lo colorectal cancer cell population harbors cancer stem cells and metastatic cells. PMID: 27813496 Ref: The Diagnostic and Prognostic Significance of Serum Neutrophil Gelatinase-Associated Lipocalin Levels in Patients with Colorectal Cancer. PMID: 27819647 Ref: Development of an FPW Biosensor with Low Insertion Loss and High Fabrication Yield for Detection of Carcinoembryonic Antigen. PMID: 27834798 Ref: Preoperative neutrophil-to-lymphocyte ratio and plateletto- lymphocyte ratio as new prognostic factors for patients with colorectal cancer. PMID: 27837617 Ref: [The relationship of A Proliferation-Inducing Ligand expression with the clinical pathology and prognosis in colorectal carcinoma]. PMID: 27852390 Ref: Efficacy of 18F-FDG PET/CT in investigation of elevated CEA without known primary malignancy. PMID: 27857471 Ref: Acrometastasis following colorectal cancer: A case report and review of literature. PMID: 27863343 Ref: Serum CA125 concentration as a predictor of peritoneal dissemination of colorectal cancer in men and women. PMID: 27893659 Ref: Relationship between serum uric acid and metastatic and nonmetastatic rectal cancer patients with undergoing no chemotherapy. PMID: 27893692 Ref: Evaluation of recurrent disease in the re-staging of colorectal cancer by (18)F-FDG PET/CT: Use of CEA and CA 19-9 in patient selection. PMID: 27895793 Ref: A nomogram improves AJCC stages for colorectal cancers by introducing CEA, modified lymph node ratio and negative lymph node count. PMID: 27941905 Ref: A Nomogram to Predict Adequate Lymph Node Recovery before Resection of Colorectal Cancer. PMID: 27992611 Ref: Elevated fibrinogen plasma level is not an independent predictor of poor prognosis in a large cohort of Western patients undergoing surgery for colorectal cancer. PMID: 28018106 Ref: Treatment Failure Following Complete Cytoreductive Surgery for Peritoneal Metastasis from Colorectal Cancer. PMID: 28133015 Ref: [The Significance and Limitations of Curative Resection for Peritoneal Metastases of Colorectal Cancer]. PMID: 28133018 Ref: [Examination to Determine Predictive Factors of Effectiveness of Surgical Treatment for Both Pulmonary and Hepatic Metastasis from Colorectal Cancer]. PMID: 28133029 Ref: [Prognostic Prediction Models for Liver Metastasis of Colorectal Cancer]. PMID: 28133031 Ref: [Pathological Complete Response in a Case of Multiple Liver Metastases from Rectal Cancer Treated with XELOX plus Bevacizumab(Bev)Therapy]. PMID: 28133117 Ref: Investigation of Efficacy Evaluation Comparison of cfDNA and CEA in Colorectal Cancer. PMID: 28164530 Ref: Predictive Value of Carcinoembryonic and Carbohydrate Antigen 19-9 Related to Some Clinical, Endoscopic and Histological Colorectal Cancer Characteristics. PMID: 28356884 Ref: Clinical observation and retrospective study of the influential factors of liver metastasis in 306 cases of colon cancer. PMID: 28485338 |
Ref: Transient elevation in serum carcinoembryonic antigen while on adjuvant chemotherapy for colon cancer: Is this of prognostic importance? PMID: 26245738 Ref: Evaluation of carcinoembryonic antigen (CEA) density as a prognostic factor for percutaneous ablation of pulmonary colorectal metastases. PMID: 27165139 Ref: The role of periodic serum CA19-9 test in surveillance after colorectal cancer surgery. PMID: 27503134 Ref: Predictive performance of TPA testing for recurrent disease during follow-up after curative intent surgery for colorectal carcinoma. PMID: 27522097 Ref: Combination of preoperative NLR, PLR and CEA could increase the diagnostic efficacy for I-III stage CRC. PMID: 27686880 Ref: Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer. PMID: 27699609 Ref: Inferior mesenteric artery lymph node metastasis in rectal cancer treated with neoadjuvant chemoradiotherapy: Incidence, prediction and prognostic impact. PMID: 27717528 Ref: Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer. PMID: 27743169 Ref: Identification of Recurrence-Predictive Indicators in Stage I Colorectal Cancer. PMID: 27872975 Ref: Clinical Performance of CEA, CA19-9, CA15-3, CA125 and AFP in Gastrointestinal Cancer Using LOCI-based Assays. PMID: 28011514 Ref: Circadian Rhythm of Methylated Septin 9, Cell-Free DNA Amount and Tumor Markers in Colorectal Cancer Patients. PMID: 28035516 Ref: Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges. PMID: 28040600 Ref: The utility of tumor marker combination, including serum P53 antibody, in colorectal cancer treatment. PMID: 28062920 Ref: Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy. PMID: 28070168 Ref: [Improvement of prognostic and predictive network of colorectal cancer based upon the 8th edition of AJCC colorectal cancer staging system]. PMID: 28105615 Ref: Correlation of RUNX3 expression with microvessel density in colorectal adenocarcinoma tissues and clinical significance. PMID: 28107874 Ref: Accessing new prognostic significance of preoperative carcinoembryonic antigen in colorectal cancer receiving tumor resection: More than positive and negative. PMID: 28128739 Ref: A systematic review of the performance of the SEPT9 gene methylation assay in colorectal cancer screening, monitoring, diagnosis and prognosis. PMID: 28128742 Ref: Pre-treatment platelet counts as a prognostic and predictive factor in stage II and III rectal adenocarcinoma. PMID: 28144399 Ref: Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence. PMID: 28178692 Ref: Circulating MIC-1/GDF15 is a complementary screening biomarker with CEA and correlates with liver metastasis and poor survival in colorectal cancer. PMID: 28206963 Ref: Mutations in codons 12 and 13 of K-ras exon 2 in colorectal tumors of Saudi Arabian patients: frequency, clincopathological associations, and clinical outcomes. PMID: 28218784 Ref: Cardiac metastasis from colon cancer effectively treated with 5-fluorouracil, leucovorin, and oxaliplatin (modified FOLFOX6) plus panitumumab: a case report. PMID: 28228152 Ref: Lymph Node Ratio as a Risk Factor for Recurrence After Adjuvant Chemotherapy in Stage III Colorectal Cancer. PMID: 28251467 Ref: The Evaluation of Colorectal Cancer Risk in Serum by anti-DESMIN-conjugated CdTe/CdS Quantum Dots. PMID: 28271681 Ref: The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial. PMID: 28282381 Ref: Incorporation of CEA Improves Risk Stratification in Stage II Colon Cancer. PMID: 28290141 Ref: Inflammation-based prognostic scores as indicators to select candidates for primary site resection followed by multimodal therapy among colorectal cancer patients with multiple metastases. PMID: 28299463 Ref: Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients? PMID: 28315907 Ref: [Assessment of predictive factors for survival in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy]. PMID: 28316153 Ref: Prognosis of ulcerative colitis colorectal cancer vs. sporadic colorectal cancer: propensity score matching analysis. PMID: 28327112 Ref: Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer. PMID: 28344808 Ref: Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA(+) Metastatic Colorectal Cancers. PMID: 28366766 Ref: Study on specificity of colon carcinoma-associated serum markers and establishment of SVM prediction model. PMID: 28386191 Ref: High expression of atonal homolog 8 predicts a poor clinical outcome in patients with colorectal cancer and contributes to tumor progression. PMID: 28393252 Ref: Circulating DNA Demonstrates Convergent Evolution and Common Resistance Mechanisms during Treatment of Colorectal Cancer. PMID: 28400427 Ref: Analysis of gene expression EGFR and KRAS, microRNA-21 and microRNA-203 in patients with colon and rectal cancer and correlation with clinical outcome and prognostic factors. PMID: 28403349 Ref: Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer. PMID: 28404964 Ref: Diagnostic value evaluation of trefoil factors family 3 for the early detection of colorectal cancer. PMID: 28405143 Ref: Nomograms for predicting the prognostic value of serological tumor biomarkers in colorectal cancer patients after radical resection. PMID: 28417967 Ref: Establishment of human metastatic colorectal cancer model in rabbit liver: A pilot study. PMID: 28475639 Ref: Use of a combination of CEA and tumor budding to identify high-risk patients with stage II colon cancer. PMID: 28478638 Ref: Application and Indication of Carcinoembryonic Antigen Triggered 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scanning in the Detection of Relapse of Colorectal Cancer Patients After Curative Therapy. PMID: 28481810 Ref: Role of family history and tumor location on prognosis of patients with colorectal cancer and synchronous metastases. PMID: 28493008 Ref: Enhanced detection sensitivity of carcinoembryonic antigen on a plasmonic nanoimmunosensor by transmission grating-based total internal reflection scattering microscopy. PMID: 28494367 Ref: High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer. PMID: 28498444 Ref: Colorectal cancer presenting as bone metastasis. PMID: 28508837 Ref: [Predictive value of serum carcinoembryonic antigen level in efficacy and prognosis for patients with rectal cancer following preoperative radiochemotherapy]. PMID: 28534328 Ref: SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery. PMID: 28577721 Ref: Correlation Between Preoperative Serum Carcinoembryonic Antigen Levels and Expression on Pancreatic and Rectal Cancer Tissue. PMID: 28579847 Ref: The Roles of Carcinoembryonic Antigen in Liver Metastasis and Therapeutic Approaches. PMID: 28588612 Ref: Factors Requiring Adjustment in the Interpretation of Serum Carcinoembryonic Antigen: A Cross-Sectional Study of 18,131 Healthy Nonsmokers. PMID: 28596788 Ref: What carcinoembryonic antigen level should trigger further investigation during colorectal cancer follow-up? A systematic review and secondary analysis of a randomised controlled trial. PMID: 28617240 Ref: A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent. PMID: 28641703 Ref: Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer. PMID: 28646161 Ref: Prognostic Impact of Intra-abdominal/Pelvic Inflammation After Radical Surgery for Locally Recurrent Rectal Cancer. PMID: 28682968 Ref: Combined Detection of Preoperative Neutrophil-to-Lymphocyte Ratio and CEA as an Independent Prognostic Factor in Nonmetastatic Patients Undergoing Colorectal Cancer Resection Is Superior to NLR or CEA Alone. PMID: 28685148 Ref: Trifluridine/tipiracil increases survival rates in peritoneal dissemination mouse models of human colorectal and gastric cancer. PMID: 28693216 Ref: Effect of adjuvant chemotherapy after pulmonary metastasectomy on the prognosis of colorectal cancer. PMID: 28702182 Ref: [Association of RAS mutations in circulating cell-free DNA in the plasma with clinicopathological features of colorectal cancer]. PMID: 28736377 Ref: The importance of a multidisciplinary team in rectal cancer management. PMID: 28781524 Ref: Serum CEA and CA 19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia. PMID: 28792134 Ref: Expression and clinical significance of absent in melanoma 2 in colorectal cancer. PMID: 28802238 Ref: Prognostic efficacy of inflammation-based markers in patients with curative colorectal cancer resection. PMID: 28808503 Ref: Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome. PMID: 28811829 Ref: Clinical implications of carcinoembryonic antigen distribution in serum exosomal fraction-Measurement by ELISA. PMID: 28817685 Ref: [Comparison of oncology outcomes and anal function among laparoscopic partial, subtotal and total intersphincteric resection for low rectal cancers]. PMID: 28836252 Ref: Clinical significance of serum anti-p53 antibody expression following curative surgery for colorectal cancer. PMID: 28855992 Ref: Examining colorectal cancer survivors' surveillance patterns and experiences of care: a SEER-CAHPS study. PMID: 28866818 Ref: Serum human epididymis protein 4 levels in colorectal cancer patients. PMID: 28894584 Ref: Prospective study on diagnostic and prognostic significance of postoperative FDG PET/CT in recurrent colorectal carcinoma patients: comparison with MRI and tumor markers. PMID: 28895416 Ref: Pre-operative to post-operative serum carcinoembryonic antigen ratio is a prognostic indicator in colorectal cancer. PMID: 28903373 Ref: Development and validation of a preoperative prediction model for colorectal cancer T-staging based on MDCT images and clinical information. PMID: 28903421 Ref: [The value of serum human tumor protein P53 in colorectal cancer combined diagnosis and postoperative monitoring]. PMID: 28910954 Ref: Expression of family with sequence similarity 172 member A and nucleotide-binding protein 1 is associated with the poor prognosis of colorectal carcinoma. PMID: 28927116 Ref: Beclin 1 and LC3 as predictive biomarkers for metastatic colorectal carcinoma. PMID: 28938618 Ref: Pathologic response after preoperative therapy predicts prognosis of Chinese colorectal cancer patients with liver metastases. PMID: 28969708 Ref: Detection of metastatic cancer cells in mesentery of colorectal cancer patients. PMID: 28974898 Ref: Circular RNA hsa_circ_0000745 may serve as a diagnostic marker for gastric cancer. PMID: 28974900 Ref: A nomogram predicting pathological complete response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer: implications for organ preservation strategies. PMID: 28978067 Ref: Serum CA19-9 as a marker of circulating tumor cells in first reflux blood of colorectal cancer patients. PMID: 28978084 Ref: Near-infrared-conjugated humanized anti-carcinoembryonic antigen antibody targets colon cancer in an orthotopic nude-mouse model. PMID: 28985840 Ref: Preoperative alkaline phosphatase elevation was associated with poor survival in colorectal cancer patients. PMID: 29030683 Ref: Invasive micropapillary carcinoma component is an independent prognosticator of poorer survival in Stage III colorectal cancer patients. PMID: 29036423 Ref: [Detection and clinical significance of circulating tumor cells in patients with colorectal carcinoma]. PMID: 29050178 Ref: [A Case of Bilateral Lymph Node Metastases of Rectal Cancer Treated with Chemotherapy and Surgery]. PMID: 29066682 Ref: Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach. PMID: 29079854 Ref: Left-sided primary tumor is a favorable prognostic factor for metastatic colorectal cancer patients receiving surgery. PMID: 29108341 Ref: [Hydrogel microchip as a tool for studying exosomes in human serum]. PMID: 29116068 Ref: Pulmonary metastasectomy: an overview. PMID: 29119017 Ref: Cell Line Secretome and Tumor Tissue Proteome Markers for Early Detection of Colorectal Cancer: A Systematic Review. PMID: 29144439 Ref: Correlations between microsatellite instability, ERCC1/XRCC1 polymorphism and clinical characteristics, and FOLFOX adjuvant chemotherapy effect of colorectal cancer patients. PMID: 29153096 Ref: Radiolabelled polymeric IgA: from biodistribution to a new molecular imaging tool in colorectal cancer lung metastases. PMID: 29156712 Ref: Colorectal Cancer in India: An Audit from a Tertiary Center in a Low Prevalence Area. PMID: 29203978 Ref: Sigmoidocolocystoplasty for neurogenic bladder reviewed after 20 years. PMID: 29223546 Ref: Density of CD8+ lymphocytes in biopsy samples combined with the circulating lymphocyte ratio predicts pathologic complete response to chemoradiotherapy for rectal cancer. PMID: 29225479 Ref: Retrospective study of predictors of bone metastasis in colorectal cancer patients. PMID: 29234589 Ref: Chemopreventive Potential of 2,3,5,4'-Tetrahydroxystilbene-2-O-beta-D-glucoside on the Formation of Aberrant Crypt Foci in Azoxymethane-Induced Colorectal Cancer in Rats. PMID: 29238715 Ref: Long-term survival after surgery for pulmonary metastases from colorectal cancer: an observational cohort study. PMID: 29268505 Ref: [Effect of adjuvant chemotherapy on the prognosis of stage II( colon cancer patients with high risk factors]. PMID: 29280121 Ref: [Establishment of nomogram model to predict peritoneal metastasis in colon cancer patients without distant metastasis by preoperative imaging examination]. PMID: 29280122 Ref: High CEA levels in a case of resected colorectal cancer: delayed diagnosis of metachronous medullary thyroid cancer. PMID: 29284496 Ref: Elevated CEA is associated with worse survival in recurrent rectal cancer. PMID: 29285304 Ref: Establishment and evaluation of four different types of patient-derived xenograft models. PMID: 29296105 Ref: Clinical Significance of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography/computed Tomography in the Follow-up of Colorectal Cancer: Searching off Approaches Increasing Specificity for Detection of Recurrence. PMID: 29333115 Ref: Surgical outcomes in patients with hepatic synchronous and metachronous colorectal metastases. PMID: 29339595 Ref: Prognostic value of lymph node metastasis in patients with T1-stage colorectal cancer from multiple centers in China. PMID: 29358866 Ref: EGFR expression in patients with stage III colorectal cancer after adjuvant chemotherapy and on cancer cell function. PMID: 29383110 Ref: Short-course neoadjuvant chemoradiotherapy and surgery are beneficial in Chinese patients: A retrospective study. PMID: 29390548 Ref: [A Case of Recurrence in the Posterior Wall of the Virginal after Radical Resection for Rectal Cancer Well Responded in a Long Period by Chemo-Radiotherapy]. PMID: 29394579 |
Ref: HSP70L1-mediated intracellular priming of dendritic cell vaccination induces more potent CTL response against cancer. PMID: 27345726 Ref: Significance of carcinoembryonic antigen mRNA in peritoneal lavage determined by transcription-reverse transcription concerted method in patients with low rectal cancer. PMID: 28291565 Ref: Impact of microRNA-375 and its target gene SMAD-7 polymorphism on susceptibility of colorectal cancer. PMID: 28374902 Ref: Clinicopathologic parameters associated with postoperative complications and risk factors for tumor recurrence and mortality after tumor resection of patients with colorectal cancer. PMID: 28710725 Ref: [Lung Metastasectomy in Pulmonary Metastatic Colorectal Carcinoma]. PMID: 28946155 Ref: MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progression. PMID: 28956178 Ref: Design, expression and evaluation of novel chimeric protein constructed from colorectal tumor-associated antigen. PMID: 29144000 Ref: The prognostic impact of serum bilirubin in stage IV colorectal cancer patients. PMID: 29168585 Ref: Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO). PMID: 29174568 Ref: Identification of mannose receptor and CD163 as novel biomarkers for colorectal cancer. PMID: 29226859 Ref: Cancer, Colon PMID: 29262132 Ref: CEA to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with colorectal cancer peritoneal carcinomatosis undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study. PMID: 29266235 Ref: Relations of Changes in Serum Carcinoembryonic Antigen Levels before and after Neoadjuvant Chemoradiotherapy and after Surgery to Histologic Response and Outcomes in Patients with Locally Advanced Rectal Cancer. PMID: 29268274 Ref: Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome. PMID: 29270608 Ref: Integrating Metal-Enhanced Fluorescence and Surface Acoustic Waves for Sensitive and Rapid Quantification of Cancer Biomarkers from Real Matrices. PMID: 29284267 Ref: Abnormal Golgi pH Homeostasis in Cancer Cells Impairs Apical Targeting of Carcinoembryonic Antigen by Inhibiting Its Glycosyl-Phosphatidylinositol Anchor-Mediated Association with Lipid Rafts. PMID: 29304557 Ref: Combined Hepatic and Pulmonary Metastasectomies From Colorectal Carcinoma. Data From the Prospective Spanish Registry 2008-2010. PMID: 29329933 Ref: Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study. PMID: 29361435 Ref: Serum microRNA signatures and metabolomics have high diagnostic value in colorectal cancer using two novel methods. PMID: 29363233 Ref: Correlation between circulating endothelial progenitor cells and serum carcinoembryonic antigen level in colorectal cancer. PMID: 29377980 Ref: Postoperative CEA is a better prognostic marker than CA19-9, hCGbeta or TATI after resection of colorectal liver metastases. PMID: 29378497 Ref: Disease recurrence following surgery for colorectal cancer: five-year follow-up. PMID: 29389929 Ref: Correlation Between Baseline Osteoprotegerin Serum Levels and Prognosis of Advanced-Stage Colorectal Cancer Patients. PMID: 29402836 Ref: Drug resistance related to aberrant glycosylation in colorectal cancer. PMID: 29416702 Ref: Hsa_circ_0001649: A circular RNA and potential novel biomarker for colorectal cancer. PMID: 29421663 Ref: Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer. PMID: 29426902 Ref: Effect of aspirin on the diagnostic accuracy of the faecal immunochemical test for colorectal advanced neoplasia. PMID: 29435322 Ref: Clinical significance and diagnostic capacity of serum TK1, CEA, CA 19-9 and CA 72-4 levels in gastric and colorectal cancer patients. PMID: 29483954 Ref: Case Report: CEA Elevation Can Be a Marker of Increased Inflammation During Treatment with Oxaliplatin. PMID: 29491106 Ref: Glycan analysis of colorectal cancer samples reveals stage-dependent changes in CEA glycosylation patterns. PMID: 29507546 Ref: Prognostic value of carcinoembryonic antigen level in patients with colorectal cancer liver metastasis treated with percutaneous microwave ablation under ultrasound guidance. PMID: 29517661 Ref: Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer. PMID: 29535803 Ref: TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer. PMID: 29540729 Ref: Monitoring colorectal cancer following surgery using plasma circulating tumor DNA. PMID: 29541205 Ref: Upper gastrointestinal malignancies in 2017: current perspectives and future approaches. PMID: 29542354 Ref: Individualized prediction of perineural invasion in colorectal cancer: development and validation of a radiomics prediction model. PMID: 29545718 Ref: Clinical laboratory and imaging evidence for effectiveness of agarose-agarose macrobeads containing stem-like cells derived from a mouse renal adenocarcinoma cell population (RMBs) in treatment-resistant, advanced metastatic colorectal cancer: Evaluation PMID: 29545721 Ref: New intra-abdominal mass after operation for colorectal cancer: desmoid tumor versus peritoneal seeding. PMID: 29550958 Ref: Age-related rates of colorectal cancer and the factors associated with overall survival. PMID: 29564176 Ref: A novel therapeutic strategy of personalized medicine based on anti-epidermal growth factor receptor monoclonal antibodies in patients with metastatic colorectal cancer. PMID: 29568913 Ref: [Relationship between the expression of DDX39 protein and prognosis of colorectal cancer]. PMID: 29577224 Ref: Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial. PMID: 29579327 Ref: Carcinoembryonic antigen as a marker of radioresistance in colorectal cancer: a potential role of macrophages. PMID: 29580202 Ref: Evaluating the Current Status of Rectal Cancer Care in the US: Where We Stand at the Start of the Commission on Cancer's National Accreditation Program for Rectal Cancer. PMID: 29580675 Ref: The Optimal Application of Transrectal Ultrasound in Staging of Rectal Cancer Following Neoadjuvant Therapy: A Pragmatic Study for Accuracy Investigation. PMID: 29581756 Ref: Is primary sidedness a prognostic factor in patients with resected colon cancer liver metastases (CLM)? PMID: 29611198 Ref: Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics. PMID: 29630649 Ref: Constructing a Novel Hypoxia-Inducible Bidirectional shRNA Expression Vector for Simultaneous Gene Silencing in Colorectal Cancer Gene Therapy. PMID: 29641253 Ref: The Assessment of Clinical Usage and Prognostic Value of YKL-40 Serum Levels in Patients With Rectal Cancer Without Distant Metastasis. PMID: 29642772 Ref: Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: a novel colorectal cancer marker. PMID: 29642865 Ref: [A Case of Colon Cancer with Brain, Liver and Lung Metastasis Successfully Treated with Bevacizumab plus Xelox Therapy]. PMID: 29650925 Ref: Predictive Nomograms for Synchronous Distant Metastasis in Rectal Cancer. PMID: 29663304 Ref: Surface plasmon resonance sensing with adjustable sensitivity based on a flexible liquid core coupling unit. PMID: 29674070 Ref: Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio Are Not Prognostic Biomarkers in Rectal Cancer Patients with Curative Resection. PMID: 29687424 Ref: Prognostic scores for colorectal cancer with peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. PMID: 29695209 Ref: Serum FBLN1 and STK31 as biomarkers of colorectal cancer and their ability to noninvasively differentiate colorectal cancer from benign polyps. PMID: 29715435 Ref: Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data. PMID: 29721106 Ref: The family of apoptosis-stimulating proteins of p53 is dysregulated in colorectal cancer patients. PMID: 29731851 Ref: Clinical value of a diagnostic score for colon cancer based on serum CEA, CA19-9, cytokeratin-1 and mucin-1. PMID: 29734875 Ref: Serum CEA and CA19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia. PMID: 29739122 Ref: Mean Corpuscular Volume as a Predictive Factor of Response to Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer. PMID: 29743887 Ref: Mina53 nuclear localization is an important indicator of prognosis in patients with colorectal cancer after adjuvant chemotherapy. PMID: 29750310 Ref: Analysis of unexplained carcinoembryonic antigen elevation after curative treatment of locally advanced rectal cancer. PMID: 29774483 Ref: Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer. PMID: 29800181 Ref: Serum Levels of TRIM72 Are Lower among Patients with Colon Cancer: Identification of a Potential Diagnostic Marker. PMID: 29806630 Ref: Clean Colorectum at Diagnostic Colonoscopy: Subsequent Detection of Extracolonic Malignancies by Plasma Protein Biomarkers? PMID: 29872358 Ref: Evaluation of appropriate follow-up after curative surgery for patients with colorectal cancer using time to recurrence and survival after recurrence: a retrospective multicenter study. PMID: 29876002 Ref: Surgical treatment of pulmonary metastasis in colorectal cancer patients: Current practice and results. PMID: 29891107 Ref: Persistent elevation of carcinoembryonic antigen as first presentation of a medullary thyroid carcinoma. PMID: 29895542 Ref: Identification of Serum Periostin as a Potential Diagnostic and Prognostic Marker for Colorectal Cancer. PMID: 29945311 Ref: Autonomic dysregulation in colon cancer patients. PMID: 29953262 Ref: Validation of Assaying Carcinoembryonic Antigen in Human Serum by Using Immunomagnetic Reduction. PMID: 29968766 Ref: Circulating PIWI-Interacting RNAs piR-5937 and piR-28876 Are Promising Diagnostic Biomarkers of Colon Cancer. PMID: 29976566 Ref: Clinical Impact of Preoperative Albumin-Globulin Ratio in Patients with Rectal Cancer Treated with Preoperative Chemoradiotherapy. PMID: 29996133 Ref: Carcinoembryonic antigen-positive pleural effusion in early stage non-small cell lung cancer without pleural infiltration. PMID: 29997989 Ref: Assessment of risk factors affecting mortality in patients with colorectal cancer. PMID: 30002769 Ref: Ultrasound/CT combined with serum CEA/CA19.9 in the diagnosis and prognosis of rectal cancer. PMID: 30003724 Ref: Value of combined detection of serum carcino-embryonic antigen, carbohydrate antigen 19-9 and cyclooxygenase-2 in the diagnosis of colorectal cancer. PMID: 30008836 Ref: Diagnostic Value of Methylated Septin9 for Colorectal Cancer Detection. PMID: 30013949 Ref: NOTCH4 Is a Novel Prognostic Marker that Correlates with Colorectal Cancer Progression and Prognosis. PMID: 30026833 Ref: Impact of primary tumour location and RAS/BRAF mutational status in metastatic colorectal cancer treated with first-line regimens containing oxaliplatin and bevacizumab: Prognostic factors from the AIO KRK0207 first-line and maintenance therapy trial. PMID: 30036739 Ref: The blood mSEPT9 is capable of assessing the surgical therapeutic effect and the prognosis of colorectal cancer. PMID: 30043648 Ref: Circulating fibrinogen to pre-albumin ratio is a promising biomarker for diagnosis of colorectal cancer. PMID: 30047185 Ref: Preoperative circulating FPR and CCF score are promising biomarkers for predicting clinical outcome of stage II-III colorectal cancer patients. PMID: 30050325 Ref: Aberrant expression of Rab1A and its prognostic significance in human colorectal cancer. PMID: 30058685 Ref: High expression of Ras-related protein 1A promotes an aggressive phenotype in colorectal cancer via PTEN/FOXO3/CCND1 pathway. PMID: 30064475 Ref: Pre-operative carcinoembryonic antigen predicts survival following colorectal cancer surgery with curative intent. PMID: 30066426 Ref: Serum CNPY2 isoform 2 represents a novel biomarker for early detection of colorectal cancer. PMID: 30070972 Ref: Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells. PMID: 30075754 Ref: Intersphincteric Resection Has Similar Long-term Oncologic Outcomes Compared With Abdominoperineal Resection for Low Rectal Cancer Without Preoperative Therapy: Results of Propensity Score Analyses. PMID: 30086052 Ref: Evaluation of platelet indices as diagnostic biomarkers for colorectal cancer. PMID: 30087357 Ref: Analysis of Clinical characteristics to predict pathologic complete response for patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. PMID: 30087709 Ref: Clinical significance of carcinoembryonic antigen in peritoneal fluid detected during operation in stage I-III colorectal cancer patients. PMID: 30090046 Ref: Carcinoembryonic antigen-targeted nanoparticles potentiate the delivery of anticancer drugs to colorectal cancer cells. PMID: 30110619 Ref: Readout-segmented echo-planar diffusion-weighted MR for the evaluation of aggressive characteristics of rectal cancer. PMID: 30135478 Ref: [Rapidly Developing Pulmonary Cyst Complicated by Pneumothorax Occurred in the Early Post-operative Period after Lung Segmentectomy]. PMID: 30185758 Ref: Alpha-fetoprotein-producing rectal cancer successfully responded to preoperative chemoradiotherapy: case report. PMID: 30191347 Ref: Predictive value of carcinoembryonic antigen and carbohydrate antigen 19-9 related to downstaging to stage 0-I after neoadjuvant chemoradiotherapy in locally advanced rectal cancer. PMID: 30214303 Ref: [Association of UCP2 rs659366 polymorphisms with the outcomes of patients after surgery for colorectal cancer]. PMID: 30226308 Ref: Extent of enhancement on multiphase contrast-enhanced CT images is a potential prognostic factor of stage I-III colon cancer. PMID: 30255251 Ref: Detection and differential diagnosis of cancer relapse using circulating tumor DNA profiling in a patient with synchronous breast and rectal cancer. PMID: 30257133 Ref: Combination of carcinoembryonic antigen with the American Joint Committee on Cancer TNM staging system in rectal cancer: a real-world and large population-based study. PMID: 30271165 Ref: TLR9 signaling activation at different stages in colorectal cancer and NF-kappaB expression. PMID: 30271180 Ref: The risk factors for bone metastases in patients with colorectal cancer. PMID: 30290664 Ref: The role of tissue and serum carcinoembryonic antigen in stages I to III of colorectal cancer-A retrospective cohort study. PMID: 30302946 Ref: Adherence to postresection colorectal cancer surveillance at National Cancer Institute-designated Comprehensive Cancer Centers. PMID: 30338661 Ref: Nadir/pre-chemoradiotherapy ratio of white blood-cell count can predict tumor response and recurrence-free survival in locally advanced rectal cancer: a multi-institutional analysis. PMID: 30350135 Ref: Clinical Value of Combined Determination of Serum B7-H4 with Carcinoembryonic Antigen, Osteopontin, or Tissue Polypeptide-Specific Antigen for the Diagnosis of Colorectal Cancer. PMID: 30363700 Ref: Prognostic Value of Progranulin in Patients with Colorectal Cancer Treated with Curative Resection. PMID: 30378010 Ref: Discovery of a diagnostic biomarker for colon cancer through proteomic profiling of small extracellular vesicles. PMID: 30382917 |